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T cell subsets 
CD3+ T cells can be divided in T helper and cytotoxic T cells based on the expression of 
CD4+ and CD8+, respectively (1,2). CD4+ and CD8+ T cell subsets can be further 
subdivided in two main subgroups, i.e. antigen-unexperienced (naïve) and antigen-
experienced (memory) cells. Naïve T cells express CD45RA and lack expression of 
CD45RO, whereas memory T cells loose expression of CD45RA and gain expression of 
CD45RO (3). Co-expression of the C-C chemokine receptor type 7 (CCR7) in combination 
with either CD45RA or CD45RO further differentiates naïve and memory T cells into 
CD45RA+CD45RO-CCR7+ naïve T cells (TNAIVE); CD45RA-CD45RO+CCR7+ central 
memory T cells (TCM); CD45RA-CD45RO+CCR7- effector memory T cells (TEM); and 
CD45RA+CD45RO-CCR7- terminally differentiated late effector memory T cells (TEMRA) 
(Figure 1).  
Figure 1.  Schematic model of T-cell differentiation subsets based 
on expression of  cell surface markers CD45RO and CCR7. 
TNAIVE cells are the truly naïve T-cells. TCM cells are antigen-
experienced cells that have a high proliferative capacity. TEM 
cells are highly differentiated memory cells of  the immune 
response, whereas TEMRA cells are terminally differentiated cells 
that may have lost part of their functional capacity (4).  
                                
Features of T-cell ageing 
Age related deterioration of the immune response, termed immunosenescence, involves a 
number of characteristic changes in the T-cell compartment. A schematic overview of the 
percentages of naïve, central memory, effector memory and TEMRA CD4+ and CD8+ cells is 
shown in Figure 2.  
 
 
Figure 2.  Pie chart depicting the distribution of 
the four different CD4+ and CD8+ T cell 
subsets (TNAIVE, TCM, TEM, TEMRA) of young and 
old healthy humans donors. Data is based on 
frequencies of T cell subsets found in Chapter 5. 
Percentage of naïve T cells decreases whereas 
the percentages of  TEM and TEMRA cells increases, 
these effects are most pronounced in CD8+ T 
cells. 
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trigger of age-related changes in the T-cell subset composition (Figure 3). Involution of the 
thymus starts early in life and results in a gradually diminished egress of newly produced 
TNAIVE cells into the periphery (5,6). However, the absolute number of CD4+ naïve T cells 
remains quite stable during life (5). This is achieved by post-thymic homeostatic 
proliferation of CD4+ TNAIVE cells (7).  Thus, the reduced output of CD4+ TNAIVE cells from 
the thymus with ageing is partly balanced by peripheral self-renewal.  
The process of peripheral self-renewal can be visualized by loss of  CD31 (PECAM-1) 
expression. CD31 is expressed by T cells that recently migrated from the thymus. CD31- 
TNAIVE cells, also referred to as central TNAIVE cells, are characterized by a reduced T cell 
receptor T-cell receptor excision circles (TREC) content. This suggest that CD31- TNAIVE 
cells result from peripheral proliferation. CD31 expression can thus be used to discriminate 
between peripherally expanded vs non expanded CD4+ TNAIVE cells (8,9). Upon ageing and 
prolonged naïve T-cell self-renewal, the number of CD4+CD31+ TNAIVE cells decreases, 
whereas the number of CD4+CD31- TNAIVE cells increases (7,10,11). CD8+ TNAIVE cells are 
characterized by a fast turnover. Although, no equivalent marker to CD31 has been 
identified so far, it is possible that a similar peripheral proliferating CD8 TNAIVE 
population exists. 
Figure 3.  Involution of the thymus results in lower output of CD4 and CD8 T cells. CD4+ TNAIVE 
cells persist due to post-thymic homeostatic proliferation. 
Introduction
13
During the course of T-cell ageing, the percentage of CD8+ TEMRA cells shows a marked
increase (12,13). CD8+ TEMRA cells may display a senescent phenotype, also characterized
by a consecutive loss of expression of CD28 and CD27 (Figure 4). Both CD27 and CD28
are important co-stimulatory receptors essential for an effective activation of the T-cell 
receptor (TCR) signaling pathway (14,15). In parallel, CD8+ TEMRA cells gain expression of
NK cell like receptors such as KLRG1 and CD57, which have been reported to characterize
exhausted / senescent T cells (14,16). Consistent with this phenotype, CD8+ TEMRA cells
show defective cognate cytokine responses and cytotoxic activity. Moreover, these cells do
not proliferate upon IL-2 stimulation and show a marked resistance to apoptosis (12,17). 
Experimental evidence suggests that accumulation of TEMRA cells is driven by chronic
antigenic stimulation by persistent viruses such as cytomegalovirus (CMV), herpes simplex
virus (HSV) and Epstein-Barr virus EBV (18,20). CD8+ TEMRA cells have been reported to
have a high capacity to proliferate in response to IL-15. In addition, IL-15 was shown to 
induce a marked downregulation of CD28 in CD8+CD27+CD45RA+CD28+CCR7+CD62L+
TNAIVE cells (21-23).  Although CD4+ TEM cells may develop towards a TEMRA phenotype, the 
number of CD4+ TEMRA cells in peripheral blood of elderly individuals is generally less 
pronounced than seen for CD8 TEMRA (14). CMV infection may accelerate the accumulation 
of CD4+ TEMRA cells. In clinical conditions, such as end stage kidney disease and in 
autoimmune disease, the accumulation of CD4+ TEMRA cells has been reported. CD4+
TEMRA cells also show expression of KLRG1 and decreased expression of CD27 and CD28.
In contrast to CD8+ TEMRA cells, loss of CD28 in CD4+ TEMRA is preceded by loss of CD27 
(24). 
Figure 4. Age-related differences in expression of T cell surface markers in CD4+ / CD8 TNAIVE
cells and CD4+ / CD8+ TEM cells. Bigger arrows indicate a more pronounced change in phenotype.
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MiRNAs and T-cell ageing 
MiRNAs are small non-coding RNA molecules of ~22 nucleotides that are processed from  
longer primary transcripts in two enzymatic steps (Figure 5). MiRNAs modulate protein 
expression at the post-transcriptional level. The specificity of a miRNA is mainly determined 
by the  seed sequence, i.e. nucleotide 2-8  of the miRNA (25,26). MiRNAs are instrumental 
for developmental processes, lineage commitment and fine-tuning homeostatic cellular 
processes. In the past decade, various miRNAs have been shown to play important 
regulatory functions in the immune system. Several of these studies suggest a profound 
impact of miRNAs on T-cell development, receptor responsiveness, activation and 
differentiation (27-31). Moreover, several miRNAs have been reported to regulate cytokine 
production and IL-2 signaling (32,33). Initial studies on the role of miRNAs in T cells were 
obtained upon a general disruption of miRNA processing in specific T cell subsets by 












Figure 5. The miRNA biogenesis pathway. The miRNA biogenesis starts with the transcription of the 
primary miRNA transcript (pri-miRNA) by RNA polymerase II. Based on the presence of a stem-loop 
like structure the pri-miRNA is cleaved by a complex of Drosha-DGCR8 in the nucleus. The resulting 
precursor (pre)-miRNA is exported from the nucleus into the cytoplasm by Exportin-5 / Ran-GPT. In the 
cytoplasm, the loop is cleaved from the stem by Dicer. One of the two strands of the double stranded 
miRNA is loaded into Argonaut 2 (Ago2) containing RNA-induced silencing complex (RISC) (shown in 
red). The other strand is degraded (shown in blue). The mature miRNA guides the RISC to its target 
mRNA and inhibits its translation into protein. 
True appreciation of the involvement of miRNAs in regulating cellular ageing has only 
recently been obtained. The first evidence of a role for miRNAs in ageing was reported on 




shown to change upon ageing in humans (36,37). MiRNAs with age-associated expression 
patterns have been reported to affect various aspects of the ageing process including the 
cellular energy balance, through regulation of insulin signaling and fat metabolism, and the 
DNA damage response (36). Functional implication of miRNAs in immune ageing has been 
shown by abnormal expression of miR-146a in macrophages of aged mice. This was 
associated with age-related defects in production of cytokines like IL-1β and IL-6 (38,39).  
More recently, age-associated differences in miRNA expression profiles have been reported 
in CD8+CD28- T cells and these changes were linked to T-cell replicative senescence (40). 
A function of both miR-181a and miR-24 has been documented in relation to T-cell 
responsiveness and susceptibility to the DNA damage repair pathway (41,42). Although 
these studies have provided evidence that miRNAs contribute to various aspects of T-cell 
ageing, current knowledge in this field of research is still limited and warrants further studies.   
 
Scope of the thesis 
The identification of specific miRNA expression signatures and their target gene repertoire in 
different cellular ageing models has set the stage to investigate the role of miRNAs in the 
physiology of T-cell ageing. The aim of this study was to investigate T cell activation induced 
kinetics of miRNA expression, define age-related expression signatures of miRNAs in 
defined T-cell subsets and to study the function of selected miRNAs in T-cell biology. In 
Chapter 2 we present an overview on the role of miRNAs in T-cell development, activation, 
differentiation and ageing. In Chapter 3, we studied regulation of selected miRNAs upon T-
cell activation. In Chapter 4 we utilized small RNA sequencing to identify miRNA expression 
changes in T-cell clones with high population doubling (senescent) compared to cells with 
lower population doublings (non-senescent), as a model for T-cell ageing. In Chapter 5, we 
studied miRNA expression signatures of T cells obtained from healthy young and elderly 
individuals. We focused on profiling of CD45RO- and CD45RO+ T cells and related the 
differentially expressed miRNA patterns to T-cell composition and activation. In Chapter 6 
we studied the possible involvement of the miR-23a~24-2 cluster in the IL-15-induced loss of 
CD28 expression in CD8 T cells. In Chapter 7 we identified functional targets of miR-21 
using a high throughput experimental target gene identification approach. Finally, in Chapter 
8 we summarize and discuss the findings of this thesis and place our findings in perspective 
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Micro (mi)RNAs are instrumental to many aspects of immunity, including various levels of T-
cell immunity. Over the last decade, crucial immune functions were shown to be regulated 
by specific miRNAs. These “immuno-miRs” regulate generic cell biological processes in T-
cells, such as proliferation and apoptosis, as well as a number of T-cell specific features 
that are fundamental to the development, differentiation and function of T-cells. In this 
review, we give an overview of the current literature with respect to the role of miRNAs at 
various stages of T-cell development, maturation, differentiation, activation and aging. 













1. MicroRNAs  
MicroRNAs (miRNAs) are single stranded ~22 nucleotides (nt) long non-coding RNAs that 
regulate gene expression at the post-transcriptional level. MiRNAs are encoded in host 
genes, which can be located in introns or exons of protein coding genes, as well as in non-
coding genes  (1). Biogenesis of miRNAs starts in the nucleus from a primary miRNA (pri-
miR) transcript, which folds into a secondary structure containing one or more hairpin loops 
(2) (Figure 1). These hairpin loops are recognized and cleaved by the microprocessor 
complex, composed of DiGeorge syndrome critical region 8 (DGCR8) and Drosha. This 
results in a stem loop precursor miRNA (pre-miR) of 60-70 nt (3). The pre-miR is 
subsequently transported to the cytoplasm where it undergoes a secondary processing step 
by Dicer resulting in a RNA duplex of 20-22 nt (2,4). The RNA duplex is incorporated into 
the RNA-induced silencing complex (RISC), where one of the strands undergoes 
degradation while the other forms the mature miRNA (5). By virtue of partial 
complementarity between the miRNA and its target mRNA, the miRNA guides the RISC to 
its target transcript (6). The miRNA:target gene binding is dependent on the degree of 
complementarity, which is usually high in the so-called seed sequence, i.e. the 5' end of the 
miRNA, and limited at the 3’ part. In general, the miRNA binds to the 3'UTR of its target 
mRNA transcript, but miRNAs can also bind to the 5’UTR and the coding region, albeit less 
frequent (7). Binding of RISC leads to translational inhibition or degradation of the targeted 
mRNA and, as a consequence, to a diminished protein expression (6,8) (Figure 1). To date, 
more than 24,500 mature miRNAs have been described in 206 species, of which more than 
2,500 in human (miRBase registry, release 20) (9). One miRNA can regulate expression of 
multiple genes and each gene can be regulated by more than one miRNA creating a 
complex network of interactions. As a consequence of this multi-specificity, up to 50% of the 
protein-coding genes are predicted to be under the control of miRNAs. It is evident that 
miRNAs play crucial roles in almost every known cellular process indicating the need for 
tight regulation (10). Tissue and cell type specific miRNA expression patterns resulting from 
both transcriptional as well as post-transcriptional regulation have been described 
(reviewed in (11)). In line with their important roles in most, if not all, cell physiological 
processes, deregulated expression of specific miRNAs has been implicated in development 
and progression of pathological conditions such as autoimmunity and cancer (12-15).  
Several studies have shown distinct miRNA expression patterns in hematopoietic stem and 
progenitor cells (HSPC), during differentiation and also in the mature hematopoietic cell 
lineages in both mouse and human (16,20). The significance of miRNAs for differentiation 
was first noted using conditional dicer deletion in embryonic stem cells and HSPC, which 
led to severe defects in the maturation of HSPC through increased apoptosis (21,22).  
A number of specific miRNAs were subsequently shown to be involved in hematopoiesis. 
Overexpression of miR-181a in HSPC resulted in an increased precursor cell commitment 
to the B-cell lineage (23). MiR-125a and miR-125b protect HSPCs from apoptosis and 
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(22,24). Conditional deletion of Dicer in hematopoietic progenitors and endothelial cells 
driven by the Tie-2 promoter resulted in impaired development and maturation of iNK/T-
cells (25). Based on these studies it has become evident that miRNAs play crucial roles in 
the hematopoietic system.   
 
Figure 1. Biogenesis of miRNAs.  MiRNAs are transcribed 
by polymerase II as long primary miRNA transcripts (pri-miRs) 
that form hairpin-like structures. These structures are 
recognized by the microprocessor complex, and cleaved by 
Drosha into a shorter (~60-70 nt) hairpin structure known as 
the precursor miRNA (pre-miR). The pre-miR is subsequently 
transported to the cytoplasm where it undergoes a second 
processing step by Dicer which releases the terminal loop 
leaving a miRNA-5p/miRNA-3p duplex. Upon incorporation 
into RNA-induced silencing complex (RISC), the RNA duplex 
is unwound, and one miRNA strand is degraded leaving a 
single stranded mature miRNA, which guides RISC to its 
target mRNA. Binding to a target transcript leads to 
translational inhibition or degradation and, as a consequence, 
to decreased protein expression. 
 
 
2. Immuno-miRs in thymic T-cell development  
Committed T-cell progenitors are produced in the bone marrow and migrate to the thymus 
where they undergo proliferation, T-cell receptor (TCR) rearrangements and differentiation 
to mature naïve T-cells (26). Based on the differential expression of the CD4 and CD8 co-
receptors, progenitor T-cells can be subdivided into double negative (DN) stage 1 to 4, 
double positive (DP) and CD4 or CD8 single positive (SP) T-cells (26). The development of 
T-cells in the thymus is controlled by a complex signaling network, which ensures proper 
induction of genes essential for T-cell maturation and depletion of auto-reactive T-cells. 
Transcription factors are responsible for the appropriate gene expression programs during 
T-cell lineage commitment. In addition to this, it has become evident that miRNAs mediate a 
crucial additional level of regulation.  
Dynamic regulation of miRNA expression in sequential stages of T-cell development is well 
documented (27). An overall increase in miRNA levels at early stages of T-cell maturation 
(DP stage) coincided with an increase in total cellular RNA content (27). However, 
individual miRNAs showed dynamic changes in distinct thymocyte subpopulations (DN, SP, 
DP) (27,28). In both studies, an inverse correlation was observed between an increase of 
individual miRNAs with a depletion of predicted target genes, suggesting that miRNAs play 
a role in thymocyte selection by regulating genes involved in TCR-induced apoptosis and 
survival signals.  




The biological relevance of miRNAs in T-cell development and function has been well 
established in vivo (29,30). Conditional deletion of Dicer at an early stage (DN to DP) of T-
cell development reduced the cellularity of DP thymocytes, which was driven mainly by 
reduced numbers and survival of αβ T-cells, whereas the number of γδ T-cells was not 
affected (29). Remarkably, while CD8 and CD4 SP T-cell numbers were decreased in the 
spleen and a reduction of total CD3+ T-cells was observed in the periphery, deletion of Dicer 
appeared to be dispensable for CD4 and CD8 commitment (29,30). Both studies clearly 
indicate the requirement of DICER, and thus of miRNAs for appropriate thymic T-cell 
development. 
Two miRNAs were studied in more detail with respect to their function in thymic T-cell 
maturation (28,31,32). Inhibition of miR-181a significantly impaired both positive and 
negative selection of DP cells (31). Its expression is high in immature T-cells (in particular at 
DP stage) and low in more differentiated Th1 and Th2 cells. MiR-181a repressed expression 
of a set of genes involved in T-cell maturation (TCRα, CD69, BCL-2) and as such regulated 
T-cell signaling and migration (27). Importantly, overexpression of miR-181a resulted in the 
development of low affinity peptide-specific T-cells by lowering the TCR signaling threshold 
(31). This indicates that the regulated expression of miR-181a during thymic development of 
immature T-cells contributes to the clonal deletion of autoreactive T-cells by modulating the 
TCR signaling threshold and survival of low-affinity peptide specific T-cells. The second 
miRNA studied specifically in relation to T-cell maturation is miR-150. MicroRNA expression 
profiling in human and mouse showed that miR-150 levels are strongly upregulated during 
T-cell maturation (28,33). Overexpression of miR-150 driven by a ubiquitously active 
promoter in miR-150 transgenic mice resulted in a block in early B-cell and thymic T-cell 
development. The transition from DN3 to DN4 was hampered, resulting in decreased 
numbers of CD4 and CD8 T-cells (33). The transcription factor c-Myb was shown to be an 
important miR-150 target that was downregulated in immature B and T cells upon miR-150 
overexpression. Besides c-Myb, miR-150 targets NOTCH3, a main regulator of T-cell 
differentiation, resulting in decreased T-cell proliferation and survival (28). In conclusion, 
there is convincing evidence that shows the significance of miRNAs in general and miR-
181a and miR-150 specifically in the process of T-cell maturation.  
 
3. Dynamic regulation of immuno-miRs during T-cell activation 
T-cell activation is initiated via TCR-MHC antigen complex interaction. The affinity of the 
TCR-MHC antigen complex interaction in combination with co-stimulatory signals provided 
by cell-cell interaction and cytokines, direct the T-cell response. Several miRNAs are 
regulated by transcription factors that are related to T-cell activation, such as NF-κB  (34,38) 
and PU.1 (39) (Figure 2). In addition, miR-21 was shown to be under positive transcriptional 
control of AP1 and STAT3 (40,42), while miR-155 was shown to be under positive 
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3. Dynamic regulation of immuno-miRs during T-cell activation 
T-cell activation is initiated via TCR-MHC antigen complex interaction. The affinity of the 
TCR-MHC antigen complex interaction in combination with co-stimulatory signals provided 
by cell-cell interaction and cytokines, direct the T-cell response. Several miRNAs are 
regulated by transcription factors that are related to T-cell activation, such as NF-κB  (34,38) 
and PU.1 (39) (Figure 2). In addition, miR-21 was shown to be under positive transcriptional 
control of AP1 and STAT3 (40,42), while miR-155 was shown to be under positive 





MiR-181a has shown to be a decisive factor in tuning the TCR signaling threshold by 
targeting multiple phosphatases, i.e. PTPN22, DUSP5, DUSP6 and SHP-2, involved in the 
regulation of kinase mediated TCR signaling (31). Indeed, miR-181a is highly 
overrepresented in immature thymocytes, which allows positive selection of immature 
thymocytes via low affinity TCR-MHC/antigen mediated signaling (described in paragraph 
2). 
IL-2 is an essential autocrine cytokine for T-cell activation. Regulation of the IL-2 signaling 
pathway involves multiple miRNAs including, miR-155, miR-181c, miR-9 and miR-31. MiR-
155 expression is markedly and quickly induced upon T-cell activation and enhances T-cell 
proliferation via direct targeting of the negative regulator of cytokine signaling SOCS1 (45) 
















Figure 2. Dynamic immuno-miR expression patterns regulate T-cell activation.  T-cell activation 
results in the dynamic regulation of several miRNAs. These miRNAs are involved directly (purple 
targets) or indirectly (blue targets) in the regulation of crucial aspects of T-cell activation, proliferation, 
survival, differentiation and cytokine signaling as depicted. Both negative and positive feed-back 
signaling circuits are activated resulting in a typical miRNA mediated fine-tuning of the T-cell response. 
In addition, miR-155 targets the negative regulator of T-cell activation CTLA-4 (46) indicating 
a second, independent route via which miR-155 promotes T-cell activation. MiR-181c has 




been shown to directly target IL-2 and by doing so modulates the activation state of T-cells 
(47). MiR-9 is enhanced upon activation of T-cells and results in a downregulation of 
BLIMP1 and BCL6 (48). Inhibition of miR-9 was shown to increase BLIMP1 and BCL6 levels 
and, as a consequence, to a decreased secretion of IL-2 and IFN-γ. MiR-31 has been 
shown to directly repress the NFκB-inducing kinase NIK and, as such, negatively regulates 
the non-canonical NFκB signaling (Figure 2) (49). In addition, it was shown that miR-31 
induces IL-2 expression in T-cells via targeting of the upstream kinase suppressor KSR2 
(50). Thus, miR-31 is involved in the acquisition of an activated T-cell phenotype. 
MiR-146a is induced upon TCR activation via activation of NFκB signaling and has, like 
many miRNAs, a dual regulatory function (34). MiR-146a regulates the TCR induced NF-kB 
signaling pathway via a negative feedback loop by directly regulating the levels of NF-kB 
signaling transducers TRAF6 and IRAK1. In addition, the delayed induction of miR-146a 
upon T-cell activation targets FADD and as such inhibits activation-induced T-cell death 
(51). 
MiR-21 has been widely studied in relation to its anti-apoptotic function, especially in cancer 
(52). MiR-21 expression is induced upon TCR triggering in the presence of co-stimulation 
and regulates several processes that are relevant for T-cell activation, such as apoptosis, 
proliferation and migration (53-55). Importantly, the regulatory function of miR-21 seems to 
depend on the differentiation status of the T-cell. Whereas miR-21 in activated memory T-
cells functions as an anti-apoptotic factor, in recently activated naïve T-cells miR-21 may be 
involved in regulating homing properties via targeting CCR7 (55). 
The miR-17~92 cluster is strongly induced in T-cells upon T-cell activation (56,57). 
Activation induced miR-17~92 promoted cell cycle progression of effector cells via targeting 
of PTEN. This resulted in enhanced mTOR signaling and mediated skewing towards short-
lived terminal effector cells. Failure to downregulate miR-17~92 resulted in a gradual loss of 
memory cells and defective central memory T-cell development (56). 
It is evident that TCR stimulation induces a marked change in miRNA pattern, and regulation 
of IL2 seems to be an essential role of the immuno-miRs involved in T cell activation. 
 
4. The role of immuno-miRs in peripheral T-cell subsets  
Differentiation of naïve CD4+ and CD8+ T-cells into memory, effector or regulatory T-cells is 
a dynamic process that depends on the presence of many environmental determinants. This 
differentiation results in a marked change in the transcriptional program and acquirement of 
lineage-specific functions (58,59). Several studies have shown that miRNAs are dynamically 
regulated during T-cell maturation and specific miRNA signatures were observed for 
specialized T-cell subsets (60-62). It should be noted that, although the overall miRNome of 
T-lymphocytes of mice and human is relatively well conserved there is a rather poor 
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    Table 1. Function of miRNAs in T-cell subset 
 
4.1 CD4+ T-cells  
Upon interaction with cognate antigen presented by antigen-presenting cells, such as 
dendritic cells (DCs), CD4+ T-cells can differentiate into a variety of effector subsets. 
Specific CD4+ T-cell subsets secrete cytokines to activate macrophages, cytotoxic T-cells 
and NK cells (Th1), stimulate B-cells and inflammation (Th2), enhance mucosal barrier 
functions (Th17), or suppress the immune response (Tregs), while others remain in 
lymphoid organs and help B-cells to differentiate into antibody secreting cells (Tfh). 
miRNA Subset Target(s) Effect Reference 
miR-10a Tfh BCL-6 Differentiation / maintenance 90 






 Th17 PTEN, IKZF4 Differentiation 72 
 Treg unknown Apoptosis / proliferation / Immunosuppression 57,82 
 Tfh PTEN, RORα, PHLPP2 Differentiation 88,89 






miR-126 Treg PIK3R2 Immunosuppression 85 
miR-130/301 CD8 CD69 Migration 91 
miR-132/212 Th17 BCL-6 Differentiation 71 
miR-139 CD8 Perforin, EOMES Cytotoxicity 92 
miR-142-3p Treg AC9 Immune supression 84 
miR-146a Treg STAT1 Proliferation/ Immunosuppression 83 
miR-155 CD8 SOCS1 Cytokine signaling 45,95-97 
 Th1/Th2 c-Maf, IFNGR1 Differentiation 65,66 
 Th17 unknown Differentiation 69 
 Treg SOCS1 Cytokine signaling 80,81 
miR-210 Th17 HIF-1α Differentiation 74 
miR-301 Th17 PIAS3 Differentiation 70 
miR-326 Th17 Ets1 Differentiation 73 




Th1 and  Th2 cells  
Th1 and Th2 cells develop from naïve CD4+ T-cells in response to cognate antigen and 
polarizing cytokines in the initiating phase of immune responses (63). Th1 cells are defined 
as IFN-γ producing cells and Th2 cells produce IL-4 and IL-5 but not IFN-γ.  
Deletion of Dicer in CD4+ T-cells results in a dramatic decrease in peripheral T-cells. T-
cells derived from Dicer deficient mice show impaired expansion and dysregulated cytokine 
expression upon Th1 and Th2 differentiation (30). In particular, repression of IFN-γ 
expression was impaired resulting in a Th1 skewed immune response (30).  One of the 
critical miRNAs that regulate differentiation towards Th-cells is miR-125b. MiR-125b is 
preferentially expressed in naïve CD4+ T-cells as compared to memory CD4+ T-cells.   
MiR-125b enforces the naïve T-cell state by regulating targets such as IFN-γ, IL10RA, 
IL2RB and BLIMP1 that all have a role in T-cell differentiation (60). 
The miR-17~92 cluster enhanced polarization towards a Th1 phenotype (64). MiR-19b, one 
of the six cluster members, was indispensible for IFN-γ production. Together with miR-17, 
another member of the cluster, miR-19b was critical in promoting Th1 responses and 
preventing differentiation into inducible Treg cells by targeting PTEN (miR-19b), TGFβRII 
and CREB1 (both miR-17) (64).  
Overexpression of miR-155 in activated CD4+ T-cells also promoted Th1 cell differentiation 
possibly by targeting the IFN-γ receptor alpha chain (IFNGR1) (65). MiR-155 deficient 
CD4+ T-cells on the other hand, were more prone to polarize towards Th2 cells (65,66). 
This was at least in part due to enhanced levels of the miR-155 target c-Maf, which is a 
potent transactivator of the Th2 specific cytokine IL-4 (66).  
A miRNA that can limit Th1 cell differentiation is miR-29. MiR-29 seed family members can 
rescue the aberrant IFN-γ expression of miRNA-deficient CD4+ T-cells by targeting the IFN-
γ inducing transcription factors T-bet and EOMES (67). Importantly, it was shown that miR-
29 can also directly target IFN-γ and miR-29b expression levels are enhanced by IFN-γ 
resulting in a negative feedback loop (68).  
Th17 cells 
The development of Th17 cells is stimulated by pro-inflammatory cytokines produced in 
response to bacteria and fungi. Several miRNAs have been shown to promote Th17 
differentiation. Mice deficient for miR-155 are characterized both by reduced numbers of 
Th1 and Th17 cells (69). Besides miR-155, miR-301 is also required for Th17 
differentiation. Th17 are characterized by relative high miR-301 expression levels in 
comparison to other T-cell subsets and in vitro differentiated T-cells (70). Inhibition of miR-
301 results in an impaired in vitro Th17 differentiation due to a decreased signaling in the 
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was shown to be a target of miR-301 and, in line with this, PIAS3 inhibition could 
phenocopy the effect of miR-301 upregulation.  
The miR-132/212 cluster enhances Th17 differentiation when induced via the Aryl 
hydrocarbon receptor under Th17 polarizing conditions (71). Inhibition of the miR-132/212 
cluster effectively repressed Th17 differentiation via lack of effective downregulation of the 
miR-132/212 target gene BCL6, which is a negative regulator of Th17 differentiation.  
Two miRNAs of the miR-17~92 cluster, i.e. miR-19b and miR-17, are critically involved in 
Th17 differentiation (72). MiR-19 was shown to act by targeting PTEN resulting in enhanced 
PI3K signaling and miR-17 inhibited IKZF4, a zinc finger transcription factor shown to 
negatively regulate Th17 differentiation.  
Compared to Th cells and inducible Treg cells, Th17 showed the highest miR-326 
expression and Th17 differentiation was promoted by increasing the levels of miR-326 (73). 
Ets1, a negative regulator of Th17 differentiation was identified as a functional target of 
miR-326 by showing that a “miR-326-resistant” Ets1 variant showed normal Th17 
differentiation. 
HIF-1α a key transcriptional regulator of Th17 cell differentiation, regulates expression of 
miR-210 (74). HIF-1α was in turn shown to be regulated by miR-210, resulting in a negative 
feedback loop. In line with these findings, T-cell specific deletion of miR-210 resulted in an 
increase in Th17 differentiation (74).  
Treg cells 
Regulatory T (Treg) cells play an essential role in controlling the immune response and 
preventing autoimmunity (75). Treg cells from both mice and human were shown to express 
a set of miRNAs that is distinct from conventional T-cells (61,62,76). Specifically, miR-146a 
and miR-21 are consistently higher expressed in Treg cells whereas the expression level of 
miR-31 is lower in Treg cells. Of note, in a detailed comprehensive analysis of miRNA 
expression profiles in naïve and memory regulatory and conventional T-cells, high miR-21 
expression was found to be restricted to the memory T-cell compartment (61). Thus, the 
widely reported high expression of miR-21 by Treg cells seems attributable to the 
predominant memory phenotype of Treg cells.  
Using a Foxp3 induced conditional Dicer KO, it was shown that miRNAs are essential for 
Treg mediated tolerance. These Foxp3 specific Dicer KO mice developed a spontaneous 
systemic autoimmune disease similar to Foxp3 KO mice (77-79). One of the miRNAs that 
has been implicated in the development of Tregs is miR-155, a miRNA that is induced by 
Foxp3 (80,81). MiR-155 KO mice have reduced Treg cell numbers without an apparent 
reduction in their suppressive function. The reduction in Treg cell numbers was explained 
by a reduced sensitivity to IL-2 signaling due to lack of suppression of the miR-155 target 
gene SOCS1 (80). Besides miR-155, a Foxp3 induced deficiency of the miR-17~92 cluster 
also resulted in reduced numbers of Treg cells due to decreased proliferation and increased 
apoptosis (82). The involvement of miR-17~92 in Treg cells, however, extends beyond 




promoting accumulation of antigen specific Treg cells. In later phases of the immune 
response, miR-17~92 controls Il-10 production and, possibly, migration (57). 
In contrast to miR-155 or miR-17~92 KO, miR-146a KO resulted in increased numbers of 
Treg cells (83). However, in vivo analysis of miR-146a deficient Treg cells in a miR-146a-
sufficient environment showed that these cells have a strongly impaired suppressive activity 
resulting in severe immune-mediated pathology. This phenotype was induced via the 
targeting of STAT1 by miR-146a. 
MiR-142-3p is negatively regulated by Foxp3 and the lower miR-142-3p levels in Treg cells 
results in higher levels of cAMP by targeting the cAMP producing enzyme Adenylyl Cyclase 
9 (84). Transfer of cAMP through gap junctions from Treg cells into conventional T-cells is a 
known suppressive mechanism employed by Treg cells.  
MiR-126 was shown to be a regulator of the suppressive activity of Treg cells (85). Inhibition 
of miR-126 leads to reduced Foxp3 expression by targeting PIK3R2,  a regulatory 
component of PI3K.   
Several other miRNAs, i.e. miR-24, miR-210 and miR-31, were shown to regulate Foxp3 by 
direct binding to the 3’UTR indicating that a network of miRNAs is involved in regulating the 
levels of Foxp3 expression (86,76).   
T follicular helper cells 
Th-cells that migrate towards sites of activated B-cells may be triggered to differentiate into 
follicular helper T-cells (Tfh). Tfh cells are antigen-experienced CD4+CXCR5+BCL6+PD1+ 
T-cells that have a critical role in germinal center formation and germinal center B cell 
maturation (87). So far only a few studies have addressed the role of microRNAs in the 
differentiation and/or function of Tfh cells (88-90).  
The miR-17~92 cluster is an important regulator of Tfh cell biology. Deletion of the miR-
17~92 cluster in CD4+ T-cells resulted in decreased numbers of Tfh and GC-B-cells upon 
viral infection while transgenic expression of this miRNA cluster resulted in increased 
numbers of both Tfh and GC-B-cells (88,89). The underlying mechanism included the miR-
17~92 target genes PTEN, nuclear receptor RORα and phosphatase PHLPP2. Deletion of 
one pten allele partially rescued the miR-17~92 KO phenotype, and deletion of one rora 
allele restored expression of several Tfh subset inappropriate genes (88). Inhibition of 
PHLPP2 in the KO background rescued Tfh differentiation while overexpression in wild type 
CD4+ T-cells impaired their ability to migrate to B-cell follicles but not to differentiate into 
Tfh cells (89). A second miRNA, linked to Tfh cell differentiation is miR-10a. MiR-10a 
targets BCL-6, which is essential for Tfh differentiation and maintenance. Inhibition of miR-
10a enhanced the conversion of inducible Treg to Tfh cells and overexpression could inhibit 
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T follicular helper cells 
Th-cells that migrate towards sites of activated B-cells may be triggered to differentiate into 
follicular helper T-cells (Tfh). Tfh cells are antigen-experienced CD4+CXCR5+BCL6+PD1+ 
T-cells that have a critical role in germinal center formation and germinal center B cell 
maturation (87). So far only a few studies have addressed the role of microRNAs in the 
differentiation and/or function of Tfh cells (88-90).  
The miR-17~92 cluster is an important regulator of Tfh cell biology. Deletion of the miR-
17~92 cluster in CD4+ T-cells resulted in decreased numbers of Tfh and GC-B-cells upon 
viral infection while transgenic expression of this miRNA cluster resulted in increased 
numbers of both Tfh and GC-B-cells (88,89). The underlying mechanism included the miR-
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10a enhanced the conversion of inducible Treg to Tfh cells and overexpression could inhibit 




Our current knowledge on how miRNAs affect the phenotype of Tfh cells is still limited. It 
may be anticipated that miRNAs targeting PD-1 and CXCR5, which are crucial for Tfh cells, 
will be important herein.   
4.2 CD8+ T-cells 
Differentiation of naïve CD8+ T-cells into effector or memory cytotoxic T-cells (CTLs) 
follows upon activation by interacting with antigen-presenting cells. Deletion of Dicer at the 
CD8 SP stage resulted in a lack of CD8 T-cell expansion upon antigenic challenge in vivo 
(91). These Dicer deficient T-cells showed prolonged expression of CD69 expression which 
was associated with a prolonged retention of the cells in lymph nodes.  
The increased CD69 expression in Dicer deficient T-cells could mechanistically be 
explained by targeting of CD69 by the miR-130/301 family which is strongly upregulated 
upon CD8+ T-cell activation (91). Others showed that activated murine CD8+ T-cells that 
lack Dicer have, next to the increase in CD69 expression, strongly enhanced expression of 
Perforin (92). MiR-139 was shown to regulate the expression of Perforin both directly, and 
indirectly via targeting of its transcriptional activator EOMES  (92). 
To further identify miRNAs that can explain the phenotype of Dicer deficient CD8+ T-cells, 
miRNA profiles were generated of antigen-stimulated CD8+ subsets. This revealed a strong 
upregulation of the miR-17~92 cluster in rapidly proliferating activated CD8+ T-cells and a 
downregulation during the differentiation from effector to memory cells (93). Indeed, 
expression of the miR-17~92 cluster is critically involved in the expansion of CD8+ T-cells 
as mice deficient for this cluster specifically in TCR activated mature T-cells have an 
impaired CD8 expansion upon viral infection. Overexpression of miR-17~92 promoted 
effector CD8+ T-cell differentiation and resulted in decreased numbers of memory T-cells. 
The overexpression of miR-17~92 resulted in a decreased expression of PTEN and other 
negative regulators of PI3K-Akt-mTOR signaling (93,94). As it has been shown that 
reduced mTOR signaling favors generation of memory cells, it is likely that downregulation 
of negative regulators of mTOR signaling by miR-17~92 contributes to this effect (95). 
Similar to miR-17~92, miR-155 levels are upregulated during activation of naïve CD8+ T-
cells and levels are higher in effector memory CD8+ T-cells as compared to naïve and 
central memory CD8+ T-cells (45,96,97). Absence of miR-155 impaired antiviral CD8+ T-
cell responses and conversely, miR-155 overexpression enhanced the antiviral responses 
(45,97,98). Inhibition of STAT1 and IRF7, two type I interferon signaling associated 
transcription factors partially rescued the impaired response of miR-155 deficient CD8+ T-
cells in vivo (97). Overexpression of SOCS1, a known miR-155 target, resulted in a similar 
phenotype as observed for the miR-155 deficient CD8+ T-cells suggesting an important role 
for this molecule (45). However, inhibition of SOCS1 in miR-155 deficient CD8+ T-cells 
could not rescue their response to virus infection in vivo indicating that miR-155 exerts its 
effects via another pathway or additionally targets genes downstream of SOCS1 (97).
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5. Immuno-miRs in T-cell aging 
Ageing related alteration of immune function, termed immunosenescence, involves a 
number of characteristic changes in the  T-cell compartment (99,100). First, as a result of 
thymic involution and continuous antigenic stimulation, a gradual shift is observed from T-
cells with a naïve phenotype to T-cells with a memory phenotype  and terminally 
differentiated T-cells (101,102). Second, characteristic changes are observed in the 
expression of defined cell surface markers including downregulation of the co-stimulatory 
receptor such as CD28 and upregulation of NK-cell related receptors (100). At present, little 
is known about the mechanisms underlying the observed age-related changes in T-cell 
composition and function. However, a number of studies indicate that miRNAs are involved 
(103-106). 
The miR-17~92 cluster, which regulates cell cycle control and apoptosis, is downregulated 
in old compared to young CD8+ CD28+ T-cells (104,107).  Expression of the miR-17~92 
cluster negatively correlates with p21 protein levels, suggesting regulation of replicative 
exhaustion of aged T-cells (107). One of the members of the miR-17~92 cluster, miR-92, 
was found to positively correlate with the percentage of naïve CD8+ T-cells (CD8+RO-
CD27+ and CD3+CD8+CD62L). This indicates that the expression of miR-92a in CD8+ T-
cells is mainly derived from naïve cells, and that miR-92a expression in CD8+ T-cells 
declines progressively with age. Indeed, age-related attrition of naïve T-cells is linked to a 
reduction of miR-92a in human T-lymphocytes (105). 
MiR-181a originally described in relation to its role in tuning the threshold for TCR signaling 
(31), was underrepresented in aged CD4+ T-cells (108). This correlated with increased 
expression of DUSP6, which impaired TCR sensitivity of aged CD4+ T-cells (see also 
paragraph 2). Consequently, DUSP6 was coined as a potential target for restoring T-cell 
responses in the elderly, to augment the effectiveness of vaccination (108).  
A miRNA cluster overrepresented in CD8+CD28- T-cells is the miR-23~27 cluster (106). 
This miRNA cluster targets multiple members of the DNA damage repair (DDR) pathway 
(109). Consistent with this, it was reported that a decreased activity of the DDR pathway is 
involved in cellular senescence and T-cell differentiation (110). Specifically, decreased 
expression of the histone H2A family member X (H2AX), a validated target of miR-24 (part 
of miR-23~27 cluster) has been reported in CD8+CD28- T-cells (106). Experimentally 
induced DNA damage resulted in decreased expression of H2AX as well as a decreased 
potential to activate the DDR response, especially in CD8+CD28- T-cells. MiR-24 could 
modulate expression of H2AX when overexpressed in Jurkat T-cells (106). However, the 
direct functional involvement of miR-24 on DDR signaling and apoptosis in CD8+CD28- T-
cells was not clearly established and might involve differential IL-15 expression by CD28+ 
and CD28- cells (106). 
The concept of immunosenescence and the involvement of ageing T-cells herein is just 
beginning to be understood. As a consequence, comprehensive concepts on how miRNAs 
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characterized by defined changes in miRNA expression levels. The miRNAs involved are 
mechanistically linked with various aspects of T-cell ageing and possibly play causal roles 
in immunosenescence. 
 
6. Conclusions  
The involvement of miRNAs in the process of T-cell differentiation, activation and function is 
irrefutable. Often, the exact molecular impact of these immuno-miRNAs on the T-cell 
phenotype is not easily defined experimentally and therefore qualified in terms of fine-
tuning. However, fine-tuning of the T-cell phenotype is the actual fundament of well-
balanced T-cell immunity and, as such, should not be judged trivial. Interestingly and 
completely in line with the current dogma of miRNA biology, similar miRNAs have been 
described in quite different and unrelated aspects of T-cell biology (34,46,51, 55,80) 
A number of miRNAs, like miR-21, miR-17~92 and miR-155 play crucial roles in T-cells 
(Figure 2 and Table 1). Their function may be generic and independent of a specific T-cell 
subset, i.e. sustaining proliferation and repression of apoptosis, but also subset specific, i.e. 
regulating CCR7 (miR-21), RORα (miR-17~92) or CTLA-4 (miR-155). The generic versus 
specific functions are likely explained by the miRNA targetome, present at a certain stage of 
T-cell development or differentiation. This clearly exemplifies the importance to consider the 
function of defined miRNAs in the relevant T-cell subset. The interplay between miRNAs 
and their targetome, both of which are expressed independently in time and by 
differentiation stage, defines signaling circuits and allows regulation of a spatio-temporal T-
cell response.  
Importantly, given the T-cell specific miRNA expression patterns, assessment of differential 
miRNA expression in unfractioned or undefined T-cell samples is of limited relevance. 
Specifically, differential miRNA expression patterns assessed in unfractioned or undefined 
T-cell samples may simply reflect slight differences in the composition of classically defined 
T-cell subsets. However, when studied in carefully defined T-cell subsets, immuno-miRs 
may help to expand our standing knowledge of T-cell phenotypes and the molecular circuits 
that direct T-cell responses in health and disease (61). 
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T-cell activation affects microRNA (miRNA) expression in T-cell subsets. However, little is 
known about the kinetics of miRNA regulation and possible differences between CD4 and 
CD8 T cells. In this study we set out to analyze the kinetics of activation-induced expression 
regulation of twelve pre-selected miRNAs. The dynamics of the expression of these 
miRNAs was studied in sorted CD4 and CD8 CD45RO- T cells of healthy individuals 
stimulated with αCD3/αCD28 antibodies. Analysis of miRNA levels at day 3, 5, 7 and 10 
showed significant activation-induced changes in expression levels of all twelve miRNAs. 
Expression levels of nine miRNAs, including miR-21, miR-146a and miR-155, were induced 
following activation, whereas expression of three miRNAs, including miR-31, were 
decreased following activation. The expression changes of miR-18a and miR-155 was 
relatively early, at day 3, whereas expression of miR-451, miR-21 and miR-146a was 
evident at day 5, 7 and 10, respectively.  Four miRNAs showed a differential regulation 
between CD4 and CD8 T cells. Induction of miR-18a and miR-21 was more pronounced 
and occurred earlier in CD4 T cells compared to CD8 T cells. Downregulation of miR-223 
and miR-451 was also more pronounced in CD4 T cells compared to CD8 T cells. In 
conclusion, we show a complex pattern of miRNA expression regulation upon T-cell 
activation with early and late as well as CD4 and CD8 T-cell specific changes. These 
differences might be the result of differences in kinetics and efficiency of CD4 and CD8 T 
cells in response to antigen priming.  
Key words: microRNA, T cell, activation 





Proper development, maturation and differentiation of T cells requires tight regulation of the 
underlying cellular processes by a complex network of transcription factors and epigenetic 
marks (1-4). In the past decade, it has become evident that microRNAs (miRNAs) play a 
significant role in regulating these processes in T cells (5-9). Distinct expression patterns of 
miRNAs have been described in specific T-cell subsets, including T helper and regulatory T 
cells, antigen-inexperienced naïve CD4 T cells as well as memory CD4 T cells (10,11). 
Specific miRNA expression patterns most likely reflect the proliferative history and 
maturation stage of specific T-cell subsets (12). MiRNAs are dynamically regulated during 
T-cell maturation and play a role in differentiation of specialized T-cell subsets (10,13). 
Deletion of dicer, a critical enzyme in miRNA maturation, skews Th1 immune response via 
a compromised ability to repress production of interferon gamma (IFN-γ) (14). Several 
individual miRNAs including miR-155, and the miR-17~92 cluster are involved in the 
development of Th1 and Th17 immune responses (15,16).  
Primary activation of naïve T cells has recently been shown to affect miRNA expression in T 
cells (17-19). Several miRNAs, such as miR-21, miR-31 and miR-155, are functionally 
involved in CD4 T-cell activation (15,20,21). MiR-9, miR-21 and miR-146a have been 
described to be altered upon T-cell receptor (TCR) stimulation and, in part, determine the 
strength of the T-cell response (17,22,23). Dynamic regulation of multiple miRNAs upon 
external stimuli has also been observed during T-cell activation and differentiation stages 
(10,24,25). MiR-155 was shown to be upregulated upon activation and its expression was 
found to be proportional to the strength of TCR signaling. MiR-146a controls the intensity 
and the duration of NF-κB signaling downstream of TCR activation (23,26,27). 
TCR-mediated recognition of antigenic peptides presented by MHC class I and II molecules 
together with ligation of the co-stimulatory receptor CD28 ensures proper activation and 
effector cell differentiation of CD4 and CD8 T cells (28). TCR stimulation was suggested to 
trigger distinct responses in CD4 and CD8 T cells that are controlled by intrinsic regulatory 
mechanisms (29-31). Proliferation of CD4 T cells depends on prolonged presence of the 
antigenic stimulation, whereas CD8 T cells are able to divide and differentiate into effector 
cells also in the case of discontinued presence of the antigen (30). Undefined cell-intrinsic 
differences in CD4 and CD8 cell subsets have been proposed to underlie the differential 
kinetics in activation and proliferation. Given the marked differences in miRNA profiles and 
the proposed effects of T-cell activation on miRNA expression patterns of CD4 and CD8 T 
cells, we hypothesized that changes in miRNA levels define the kinetics of activation of CD4 
and CD8 T cells. Although some previous studies report on changes in miRNA expression 
levels upon activation of either CD4 or CD8 T cells none of these studies directly compared 
CD4 and CD8 T cells. In this study, we analyzed T-cell activation induced changes in
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expression of thirteen selected miRNAs in sorted CD4 and CD8 CD45RO- T cells over a 
period of 10 days.  
Results and Discussion 
Peripheral blood mononuclear cells (PBMC) were isolated from 7 healthy donors (3 males 
and 4 females) with a median age of 27 (range 24 to 28 yrs of age). CD45RO- CD4 and 
CD8 T-cell subsets were stained with anti-CD3, anti-CD4 and anti-CD45RO antibodies and 
sorted following the strategy as shown in Supplementary Figure S1. Sorted CD4 and CD8 
CD45RO- T-cells were activated with αCD3/αCD28 monoclonal antibodies for 10 days. To 
confirm effective activation we analyzed expression of the Interleukin (IL)-2 receptor α-
subunit (CD25) on days 3, 5, 7 and 10. A marked increase in the percentage of CD25-
positive cells was observed in both CD4 and CD8 T cells of all seven individuals at all-time 
points. In addition, we observed induction of CD45RO expression consistent with an 
acquired memory phenotype (Figure 1 and Supplementary Figure S1). Together, these 
observations confirmed that the majority of both CD4 and CD8 T-cell subsets had acquired 
an activation-induced phenotype (Figure 1).  
We next assessed the expression kinetics of 13 selected miRNAs following stimulation of 
CD4 and CD8 T cells. 11 out of 13 miRNAs (miR-155, miR-21, miR-146a, miR-31, miR-9, 
miR-17, miR-18a, miR-19a, miR-19b, miR-20a, miR-92a) were selected based on previously 
published literature on T-cell activation and 2 out of 13 miRNAs (miR-223 and miR-451) 
were chosen based on our own previous observations (data not published). Expression 
levels of miR-9 were very low (Ct above 35) in both CD4 and CD8 T cells at all-time points 
(data not shown). The other 12 miRNAs showed higher expression levels and underwent 
significant and dynamic changes in both CD4 and CD8 T-cell subsets (Supplemental Figure 
S2). The fold changes in expression levels in comparison to the median value of CD4 T cells 
on day 0 are shown in Figure 2. Nine out of 12 miRNAs, i.e. miR-155, miR-21, miR-146a 
and all six members of the miR-17~92 cluster were induced upon T-cell activation, while 






Figure 1. Phenotype of activated CD4 and CD8 T cells. Expression analysis of A, cell surface 
activation marker CD25 and B, CD45RO analyzed after 3, 5, 7 and 10 days stimulation with anti-
CD3/CD28. Shown is the percentage of positive cells for the indicated marker. Black bars indicate CD4 
T-cells, open bars indicate CD8  T cells. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001. 
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Interestingly, we identified several specific patterns of miRNA expression with early (day 3), 
intermediate (day 5) and late (day 7, 10) induction following T-cell stimulation (Table 1). 
MiR-155 levels reached maximum levels at day 5. Upregulation of miR-155 has been 
previously described upon Th1 differentiation in CD4 cells and in effector memory CD8 T 
cells upon viral exposure (15,32). Expression of miR-18a, a member of the miR-17~92 
cluster, was strongly induced at day 3 upon T-cell activation and levels remained more or 
less stable until day 10 within CD4+ T cells. Induction of other members of the miR-17~92 
cluster followed a similar pattern but was less prominent consistent with previously 
published literature (33). Enhanced expression of the members of the miR-17~92 cluster 
was shown to be required for the proper differentiation of memory cells (13,33). The 
functional impact of miR-17~92 induction in CD4 T cells has not been investigated yet. 
Induction of miR-21 was evident at day 5 (CD4) and day 10 (CD8), somewhat delayed in 
comparison to miR-155 and miR-18a in both CD4 and CD8 T cells. Induction of miR-21 has 
previously been shown upon TCR/CD28 stimulation in primary naïve T cells. Functional 
studies showed that miR-21 negatively regulates signal transduction of T cells via targeting 
the AP-1 transcription factor (17,34). Induction of miR-146a occurred even later, with 
maximal levels being reached at day 10. Upregulation of miR-146a upon TCR stimulation 
has been reported previously in both CD4 and CD8 T cells (23,35). MiR-146a modulates 
activation induced cell death via targeting  Fas-associated death domain (FADD) in CD4 T 
cells (23).  
Downregulation of miR-31, miR-223 and miR-451 was evident at day 3. Levels remained 
low in both CD4 and CD8 T cells, with the exception of miR-223 levels in CD8 T cells, which 
returned back to normal after 7 days. MiR-31 levels were decreased in both CD4 and CD8 T 
cells (Figure 2). However, miR-31 was reported to be induced upon TCR/CD28 engagement 
and to positively regulate T-cell activation via direct targeting of KSR2, a repression factor of 
RAS2 kinase (20). This potential discrepancy may be explained by differences in 
concentrations of αCD3/αCD28 used and duration of the stimulation. Expression of miR-31 
was shown to be upregulated after 12 hours of stimulation, whereas the earliest time point 
we assessed miR-31 levels was after 3 days of stimulation. Expression of miR-223 is highly 
induced in inflamed T cells of rheumatoid arthritis patients (36), which leads to decreased 
production of interleukin (IL)-10, via suppressing insulin-like growth factor (IGF)-1 (37). Low 
levels of miR-223 might thus be required for proper production of IL-10 and protection 
against autoimmune diseases. However, changes of miR-223 levels with regard to T cell 
activation have not been studied so far. Similarly to miR-223, expression of miR-451 
positively correlated with rheumatoid arthritis activity and very little is known about the 
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Figure 1. Phenotype of activated CD4 and CD8 T cells. Expression analysis of A, cell surface 
activation marker CD25 and B, CD45RO analyzed after 3, 5, 7 and 10 days stimulation with anti-
CD3/CD28. Shown is the percentage of positive cells for the indicated marker. Black bars indicate CD4 
T-cells, open bars indicate CD8  T cells. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001. 
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Interestingly, we identified several specific patterns of miRNA expression with early (day 3), 
intermediate (day 5) and late (day 7, 10) induction following T-cell stimulation (Table 1). 
MiR-155 levels reached maximum levels at day 5. Upregulation of miR-155 has been 
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cluster, was strongly induced at day 3 upon T-cell activation and levels remained more or 
less stable until day 10 within CD4+ T cells. Induction of other members of the miR-17~92 
cluster followed a similar pattern but was less prominent consistent with previously 
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was shown to be required for the proper differentiation of memory cells (13,33). The 
functional impact of miR-17~92 induction in CD4 T cells has not been investigated yet. 
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comparison to miR-155 and miR-18a in both CD4 and CD8 T cells. Induction of miR-21 has 
previously been shown upon TCR/CD28 stimulation in primary naïve T cells. Functional 
studies showed that miR-21 negatively regulates signal transduction of T cells via targeting 
the AP-1 transcription factor (17,34). Induction of miR-146a occurred even later, with 
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cells (23).  
Downregulation of miR-31, miR-223 and miR-451 was evident at day 3. Levels remained 
low in both CD4 and CD8 T cells, with the exception of miR-223 levels in CD8 T cells, which 
returned back to normal after 7 days. MiR-31 levels were decreased in both CD4 and CD8 T 
cells (Figure 2). However, miR-31 was reported to be induced upon TCR/CD28 engagement 
and to positively regulate T-cell activation via direct targeting of KSR2, a repression factor of 
RAS2 kinase (20). This potential discrepancy may be explained by differences in 
concentrations of αCD3/αCD28 used and duration of the stimulation. Expression of miR-31 
was shown to be upregulated after 12 hours of stimulation, whereas the earliest time point 
we assessed miR-31 levels was after 3 days of stimulation. Expression of miR-223 is highly 
induced in inflamed T cells of rheumatoid arthritis patients (36), which leads to decreased 
production of interleukin (IL)-10, via suppressing insulin-like growth factor (IGF)-1 (37). Low 
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Figure 2. T-cell activation-induced dynamic changes in miRNA expression. Expression pattern of 
A, miR-155; B, miR-18a; C, miR-21; D, miR-146a; E, miR-17; F, miR-20a; G, miR-19a; H, miR-19b; I, 
miR-92; J, miR-223; K, miR-31; L, miR-451 in CD4 and CD8 T cells at day 0, 3, 5, 7 and 10 following T-
cell stimulation. MiRNA expression was normalized to expression of RNU44. Expression changes from 
day 3, 5, 7 and 10 were compared to day 0 (median value of CD4 t=0 set to 1) and fold change (FC) 
has been calculated respectively. Data are presented as median (solid line) with interquartile range 
(dashed lines). *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001. 
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To gain insight in the relevance of these activation induced changes in miRNA levels, we 
summarized the currently known target genes validated in T cells (Supplementary Table 
S1). A large number of these validated targets are involved in T cell activation and co-
stimulation pathways. AP-1 and  KSR2  regulate the signaling cascade downstream of  the 
TCR, whereas others such as ICOS, CREB1 and PHLPP2 are linked to the T cell co-
stimulatory signaling pathway (16,17,20,38,39). In addition, some of the other validated 
targets such as STAT1 and SOCS1 are responsible for  transcriptional regulation of genes 










Figure 3. Schematic overview of dynamic changes of miRNAs in CD4 and CD8 CD45RO- T cells. 
Expression of miR-155, miR-21, miR-18a, miR-223 and miR-451 in CD4+ and CD8+ T cells following 
stimulation. Solid line indicates CD4 pattern and the dashed line indicates the pattern in CD8 T cells.  
In a direct comparison of the activation-induced expression patterns of CD4 and CD8 T cells 
we noticed marked differences for 4 out of 12 miRNAs, i.e. miR-18a, miR-21, miR-223 and 
            FC  
miRNA Day  CD4          CD8 
miR-18a 3 31,2 17,6 
miR-223  3 -8,4 -3,8 
miR-31 3 -6,5 -2,4 
miR-451 5 -32,8 -15,7 
miR-155 5 22,7  29,8 
miR-21 7 17,6   6,2 
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miR-451 (Figure 3). Expression of miR-18a was induced in both CD4 and CD8 T cells. In 
CD4 T cells, miR18a expression peaked at day 3 and gradually declined thereafter, while in 
CD8 T cells a less profound induction of miR-18a levels were observed but  over a 
prolonged period. We observed delayed induction of miR-21 in CD8 versus CD4 T cells, 
which may in part be explained by a somewhat delayed response of CD8 T cells upon 
activation as judged by their CD45RA to RO progression (Figure 1). CD8 T cells are 
essential for protection against viruses, intracellular bacterial infection and tumor cells. CD4 
T cells play an important role in the initiation and persistence of CD8 T-cell responses (42). 
Downregulation of miR-223 and miR-451 was more pronounced in CD4 when compared to 
CD8 T cells. These differences can at least in part be explained by differences in basal 
expression levels at day 0, which were 1,6 and 3,5 fold lower in CD8 T cells for miR-223 and 
miR-451 respectively (Supplementary Figure S2). In CD8 T cells levels of miR-223 were 
decreased at day 3, but returned back to basal levels after 7 days, while in CD4 T cells miR-
223 remained low. MiR-451 inhibits proliferation of mesangial cells by targeting tyrosine 3-
monooxygenase / tryptophan 5-monooxygenase activation protein zeta (YWHAZ) (43), but 
it’s role in CD4 and CD8 T cells remains to be investigated. The observed differences in 
miRNA induction between CD4 and CD8 T cells may in part be explained by the differential 
kinetics of CD4 and CD8 T-cell responses upon antigenic challenge (30,31). The less 
pronounced changes of miRNA levels in CD8 T-cells, do not reflect the rapid differentiation 
of CD8 T-cell subsets into effector cells after primary stimulation. This might indicate that 
miRNAs are less important in regulating CD8 T cell activation as compared to CD4 T cell 
activation, although this needs to be studied in more detail.  
Overall, we show dynamic changes in the levels of specific miRNAs during the process of T-
cell activation with clear differences between CD4 and CD8 T cells. Also, we observed 
marked timing differences with early responses for miR-18a, miR-223, miR-31 and late 
responses for miR-21 and miR-146a upon activation.  
 
Materials and Methods 
Ethics statement 
All participants provided written informed consent according to the Declaration of Helsinki to 
participate in this study that was approved by The Medical Ethical Committee (METC) 
(project number: 2009.118) of the University Medical Center Groningen UMCG. 
Isolation of CD4 and CD8 T cells 
Peripheral blood mononuclear cells(PBMC) from healthy donors were isolated by density 
gradient centrifugation using Lymphoprep (Axis-shield, Oslo, Norway) immediately after 
blood withdrawal into heparin vacutainer tubes (Becton Dickinson, Franklin Lakes, USA). 
CD4+, CD4- CD45RO- T cells were isolated from PBMCs by fluorescence-activated cell 
sorting (FACS) (MoFlo, Beckman Coulter, Brea, USA) using anti-human CD3 (OCT-3, 
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eBioscience) anti-human-CD4 (OCT-4, eBioscience), and anti-human-CD45RO (UCHL1, 
BD Biosciences, San Diego, USA).  
T-cell activation with αCD3/CD28 mAbs  
T cell stimulation of isolated CD45RO- T cells was performed with plate-bound anti-human-
CD3 and soluble anti-human-CD28 mAbs. Briefly, culture plates were incubated with goat-
anti-mouse-IgG2a Ab (#1080-01, Southern Biotechnology) at 4°C overnight. After washing 
with PBS, cells were incubated with hybridoma-culture supernatant, containing anti-human-
CD3 IgG2a mAb (clone WT32, approx. conc. 1µg IgG/mL) at RT for 1h. Unbound anti-CD3 
antibody was removed by washing 4 times with an excess of PBS and T cells were seeded 
at a density of 0.5x106 cells/mL in medium supplemented with 5% V/V hybridoma-culture 
supernatant containing anti-human CD28 IgG1 mAb (clone 20-4669) at a final concentration 
of about 0.1µg IgG/mL. Cells were split every 2-3 days and placed in fresh medium 
supplemented with anti-CD3 and anti-CD28. At indicated time points, cells were harvested, 
stained for flow analysis or lysed with Qiazol reagent (Qiagen) and stored at -20°C until RNA 
extraction procedure.  
FACS analysis of cell surface markers 
Flow cytometry analysis was performed to assess changes in expression of CD45RO and 
CD25 upon stimulation by staining with monoclonal antibodies against human CD45RO 
(FITC labeled, UCHL1) and CD25 (APC labeled, BC96). Cells were analyzed on a FACS 
Calibur flow cytometer using Cell Quest software (BD Biosciences). Data were analyzed 
using the Kaluza Flow Analysis Software (Beckman Coulter). 
RNA Isolation and quantitative reverse-transcription-polymerase chain reaction (qRT-
PCR) 
Total cellular RNA was extracted using the miRNeasy Mini Kit (Qiagen, Venlo, The 
Netherlands) following the manufacturer’s instructions. The RNA quantity was measured on 
a NanoDrop ND-1000 Spectrophotometer (NanoDrop Technologies, Wilmington, DE). 
MiRNA expression levels were analyzed by qRT-PCR. RNA was reverse transcribed using 
the Taqman MicroRNA Reverse Transcription kit in combination with multiplexed reverse 
transcription primers of TaqMan microRNA Assays (Life Technologies, Carlsbad, USA): for 
miR-21 (ID: 000397), miR-146a (ID: 000468), miR-155 (ID: 002623), miR-31 (ID: 002279), 
miR-17 (ID: 002308), miR-18a (ID: 002422), miR-19a (ID: 000395), miR-19b (ID: 000396), 
miR-20a (ID: 000580), miR-92a (ID: 000431), miR-223 (ID: 002295), miR-451 (ID: 00105) 
and RNU44 (ID: 001094)(44). The qPCR reaction was performed using qPCR MasterMix 
Plus (Eurogentec, Liege, Belgium), and Taqman gene expression assays. All reactions were 
run in triplicate. Mean cycle threshold (Ct) values for all genes were quantified with the 
Sequence Detection Software (SDS, version 2.3, Life Technologies), using ABI7900HT 
thermo cycler (Life Technologies). RNU44 served as an endogenous control. Relative 
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Results obtained from qRT-PCR are expressed as median and range. For comparisons of 
unstimulated and stimulated CD4 and CD8 T cells we applied the Kruskal-Wallis 
nonparametric test with Dunn’s posttest, data from day 0 was compared to other days of 
stimulation (day 3, 5, 7, 10). Statistical analyses were performed with GraphPad Prism 
version 5.0 (GraphPad Software, San Diego, CA, USA) and SPSS Statistics version 22.0 
(IBM Corp. Armonk, NY, USA). P < 0.05 was considered statistically significant. 
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Supplementary Figure S1. T-cell sorting strategy and activation induced phenotype. A, 
Representative FACS plot depicting the gating strategy used to isolate CD4 and CD8 T CD45RO- cell 
populations. B and C, Representative FACS plot depicting T cell activation on day 7 as shown by 
expression of CD25 and CD45RO expression in activated CD4 and CD8 T cells. Isolated CD4 and CD8 
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Supplementary Figure S2. T-cell activation induced dynamic changes in miRNA expression. 
Expression patterns of miRNAs in CD4 (left panel) and CD8 T cells (right panel). Expression pattern of 
A, miR-155; B, miR-18a; C, miR-21; D, miR-146a; E, miR-17; F, miR-20a; G, miR-19a; H, miR-19b; I, 
miR-92; J, miR-223; K, miR-31; L, miR-451 in CD4 and CD8 T cells at day 0, 3, 5, 7 and 10 following T-
cell stimulation. MiRNA expression was normalized to expression of RNU44. Each dot in the graph 
indicates a single sample used for analysis. Data are presented as relative expression, for each time 
point the medians are indicated. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001. 
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* No distinction was made between miR-17 and miR-20a as they both have the same seed sequence 
and thus likely target a similar set of genes. The same accounts for miR-19a and miR-19b. For miR-451 
no validated targets in T-cells have been published. 
 
  
miRNA Gene Subset Species Ref. 
miR-17* 
CREB1 CD4 mouse (1) 
IKZF4 CD4 mouse (2) 
PHLPP2 CD4 mouse (3) 
RORA CD4 mouse (4) 
STAT3 CD8 mouse (5) 
TGFβRII CD4 mouse (1) 
miR-18a RORA CD4 mouse (4) 
miR-19* 
PTEN CD4 mouse (1,2) 
RORA CD4 mouse (4) 
miR-21 
AP-1 CD4 human (6) 
CCR7 CD4 human (7) 
SMAD7 CD4 mouse (8) 
SPROUTY1 CD4 mouse (9) 
TIPE2 CD4 mouse (10) 
miR-31 
FOXP3 CD4 human (11) 
KSR2 CD4 human (12) 
miR-146a 
CD84 CD4 mouse (13) 
ICOS CD4 mouse (13) 
PRKCε CD4 human (14) 
SLAMF1 CD4 mouse (13) 
STAT1 CD4 mouse (13) 
miR-155 
FOSL2 CD4 mouse (15) 
IFNγ Rα CD4 human (16,17) 
PELI1 CD4 mouse (15) 
PTPN2 CD8 mouse (18) 
 SOCS1     CD8 mouse (19) 
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A decline of certain phenotypes of T cells in number and function appears to be a key 
feature of human immune cell aging. The objective of this study was to generate miRNA 
expression signatures related to T-cell ageing by small RNA sequencing. We used T-cell 
clones from young and old donors with either a low or high number of population doublings 
(PDs) as a longitudinal model of age-associated gene expression changes potentially 
paralleling in vivo phenomena. We showed that the cumulative number of PDs correlated 
with lower expression of CD28 and less IL-2 production. Principal component analysis of 
252 miRNAs expressed in at least 3 out of 12 samples showed two main clusters, one of all 
samples with a low number of PDs and the other with a high number of PDs, irrespective of 
the age of the clone donor. We identified 10 miRNAs with significantly differentially 
expression levels of which miR-9 and miR-34a were validated in the same and additional T-
cell clones. Analysis of genes enriched in the Ago2-IP fraction of Jurkat cells revealed 21 
targets with binding sites for both miR-34a and miR-9. For one of three tested targets, i.e. 
the senescence marker CNOT6L, we observed a significant association. To establish the 
relevance of our findings in primary T cells, we analyzed miR-9 and MiR-34 levels in CD28+ 
and CD28- T cells. A significant higher level of miR-9 but not of miR34a was observed in 
CD28- T cells. Inhibition of miR-9 in Jurkat cells had no clear effect on both transcript and 
protein level of CD28, despite of  the presence of several miR-9 binding sites in the CD28 
transcript. MiR-9 inhibition led to reduced levels of IL-2 production and inhibition of growth 
of Jurkat cells. Thus, our results show a PD-associated miRNA expression pattern in T-cell 
clones with increased miR-9 and miR-34a levels in T-cell clones with higher PD. MiR-9, but 
not miR-34a, levels are increased in CD28- primary T cells and miR-9 is a regulator of IL-2 
production and T-cell survival.  
Key words: T-cell clones, microRNA, ageing 




CD4+ T-cell clones show changes in surface molecule expression and cytokine secretion 
patterns over time, which are believed to reflect the process of in vivo ageing of T cells (1,1-
3). T-cell clones have been widely utilized to investigate aspects of clonal expansion and 
contraction that are essential for adaptive immunity. These studies have increased our 
insight at the genomic, proteomic and functional level (1,4,5). Clones with a relatively low 
number of population doublings (PD’s, <30) are well maintained and may continue to 
expand efficiently. Growth of T-cell clones with >40 PDs is often decreased and these cells 
become more susceptible to apoptosis (2). Understanding the nature of the changes in T-
cell clones might facilitate intervention and thereby improve immune responses in the 
elderly. 
MicroRNAs (miRNAs) are small noncoding RNA molecules that regulate protein translation 
by binding to messenger RNA (mRNA) transcripts (6). There is ample evidence supporting 
a role of miRNAs in T-cell development and function (7-9). Different aspects of aged T cells 
have been shown to be under tight regulation by miRNAs (10-12). However, our knowledge 
on the involvement of miRNAs in fundamental aspects of T-cell ageing is limited.  
We studied miRNA expression changes in T-cell clones of healthy young and elderly 
donors harvested at low and high PDs by small RNA-sequencing. We verified miRNA 
expression changes, studied miR-9 and miR-34a targets associated with cellular 
senescence/cell proliferation and investigated the functional impact of miR-9 on T-cell 
immune responses and T-cell survival.  
 
Results 
T-cell clones with high PDs are characterized by low CD28 and IL-2 expression 
T-cell clones used in this study were derived from one young donor (31 yrs) and from two 
healthy old (>85 yrs) and two healthy centenarians (100 yrs). For all T-cell clones a 
passage at a low number of PDs (<40, median 28) and a passage at a high number of PDs 
(>50, median 58) were obtained (Table 1). We determined  expression of membrane CD28 
and levels of soluble IL-2 in the culture supernatant. We observed an inverse correlation 
between PDs and the mean fluorescence intensity (MFI) of CD28 and also between PDs 
and the level of IL-2 (Fig1 A,B), consistent with a senescent phenotype of T-cell clones with 
high PDs.  
The number of PDs determines the miRNA expression signature of T-cell clones  
We performed small RNA sequencing to define the miRNA signatures of T-cell clones with 
low and high population doublings derived from young and old donors. The young donor 
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Table 1. T-cell clone characteristics  
Donors Age (y) Clone Low PDs High PDs RNA-seq qPCR 
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Principal component analysis of the 252 miRNAs which were detected in at least 3 of the 12 
samples revealed a segregation of the T-cell clones into two main groups. One cluster 
included all samples with a low number of PDs and the second cluster contained all 
samples with high number of PDs (Fig 2A). No clustering was observed according to the 
age of the donor. Ten miRNAs showed significant differences in expression between low 
and high number of PDs (Figure 2B).  Five of these 10 miRNAs were selected for validation 
based on having high expression levels  and a more than 1.5 fold change in expression 
levels (see Supplementary Table S1). miR-16 and miR-106b expression levels were not 
significantly associated with the number of PDs. Based on these results we focused our 







Fig 1. The number of PDs negatively correlates with CD28 expression and IL-2 production of T-
cell clones. A, Per cell surface expression of CD28 depicted as mean fluorescence signal intensity 
(MFI). B, Expression of soluble IL-2. Filled circles represent the RNA samples of the clones used for 
small-RNA sequencing, open circles represent the samples of the remaining T-cell clones used for 
validation by qRT-PCR (Table 1). For 5 of the low and 4 of the high number of PDs T-cell clones were 
not analysed for CD28 and IL-2, respectively. **p ≤ 0.01.  
MicroRNA signature in T-cell clones identified by small RNA sequencing 
 
61 
miR-9 and miR-34a target genes are involved in cell cycle regulation and survival 
We next performed a Ribonucleoprotein Immuno Precipitation (RIP-Chip) using anti-Ago2 
antibodies in Jurkat cells to identify miR-9 and miR-34a targets. Among  14,514 expressed 
genes 905 (6,2%) were predicted targets for miR-9 and 478 (3,3%) were predicted targets 
for miR-34a. A total of 1.835 genes were enriched at least two fold in the IP fraction as 
compared to the total fraction. Among these, 186 were predicted target genes of miR-9 
(10%) and 85 (4,6%) were predicted targets of miR-34a. 21 of these genes were predicted 
target genes of both miR-9 and miR-34a (Figure 3A). Two of the most enriched genes (≥ 7 
fold) are related to cell cycle regulation and proliferation, i.e. Cyclin E2 (CCNE2) and 
Pleiomorphic Adenoma Gene 1 (PLAG1). CCR4-NOT Transcription Complex, Subunit 6-
Like (CNOT6L) a regulator of cellular senescence was xx fold enriched (Supplementary 
Table S3). Analyses of the expression levels of these three genes revealed a significant 
positive correlation between CNOT6L and the number of PDs (Fig 3 B,C,D). Thus, high 
levels of miR-9 and miR-34a positively correlate with cellular senescence of T-cell clones 













Fig 2. MiRNA expression identifies differences between low and high number of PDs T-cell 
clones. A, Principal component analysis (PCA) defining biological differences in miRNA expression 
between high and low number of PDs T-cell clones from young and old donors. Symbols in red indicate 
samples with high number of PDs and symbols in blue indicate samples with low number of PDs; 
samples from young donors are indicated by triangles and from old donors by squares B, Significantly 
differentially expressed miRNAs between high and low number of PDs. Blue to red gradient indicates 
miRNA expression intensity varying from low (blue) to high (red). C, Significantly differentially 
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sequencing and open symbols indicate samples of the other T-cell clones used for small-RNA 
sequencing data validation (Table 1). MiRNA expression was normalized to the expression of RNU44. 
**p ≤ 0,01; ***p ≤ 0,001. 
 
miR-9 is increased in primary CD28- T cells  
Loss of CD28 expression is a hallmark of aged T cells. To explore if the observed changes 
in miR-9 and miR-34a levels are also observed in vivo, we sorted CD3+CD28+ and 
CD3+CD28- T cells from peripheral blood of 6 healthy young (27 yrs) and 4 healthy old (64 
yrs) donors. Sorting strategy of the T-cell subsets is shown in Supplementary Figure S1. 
QRT-PCR analysis revealed significantly higher levels of miR-9 in the CD3+CD28- T-cell 
population than in the CD3+CD28+ T cells (Fig 4A). However, no significant differences 
were observed for miR-34a (Fig 4B). 
 
Fig 3. Overlapping targets of miR-9 and 
miR-34a are enriched in cell cycle 
regulation and pro-survival pathways. A, 
Venn diagram showing the overlap between 
miR-9 and miR-34a predicted target genes 
which were enriched in the 
Immunoprecipitated (IP) fraction of EV of 
Jurkat T cells. 21 overlapping target genes 
were enriched in IP vs total fraction (T) of EV 
≥2 fold. Expression of B, CCNE2, C, PLAG1, 
D, CNOT6L in T-cell clones with low and high 
number of PDs *p ≤ 0,05. 
 
miR-9 positively regulates IL-2 production and regulated T cell survival 
Next we assessed the physiological role of miR-9 in regulation of the T-cell response. To 
determine if the effects on CD28 and IL-2 are a consequence of direct targeting by miR-9 
we analyzed the presence of binding sites in the 3’UTR. Two putative bindings sites were 
identified for miR-9 in the CD28 transcript  (Supplementary Fig S2). Inhibition of miR-9 in 
Jurkat cells for 8, 16 and 24 days however did not affect cell surface expression of CD28 as 
determined by flow cytometry (Fig 4D). No binding sites were identified in the IL-2 gene 
transcript. Despite the absence of miR-9 binding sites we did see decreased IL-2 production 
upon inhibition of miR-9 in Jurkat cells treated with αCD3/αCD28 for 72 hrs (Fig 4C).  To 
test whether miR-9 is essential for growth of Jurkat cells, we perfromed a GFP competition 
assay. We observed a significant decrease of 40% in growth as compared to the control 
inhibitor over a period of 22 days (Fig 4E).  






















Fig 4. miR-9 is up-regulated in CD28- T cells, positively regulates expression of IL-2 and is 
required for T-cell survival. Expression of A, miR-9 and B, miR-34a in ex vivo isolated human 
primary CD28+ and CD28- T cells from young and old donors. MiRNA expression levels were 
normalized to the expression levels of RNU44 C, Concentration of soluble IL-2 determined in Jurkat T 
cells transduced with control and miR-9 inhibitor followed by stimulation with αCD3/CD28. D, Jurkat 
cells transduced with control and miR-9 inhibitor and CD28 expression was determined by flow 
cytometry on day 8, 16 and 24. E, Jurkat T cell growth disadvantage following inhibition of miR-9. Data 
were normalized to the first measurement at day 4. Each line represents a separate experiment  (n=3). 
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Material and Methods 
Generation of T-cell clones 
T-cell clones were generated from phytohemagglutinin (PHA)-stimulated peripheral blood 
mononuclear cells (PBMC) by limiting dilution in the presence of IL-2 and pooled irradiated 
PBMC feeder cells as previously described (1). Three CD4+ T-cell clones from two healthy 
old and three CD4+ T-cell clones from one healthy young donor with low and high PDs 
were selected for small RNA sequencing (n=12 samples). The other clones were used only 
for the validation experiments by qRT-PCR analysis (Table 1). CD28 expression and IL-2 
production on low and high number of PDs T-cells clones were assessed as reported 
previously (2).  
RNA isolation 
Total RNA was extracted using the miRNeasy Mini Kit (Qiagen, Venlo, The Netherlands) 
following the manufacturer’s instructions. Micro Bio-SpinTM chromatography columns, 
supplied with Bio-Gel P-6 polyacrilyamide gel matrices, were applied for efficient cleanup 
and purification of RNA samples following the manufacturer’s protocol (Bio-Rad laboratories 
B.V. Veenendaal, The Netherlands). The ExperionTM RNA stdSens and HighSens analysis 
kits (Life Science, Bio-Rad Laboratories B.V, Veendal, The Netherlands) were used to 
determine the RNA quality indicator (RQI) score. The RNA concentration was measured on 
a NanoDrop ND-1000 Spectrophotometer (NanoDrop Technologies, Wilmington, DE).   
Small RNA sequencing and data analysis  
T-cell clones with the biggest difference between low and high PDs samples were selected 
for small RNA-sequencing. Samples were barcoded and sequenced with Illumina HiSEQ 
2000 flowcell (Illumina). The sequence reads were analyzed using the CLC BIO Genomic 
Work Bench Suite 4.5 (CLC BIO, Arhus, Denmark). Reads were mapped to the mature 
miRNAs using miRDeep2 (13). The number of mapped reads of each sample was 
normalized to 1x106. Normalized data were imported to GeneSpring (v.11.5.1) for analysis. 
A total of 252 miRNAs were present in at least 3 out of 12 samples with a read count >10. 
Mann-Whitney U test was performed to identify significantly differentially expressed 
miRNAs. Genesis (Release 1.7.6) was used to generate heatmaps. 
Isolation of primary T cells by fluorescence-activated cell sorting (FACS) 
Peripheral blood mononuclear cells (PBMCs) were isolated by density gradient 
centrifugation using Lymphoprep (Axis-Shield, Oslo, Norway) according to the 
manufacturer’s protocol. CD3+CD28+ and CD3+CD28- cells were isolated from 6 healthy 
young and 4 healthy old donors (Supplementary Table S2) using combinations of the 
following anti-human monoclonal antibodies: CD3-e450 (eBioscience, Vienna, Austria), 
CD28-PECY7 (Biolegend). See Supplementary Fig S1 for sorting schemes. 
 




MiRNA and gene expression levels were determined by quantitative reverse-transcription-
polymerase chain reaction (qRT-PCR). cDNA synthesis for miRNAs was performed with 
Taqman MicroRNA Reverese Transcription kit using a multiplex reverse transcription 
approach with primers of the TaqMan microRNA Assays (Life Technologies, Carlsbad, 
USA): for miR-9-5p (000583), miR-34a-5p (000426), miR-16-5p(000391), miR-93-5p 
(001090), miR-106b-5p (000442) and RNU44 (001094). RNU44 served as an endogenous 
control. 
cDNA synthesis for mRNA was performed using Superscript III RTase (Life Technologies). 
The qPCR reaction was performed using qPCR MasterMix Plus (Eurogentec, Liege, 
Belgium) and Taqman Gene expression assay for detection of CCNE2 (Hs00180319_m1), 
PLAG1 (Hs00965049_g1), CNOT6L (Hs00375913_m1) or gene specific primers and 
probes for detection of TBP: forward 5’-GCCCGAAACGCCGAATAT-3’, reverse 5’-
CCGTGGTTCGTGGCTCTCT-3’, probe 5’-6-FAM-ATCCCAAGCGGTTTGCTGCGG-BHQ-
1-3’ (Integrated DNA Technologies, Coralville, USA). TBP served as an endogenous 
control. All reactions were run in triplicate. Mean cycle threshold (Ct) values for all genes 
were quantified with the Sequence Detection Software (SDS, version 2,3, Life 
Technologies). Relative expression levels were quantified using the 2 –ΔCt  (ΔCt= Ct gene - 
Ct reference gene). 
Viral transduction 
Lentiviral particles were produced by CaPO4 mediated transfection of HEK293T cells cells 
with pmiRZip-9 (miR-9 inhibitor), or pmiRZip-scrambled hairpin (control inhibitor) (SBI, 
Systems Biosciences, CA) together with pMSCV-VSV-G, pRSV.REV and pMDL-gPRRE 
expression vectors. Lentiviral particles were collected 48 hrs after viral transduction, passed 
through a 0,45 µM millex HV PVDF filter (Millipore). Jurkat  cells at a concentration of 25 
x104/ml were transduced with the virus and placed in a 6 wells plate and incubated at 37°C 
overnight. The next day, Jurkat cells were washed 3x times with PBS and diluted to a 
concentration of 25 x104/mL.   
Activation of Jurkat cells with αCD3/αCD28 mAbs  
Jurkat cells transduced with with pmiRZip-9 (miR-9 inhibitor) or pmiRZip-scrambled (control 
inhibitor) were stimulated with plate-bound human αCD3 and soluble human αCD28 mAbs. 
Briefly, culture plates were incubated with goat-anti-mouse-IgG2a Ab (Cat. No. 1080-01, 
Southern Biotechnology) at 4°C overnight. After washing with PBS, cells were incubated 
with hybridoma-culture supernatant, containing anti-human-CD3 IgG2a mAb (clone WT32, 
approx. conc. 1µg IgG/mL) at RT for 1h. Unbound anti-CD3 antibody was removed by 
washing 4 times with an excess of PBS and Jurkat cells were seeded at a density of 5x105 
cells/mL in medium supplemented with 5% V/V hybridoma-culture supernatant containing 
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for 72 hrs. Next, cells were spun down for 5 minutes and supernatants were collected and 
stored at -20⁰C for IL-2 analysis. 
IL-2 detection in jurkat cells  
Soluble IL-2 protein levels were measured by ELISA (R&D Systems, Minneapolis, MN, 
USA) according to the instructions provided by the manufacturer.  
Analysis of CD28 expression 
Membrane CD28 expression levels of Jurkat cells transduced with miR-9 inhibitor or control 
inhibitor were assessed using anti-CD28-PECY7 (CD28.2). Cells were analyzed on a BD 
LSR-II Flow Cytometer by Diva software (BD Biosciences). Data analysis was performed 
with Kaluza Flow Analysis Software (1.2) (Beckman Coulter).  
Ago2 ribonucleoprotein immuno precipitation (RIP-Chip)  
Immunoprecipitation of Ago2-containing RISC complexes was performed as described 
previously by Tan et al. and Slezak-Prochazka et.al (14,15). RNA from total and Ago2-IP 
fractions of Jurkat-EV cells was used for microarray analysis. Labeling and hybridization 
was performed using two-color Low Input Quick Amp Labeling Kit, according to the 
manufacturer’s protocol (Agilent, Santa Clara, USA). Slides were scanned with SureScan 
Dx Microarray Scanner (Agilent). Scanned images were used for Agilent Feature Extraction 
software version 10.5, converted into Linear and Lowess normalized data. Probes not 
detected in more than half of the samples and probes that are inconsistent  (more than 2 
fold different) in Cy-3 and Cy-5 replicates of the same sample were filtered out. The 
average signals for Cy-3 and Cy-5 replicates were used to calculate the IP/T ratio for each 
sample. 
GFP competition assay  
Jurkat cells were infected with miR-9 inhibitor (pmiRZip-21) or control-inhibitor (pmiRZip-
scrambled) with an infection rate varying between 25-35%. GFP percentage was analyzed 
triweekly for 22 days. Data were acquired on a FACS Calibur flow cytometer (BD 
PharMingen) and analyzed using FlowJo software (version 7,6, Treestar, Ashland, OR). 
The GFP percentage at the first day of measurement (day 4) was set to 1. The GFP 
competition assay was performed in 3 independent experiments. The average decline of 
GFP of 3 the experiments was used to determine whether the decline in GFP percentage of 
miR-9 inhibited cells was significantly different from the GFP percentages of the cells 
infected with control-inhibitor.  
Statistical analysis 
Results obtained from qRT-PCR are expressed as medians. Unpaired samples were 
compared using the Mann-Whitney U test and paired samples using the Wilcoxon signed-
rank test. For correlation comparisons the Spearman test was used. For the GFP 
competition assay, we used repeated measures one-way ANOVA, with Dunnet's multiple 
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comparison posttest, p<0.05 was considered statistically significant. Statistical analyses 




T-cell clones have been extensively used to study functional and molecular aspects of T-
cell ageing (1,3,4). We observed a negative correlation between the number of PDs and the 
expression level of CD28 and IL-2 production, which is consistent with the previously 
reported senescent phenotype (1). Loss of CD28 is regarded as one of the detrimental 
changes of T-cell ageing (16).   
Using T-cell clones with low and high number of PDs derived from young and old donors, 
we showed clear PD-associated differences in miRNA expression independent of donor 
age. Our observations are consistent with previous findings showing that T-cell clones from 
centenarian and young adults behave similary. This implies that clonable centenarian-
derived T cells are not functionally compromised (17). We identified ten significantly 
differentially expressed miRNAs in T-cell clones with low and high numbers of PDs. We 
confirmed an association with the number of PDs for miR-34a and miR-9.  
To identify the pathways related to miR-34a and miR-9 in T-cell ageing, we focused on the 
21 experimentally identified miRNA targets in Jurkat cells that contain predicted binding 
sites for both miRNAs. Three of these genes, i.e. CCNE2, PLAG1 and CNOT6L, have been 
linked to cell cycle regulation and cellular senescence (18-20). In our analysis, CNOT6L 
expression levels showed a positive correlation with cumulative PDs of T-cell clones. The 
positive correlation between CNOT6L and the high number of PDs can be partly explained 
by acquisition of a senescence phenotype following long-term in vitro culture of the T-cell 
clones. Several pathways related to senescence have been identified in late passage T-cell 
clones, such as cell survival, motility and proliferation (4,5). CNOT6L may thus play a role in 
regulation of cell proliferation and senescence in T-cell clones at high population doublings. 
MiR-34a expression was shown to be under tight regulation of p53 and was reported to 
regulate expression of SIRT1 to limit longevity (21,22). We did not observe a negative 
correlation between expression levels of miR-34a and SIRT1 in T-cell clones (data not 
shown). However, this does not exclude targeting of SIRT1 by miR-34a or regulation of 
SIRT1 by miR-34a through indirect mechanisms. Thus, further experiments on T-cell clones 
with more extreme differences between low and high PDs are required to confirm PD-
associated differences and decipher regulation of miR-34a and miR-9 shared target genes. 
To establish an association of miR-34a and miR-9 with aging of primary T cells we studied 
CD28+ and CD28- cells. Consistent with the findings in the T-cell clones we observed 
significantly higher miR-9 levels in primary CD28- T cells. MiR-9 was previously shown to 
positively regulate T-cell responses by enhancing production of IL-2 via targeting PR 
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2 levels upon inhibition of miR-9. As miR-9 does not directly target the IL-2 transcript, we 
wondered if miR-9 might affect levels of IL-2 by regulating CD28 expression as CD28 has 
been shown to regulate expression of IL-2 (24). We indeed identified miR-9 bindings sites in 
the 3’UTR of CD28, although CD28 transcripts did not reach the fold enrichment cut for 
being regulated by miRNAs in the Ago2-IP experiment. Inhibition of miR-9 did not yield 
siginificant changes in CD28 expression levels, which is consistent with the Ago2-IP data. 
However, we did observe significantly reduced IL-2 levels upon miR-9 inhibition in Jurkat 
cells. This indicates that the miR-9 associated downregulation of IL-2 is not mediated via 
CD28. We anticipate that increased expression of mR-9 in T-cell clones with a high number 
of PDs might represent a compensatory mechanism to maintain IL-2 levels, which fails to 
be effective for other unknown reasons. A decline of T-cell immune responses, indicated by 
a decrease in IL-2 producing capacity might result in inhibition of T-cell growth. Consistent 
with this, we observed a decline in T-cell growth upon inhibition of miR-9. This illustrates the 




Our results provide evidence for changes in levels of certain miRNAs with increasing 
number of PDs in T-cell clones. At a high number of PDs, T-cell clones are characterized by 
a decreased expression of CD28 and IL-2 which inversely correlates with the expression of 
miR-9 and miR-34a. Both microRNAs are known to be related to cellular senescence. MiR-
9, but not miR-34a, levels are increased in primary CD28- T cells and miR-9 is a regulator 
of IL-2 production and T-cell survival.  
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Supplementary Table 2. Characteristics of the donors and isolated T-cell subsets 
    
Donors Age (y) Sex Isolated T- cell subsets 
1 25 F CD3+ CD28+  and  CD3+ CD28- 
2 24 F CD3+ CD28+  and CD3+ CD28- 
3 27 F CD3+ CD28+  and  CD3+ CD28- 
4 28 F CD3+ CD28+  and CD3+ CD28- 
5 27 F CD3+ CD28+  and  CD3+ CD28- 
6 29 F CD3+ CD28+  and  CD3+ CD28- 
7 67 M CD3+ CD28+  and  CD3+ CD28- 
8 74 F CD3+ CD28+  and  CD3+ CD28- 
9 62 F CD3+ CD28+  and  CD3+ CD28- 
10 62 F CD3+ CD28+  and  CD3+ CD28- 
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Gene symbol IP/T FD GO ontology (functional annotation) 
CCNE2 8,6 Cell cycle regulation 
PLAG1 7,8 Cell proliferation 
FNDC3B 7,8 Adipogenesis regulation 
C5orf41 7,5 Endoplasmic reticulum stress response 
BRPF3 6,1 Protein binding and zinc ion binding 
CLOCK 5,4 Circadian rythm and metabolism 
IRF1 4,6 
Regulation of IFN and IFN-inducible genes 
immune responses 
USP31 4,2 Cysteine-type peptidase activity  
CNOT6L 3,6 Cell proliferation, cellular senescence 
TMEM164 2,9 Transmembrane protein 
C3orf58 2,6 Chromosome 3 open reading frame 
FAM126B 2,4 Family with sequence similarity 126, member B 
TMEM33 2,4 Transmembrane protein 
RORA 2,3 Lipid metabolism 
ZIC5 2,2 Neural crest development 
SMAD4 2,2 Mediator of signal transduction by TGF-β 
RNF44 2,1 Zinc ion binding 
AP1S2 2,1 Clathrin-dependent protein traffic 
FAM43B 2,1 Family with sequence similarity 73 
GIGYF1 2,1 Tyrosine kinase receptor signaling 
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Supplementary Fig S1. Sorting strategy of CD3+CD28+ and CD3+CD28- T cells. Peripheral blood 
mononuclear cells (PBMC) were isolated and CD3+CD28+ / CD3+CD28- T cells were FACS sorted 







Supplementary Fig S2. Two binding sites of miR-9 in the 3’UTR of the human CD28 transcript. A, 
Schematic overview of the 2 putative miR-9 binding sites in the 3’UTR of CD28. B, Putative base pairing 
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Abstract 
MicroRNAs (miRNAs) have emerged as important players in the regulation of T-cell 
functionality. However, comprehensive insight into the extent of age-related miRNA changes 
in T cells is lacking. We established miRNA expression patterns of CD45RO- naïve and 
CD45RO+ memory T-cell subsets isolated from peripheral blood cells from young and 
elderly individuals. Unsupervised clustering of the miRNA expression data revealed an age-
related clustering in the CD45RO- T cells, while CD45RO+ T cells clustered based on 
expression of CD4 and CD8. Seventeen miRNAs showed an at least 2-fold up- or 
downregulation in CD45RO- T cells obtained from young as compared to old donors. 
Validation on the same and independent samples revealed a statistically significant age-
related upregulation of miR-21, miR-223 and miR-15a. In a T-cell subset analysis focusing 
on known age-related phenotypic changes, we showed significantly higher miR-21 and miR-
223 levels in CD8+CD45RO-CCR7- TEMRA compared to CD45RO-CCR7+ TNAIVE-cells. 
Moreover, miR-21 but not miR-223 levels were significantly increased in CD45RO-CD31- 
post-thymic TNAIVE cells as compared to thymic CD45RO-CD31+ TNAIVE cells. Upon 
activation of CD45RO- TNAIVE cells we observed a significant induction of miR-21 especially 
in CD4+ T cells, while miR-223 levels significantly decreased only in CD4+ T cells. Besides 
composition and activation induced changes, we showed a borderline significant increase in 
miR-21 levels upon an increasing number of population doublings in CD4+ T-cell clones. 
Together, our results show that ageing related changes in miRNA expression are dominant 
in the CD45RO- T-cell compartment. The differential expression patterns can be explained 
by age related changes in T-cell composition, i.e. accumulation of CD8+ TEMRA and CD4+ 
post-thymic expanded CD31- T cells and by cellular ageing, as demonstrated in a 
longitudinal clonal culture model. 
Keywords:  T cell, microRNA, ageing




Advanced age has been associated with defects of the immune system to mount 
appropriate antigen specific responses to pathogens. The most profound age-associated 
changes are observed in T cells. Due to thymus involution with age, the output of naïve T 
cells is reduced, while the proportion of memory T cells increases, thereby compromising 
the diversity of the T-cell pool. 
Naïve T cells express CD45RA, while being negative for CD45RO (1). Within the CD8+ T 
cell fraction, expression of CD45RA or CD45RO in combination with the C-C chemokine 
receptor type 7 (CCR7) is used to further define CCR7+CD45RA+(CD45RO-) naïve (TNAIVE), 
CCR7+CD45RA-(CD45RO+) central memory (TCM), CCR7-CD45RA-(CD45RO+) effector 
memory (TEM) and CCR7-CD45RA+(CD45RO)- late-stage effector memory (TEMRA) T-cell 
subsets (2). Whether or not this model can also be applied to the CD4+ subset is still a 
matter of debate. Various age-related differences have been reported in the distribution of T-
cell phenotypes in peripheral blood. For instance, the proportion of CD8+ TEMRA cells is 
higher in elderly than in young individuals (3). Within the CD4+CD45RO- T-cell population, 
the proportion of CD31- TNAIVE cells increases with age, while the fraction of CD31+ T cells 
progressively decreases (4). Kohler et al (5) characterized CD4+CD31+ T cells as recent 
thymic emigrants, while CD4+CD31- T cells represented central naïve peripherally 
expanded CD4+ T cells. Downregulation of surface expression of CD31 has been 
associated with homeostatic proliferation (6). In elderly individuals, clonal expansion of 
memory T cells is required to preserve effective immune responses for combating antigenic 
re-challenges. This leads to a marked proliferative stress resulting in clonal exhaustion and 
senescence (7-9). Human T-cell clones are characterized by altered cell surface and 
cytokine expression signatures that resemble the in vivo situation of chronic antigenic stress.  
Long-term cultured T cell clones may thus represent a model for cellular ageing (10). 
MiRNAs are a class of small non-coding RNAs that bind to mRNA transcripts of protein-
coding genes in a sequence-specific manner. Based on the degree of sequence 
complementarity they induce degradation of the mRNA or repress translation (11). A single 
miRNA potentially regulates up to several hundreds of target genes, thus orchestrating 
many pathways (12). Differentiated cells in complex cellular systems are characterized by 
the expression of specific miRNA profiles. Moreover, miRNAs are fundamental to the 
regulation of complex cellular processes, such as those that regulate the immune system.  
The contribution of changes in miRNA expression patterns to the age-associated decreased 
functionality of the immune system is largely unexplored. Differential miRNA expression 
patterns were shown in replicative in vitro and in in vivo models of CD8 T-cell ageing (13). 
Some of the deregulated miRNAs were shown to be involved in the DNA damage response 
(14). A role of miR-92a has been reported in age-related attrition of CD8+ TNAIVE cells (15). 
In addition, a role has been proposed for miR-181a in modulation of TCR sensitivity of CD4+ 
T cells upon ageing (16).  
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There are no comprehensive studies of differences in miRNA expression patterns in primary 
human T cells from younger and older donors. To address this issue, we analyzed miRNA 
expression in CD4+ and CD8+ T cells sorted based on expression of CD45RO from 
peripheral mononuclear blood cells (PBMCs) of young and elderly individuals. We observed 
age-related differences in miRNA expression predominantly within the CD45RO- T-cell 
compartment. These differences could be explained by a combination of age-associated 
accumulation of TEMRA and CD31- T cells, T-cell activation and by cellular ageing. Finally, we 
assessed changes longitudinally in a clonal T cell culture model and found alterations in 
miRNA expression as a function of population doublings in vitro. 
 
Results 
Age-related miRNA expression differences are restricted to CD45RO- T cells  
To identify age related differences in T cells, we compared miRNA expression profiles from 
sorted T cells from peripheral blood of 5 healthy young (median age 27) and 5 healthy old 
(median age 64) donors. CD4 and CD8 T cells were sorted from the CD45RO- and 
CD45RO+ gates (Supplementary Fig S1A-B). Sorting strategy and purity of the T-cell 
subsets are shown in Supplementary Fig S2A. Equal amounts of RNA were pooled for each 
T-cell subset resulting in a total of 8 T-cell subset pools. MiRNA signatures were generated 
from these pools by miRNA expression arrays. Unsupervised hierarchical clustering of the 
166 miRNAs that were detected in at least 7 out of 8 samples revealed a clustering into two 
main groups, i.e. CD45RO- and CD45RO+ T-cells (Supplementary Fig S3, Table S3). In the 
CD45RO- T cell subset, the clustering was based on age, irrespective of CD4 and CD8 
expression status (Fig 1A). In the CD45RO+ T-cell subset, the clustering was between 
CD4+ and CD8+ T cells, irrespective of age. Based on this marked difference we focused 
our further analysis on the CD45RO- T-cell subset. 
Seventeen miRNAs showed a ≥ 2-fold difference in expression level between young and old 
CD45RO- T cells (Fig 1B). Based on miRNA expression level and availability of qRT-PCR 
assays, 13 out of the 17 miRNAs were selected for validation on the individual samples of 
the pools used for the array analysis combined with a second independent cohort (young; 
n=12, median age 27; old; n=13, median age 65) (Supplementary Tables S1 and S4). Array 
results of miR-21, miR-223 and miR-15a were validated on the combined cohort (Fig 1C). 
MiR-28-5p expression levels were increased in old compared to young subjects, but this 
difference did not reach significance (Supplementary Fig S4). Of the other selected miRNAs, 
we could not validate differences between young and old donors for miR-197, miR-766, 
miR-328 and miR-451 (Supplementary Fig S4). We next studied if the observed changes 
could be assigned to ageing related changes in the T-cell composition. We focused these 
analyses on miR-21 and miR-223, as the miR-15a levels were very low.  
  










Fig 1. Age-related differences in miRNA expression are predominantly found in CD45RO- T cells. 
(A) Unsupervised hierarchical cluster analysis of 166 miRNAs revealed a clear distinction between 
CD45RO- and CD45RO+ T cells. Within the CD45RO- subgroup the next separation was based on age, 
whereas in CD45RO+ T cells the next clustering was based on expression of CD4/CD8 (the complete 
heatmap can be seen in Supplementary Fig S3). (B) Heatmap of miRNAs differentially expressed in 
young versus old CD45RO- T cells (n=17) using a 2-fold expression change cut-off (≥ 2 fold) between 
young and old CD45RO- T cells. The blue to red gradient on the heatmap indicates relative miRNA 
expression levels varying from low (blue) to high (red). (C) Relative expression levels in CD45RO- T 
cells from young and old donors as determined by qRT-PCR of miR-21, miR-223 and miR-15a in 
CD45RO- T cells from young and old donors. MiRNA expression levels were normalized to the 
expression levels of RNU49 (lines indicates median). Filled circles indicate CD4 T cells and open circles 
indicate CD8 T cells, *p ≤ 0.05, **p ≤ 0.01. 
 
Increased numbers of CD8+ TEMRA cells in elderly contributes to the higher miR-21 
and miR-223 levels in CD45RO- T cells  
Loss of CCR7 expression is a hallmark of differentiation from central memory to effector and 
late effector CD8+ TEMRA cells. To explore if the observed changes in miR-21 and miR-223 
levels are related to the increase of TEMRA cells in elderly, we sorted CD45RO-CCR7+ TNAIVE 
and CD45RO-CCR7- TEMRA cells from peripheral blood of 7 healthy young (median age 27) 
and 7 healthy old (median age 67) donors (Supplementary Fig S1C-F). Sorting strategy and 
purity of the T cell subsets are shown in supplementary figure S2B. The percentage of 
CD45RO-CCR7+ TNAIVE cells within the CD4+ gate was high for both young (median is 
93,6%) and old donors (median is 87,1%) (Fig 2A). The yield of CD4+CD45RO-CCR7- 
TEMRA cells was insufficient for the qRT-PCR analysis. For CD8+ T cells we observed a 
significantly lower percentage of CD45RO-CCR7+ TNAIVE cells in elderly donors (median of 
33% in elderly vs 59% in young) with a concomitant significant increase in the percentage of 
TEMRA cells (median percentage 67% in elderly vs 41% in young) (Fig 2B). QRT-PCR 
analysis revealed significant higher expression of both miR-21 and miR-223 in the TEMRA 
populations when compared to TNAIVE cells (Fig 2C-D).  Hence, increased expression of both 
miRNAs in the CD45RO- T-cell subset upon ageing can at least in part be explained by the 
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Fig 2. Age-related upregulation of miR-21 and miR-
223 can be partly explained by the accumulation of 
TEMRA (CD8 T cells) in the CD45RO- T-cell 
compartment. Percentage of (A) TNAIVE 
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CD8+ T cells. *p ≤ 0.05, **p ≤ 0.01. 
 
Increased numbers of CD31- central naïve T cells contributes to the increased levels 
of miR-21 in CD45RO- T cells  
As a next step, we studied expression patterns of miR-21 and miR-223 in relation to CD31 
expression as it is known that CD31- central naïve T cells increase with age especially in the 
CD4+ T cell subset. CD31+ and CD31- T cells were sorted from the CD45RO- compartment 
for both CD4 and CD8 from PBMCs of 8 healthy young (median age 28) and 7 healthy old 
(median age 75) donors (Fig S1G-J). Sorting strategy and purity are given in supplementary 
figure S2C. The percentage of CD4+CD31- T cells was significantly higher in elderly donors 
(median is 45%) when compared to younger individuals (median is 19%). In the CD8 
compartment, we observed a slightly higher, albeit not significant, percentage of CD31- T 
cells in elderly (median is 17%) compared to young donors (median is 9,3%)(Fig 3A-B).  
 
 
Fig 3. MiR-21 is upregulated in CD31- T cells in the 
CD45RO- compartment. Percentage of CD31+ and 
CD31- in (A) CD4+CD45RO- and (B) CD4-CD45RO- 
T cells in young and old donors. Relative expression 
of (C) miR-21 and (D) miR-223 in CD31-and CD31+ 
T-cell subset sorted from the CD45RO- T-cell 
compartment. MiRNA expression was normalized to 
the expression of RNU49 (line indicates median). 
Squares indicate cells from young and triangles 
indicate cells from old donors. Filled symbols indicate 
CD4+ T cells and open symbols indicate CD8+ T cells. 
*p ≤ 0.05. 
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The expression level of miR-21 was significantly increased in CD45RO-CD31- T cells 
compared to CD45RO-CD31+ T cells, whereas the miR-223 levels were similar in CD31+ 
and CD31- T cells (Fig 3C-D). Thus, the accumulation of CD31- T cells contributes to the 
observed age related increase of miR-21 levels, especially in the CD4+CD45RO- T cell 
compartment in which CD31 loss is most pronounced. 
 
MiR-21 is upregulated upon activation of CD45RO- TNAIVE cells  
Prolonged exposure of T cells to pathogens in elderly increases the number of TCR primed 
antigen-experienced memory T cells. To explore a relation between the increased miR-21 
and miR-223 levels in elderly and T cell activation, we sorted both CD4+ and CD8+ 
CD45RO- T cells from peripheral blood of 7 healthy young donors (median age 27) 
(Supplementary Table S1) and stimulated these cells with αCD3/CD28. Stimulation of 
CD45RO- T cells in vitro induced an activated memory phenotype with a marked induction 
of both CD25 and CD45RO (Supplementary Fig S5A-B). A significant induction of miR-21 
was observed in CD4+ T cells and a borderline significant induction in CD8+ T cells after 
stimulation for 10 days (Fig 4A-B). Expression of miR-223 was significantly decreased upon 
αCD3/CD28 triggering in CD4+ T cells, whereas no difference was observed in CD8+ T cells 




Fig 4. T-cell activation induces upregulation 
of miR-21 and downregulation of miR-223. 
Relative expression of miR-21 in stimulated (A) 
CD4+CD45RO- and (B) CD4-CD45RO- T cells. 
Relative expression of miR-223 in stimulated (C) 
CD4+CD45RO- and (D) CD4-CD45RO- T cells. 
MiRNA expression was normalized to the 
expression of RNU49 (line indicates median). 
*p<0.05. 
 
Thus, our data show that in vitro activation of CD4+ T cells is associated with the 
transgression to the memory phenotype (CD45RO+), induction of miR-21 and reduction of 
miR-223. In vitro activation of CD8+ T cells is also associated with acquisition of the memory 
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MiR-21 is increased in aged CD4+ T cell clones 
We next tested, if besides T-cell composition and activation, we could also identify an age-
related component that could contribute to the enhanced miR-21 and miR-223 levels. As an 
in vitro model of T-cell aging, we studied expression of these two miRNAs in 16 CD4+ T-cell 
clones harvested at a lower (<40) (median population doubling (PD) is 28) and a higher 
(>40) (median PD is 55) number of PDs. Expression of miR-21 tended to be increased in 
high vs low PD T-cell clones (p=0.0525), whereas the miR-223 levels did not differ in T-cell 
clones with low and high population doublings (Fig 5A-B). Thus, based on this in vitro model 
of T-cell ageing, the age-related increase of miR-21 may be associated with increased 
numbers of cell divisions and continuous activation of the T-cell clones.  
 
Fig 5. MiR-21 is upregulated with 
increasing population doublings in T-cell 
clones. Relative expression of (A) miR-21 
and (B) miR-223 in T cell clones harvested 
at lower and higher number of population 
doublings (PD). MiRNA expression was 
normalized to the expression of RNU49. 
 
Discussion 
In order to decipher age-related differences in miRNA expression patterns we studied 
CD45RO+ and CD45RO- T cells of healthy young and elderly individuals. We observed 
clear differences in miRNA expression patterns between CD45RO- and CD45RO+ T cells, 
consistent with previous studies (21,22). The next clustering step indicated an age-related 
difference in CD45RO- T cells and a CD4/CD8 based clustering in CD45RO+ T cells. The 
pronounced age-related clustering in CD45RO- T cells has not been described previously. 
Seventeen miRNAs were found to be ≥2-fold differentially expressed. For miR-15a, miR-21, 
miR-22 and miR-223 a relation with age was shown previously in studies conducted in 
humans, mice and rhesus monkeys (23,24). RNA sequencing of skeletal muscles of old 
rhesus monkeys revealed age-related upregulation of miR-15a, of which functional 
involvement in ageing yet remains to be identified (25). An age-related elevated expression 
of miR-21 has been described in plasma samples of healthy elderly and geriatric patients 
with cardiovascular disease and, as such, miR-21 has been established as a circulating 
marker of inflammageing (23). Expression of miR-22 was prominently upregulated during 
cardiac ageing of C57/BI6N mice and overexpression was shown to induce cellular 
senescence of cardiac fibroblasts (26). MiR-223 levels were increased in bone marrow 
derived dendritic cells from aged C57BL/6 mice (27). Several previously reported age-
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related miRNA expression changes in T cells were confirmed by our study. Expression 
levels of the miR-17, miR-19, miR-20a and miR-106a were downregulated in a mix of naïve 
and memory CD8+CD28+ T cells (13). We did not find downregulation of these miRNAs in 
naive CD45RO- T-cell subsets. However, in memory CD8+CD45RO+ T cells we observed a 
similar age-related downregulation for miR-17, miR-19 and miR-20a, whereas the levels of 
miR-106a were below detection limit in most samples. In CD4+ TNAIVE cells an age-
associated decline of miR-181a expression has been reported (16). Consistent with this 
finding we also observed a decreased expression of miR-181a expression with age although 
this did not reach our 2-fold cut off criterion (1.5 fold). Thus our data substantially increase 
the list of currently known age-related miRNA expression changes in specific T-cell subsets. 
We next assessed if the observed age related differences in miRNA expression patterns are 
caused by heterogeneity in the composition of the CD45RO- T cells or are truly associated 
with age. In the CD8 T-cell compartment we showed that the expression levels of miR-21 
and miR-223 were strongly upregulated in CD45RO-CCR7- TEMRA vs CD45RO-CCR7+ 
TNAIVE CD8+ cells. CCR7 is a predicted target for miR-21 and we previously demonstrated 
that miR-21 regulates expression of CCR7 in CD4+CD45RO- TNAIVE cells following activation 
(28). The increased expression of miR-21 in CD8+CD45RO-CCR7- TEMRA cells is thus 
consistent with its CCR7 targeting potential. There are currently no studies showing a direct 
link between miR-223 and CCR7. MiRNA target gene prediction algorithms such as 
TargetScan, PicTar and miRanda also showed no predicted miR-223 binding sites in the 
CCR7 transcript. In CD4+ T cells, ageing has also been shown to alter T-cell composition, 
i.e. loss of CD31 a characteristic marker of post-thymic central naïve CD4+ T cells (5). We 
observed higher levels of miR-21 in central naive CD4+CD31- T cells compared to CD31+ 
TNAIVE cells. As miR-21 expression levels are induced upon activation (28) and  central naïve 
CD4+CD31- T cells have a history of antigenic stimulation (29), it might be anticipated that 
stimulation of CD31+ and CD31- CD4+ T cell subsets will result in differential induction of 
miR-21 levels. Target gene prediction programs show no predicted target sites for miR-21 in 
the 3’-UTR of the CD31 mRNA transcript. Thus, it remains unclear if and how increased 
miR-21 levels affect CD31 loss. Overall, our data show that ageing-related changes in 
miRNA expression levels are at least partly induced by changes in T-cell subset 
composition. 
Stimulation of T cells with αCD3/CD28 results in enhanced miR-21 levels (30). Consistent 
with this we showed that miR-21 is highly induced upon TCR triggering, with the most 
pronounced effects in CD4+ T cells. As the increase of both TEMRA and CD31- T cells in 
elderly is at least in part related to prolonged stimulation, this might explain the accumulation 
of miR-21 in these T-cell subsets. The vast majority of CD4 and CD8 CD45RO- T cells in 
young individuals are CD28+ (31). Nonetheless, we cannot exclude the possibility that 
differences in CD28 expression between the CD4 and CD8 populations could influence the 
effectiveness of the αCD3/CD28 stimulation and thus the degree of miRNA expression 
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TEMRA cells clonally expand as a result of chronic antigenic stimulation and their numbers 
increase upon ageing (32). CD8+ TEMRA cells re-express CD45RA and lose expression of 
CD45RO, CD27 and CD28. Hence, TEMRA cells are considered senescent T cells with 
impaired T-cell functionality (2,33). Our data show that age-related differences in miR-21 
and miR-223 expression levels in CD45RO- T cells may partly reflect the accumulation of 
CD8+ TEMRA cells in elderly. Post-thymic proliferating central naïve CD31- T cells have 
undergone TCR stimulation, which might explain the increased miR-21 levels in central 
naïve T cells. Induction of miR-21 in response to TCR engagement has been reported 
previously and the levels of miR-21 are increased in inflammatory conditions, such as 
rheumatoid arthritis (29,34). Moreover, miR-21 is well characterized in terms of its anti-
apoptotic and pro-survival properties in T cells (35,36). In line with this, miR-21 was shown 
to act as an oncomiR in a conditional mouse model (37). Another study showed increased 
miR-21 levels upon replicative and stress-induced senescence in endothelial cells, 
suggesting a role for miR-21 in senescence-induced growth arrest (38). MiR-21 mediates 
suppression of apoptosis in part by targeting Tipe2 (36). These data support a role of the 
TCR-induced increase of miR-21 in expansion and survival of both TEMRA and central naïve 
T cells in aged individuals. Expression of miR-223 was decreased in naïve CD4+ T cells 
following αCD3/CD28 stimulation, whereas levels remained constant in CD8+ T cells. This is 
in line with the previously reported reduction of miR-223 upon activation of TNAIVE cells (39). 
To study whether CD4+ T cell changes in miR-21 and miR-223 could also be related to 
cellular ageing we used T-cell clones with low and high population doublings as an in vitro 
model of ageing (10). Extensive inter-clonal heterogeneity made it difficult to establish a 
clear correlation for miR-223, but there was a borderline significant increase in miR-21 with 
increasing PD when averaging the results from all the clones. This heterogeneity is not 
unexpected among monoclonal T cell populations of different individuals. Next to the 
proposed role of miR-21 on survival of TEMRA and central naïve T cells, we propose that an 
age-related increase in miR-21 expression levels may also contribute to the increased miR-
21 levels in ageing T cells.  MiR-21 was found to induce replicative and stress-induced 
senescence in human endothelial cells via targeting p21(CIP) and CDC25A cell cycle genes 
(38). These T-cell clone experiments thus provide a first indication that changes in levels of 
miR-21 and potentially also miR-223 measured longitudinally may be related to cellular 
ageing, but further experiments are required to substantiate this notion.  
 
Conclusions  
Taken together, our results provide an evidence for an age-related miRNA expression 
pattern especially in CD45RO- T cells. These changes are most likely defined by a 
combination of ageing-related changes in T-cell composition, activation and the number of 
cell divisions. MiR-223 changes are associated specifically with an accumulation of TEMRA 
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cells, whereas increase in miR-21 levels are related to the number of cell divisions, the 
accumulation of TEMRA and CD31- central naïve T cells, the latter likely reflecting post-thymic 
TCR stimulation. 
 
Material and Methods 
Participants  
In total 27 healthy young (≤ 30 yrs) and 24 healthy elderly (≥ 55 yrs) participants were 
included in this study. Demographic characteristics of all donors and miRNA analysis 
strategies are summarized in Supplementary Table S1. Healthy young and old were 
recruited via advertisements and contacting the elderly association and were selected for 
healthiness based on the Senieur health admission criteria for immunogerontological studies 
(17). None of the subjects had a history of infection, malignancy, autoimmune disease, 
chronic liver or kidney disease, alcohol or drug abuse, diabetes mellitus, current pregnancy 
or immunosuppressive therapy. An elevated blood pressure and the use of anti-hypertensive 
treatment were accepted. 
T-cell clones were generated from phytohaemagglutinin (PHA) – stimulated peripheral blood 
mononuclear cells (PBMC) by limiting dilution in the presence of IL-2 using irradiated 
PBMCs as feeder cells (10,18). In total, we included 16 CD4+ T-cell clones for each clone a 
sample with a low and a sample with a high number of population doublings. The T-cell 
clones were initially isolated from 5 individual donors (Table S2).   
Ethics statement 
All participants provided written informed consent according to the Declaration of Helsinki to 
participate in this study that was approved by The Medical Ethical Committee (METC) 
(project number: 2009.118) of the University Medical Center Groningen UMCG.  
PBMC isolation and fluorescence-activated cell sorting (FACS) of human primary 
lymphocyte subsets 
Peripheral blood was collected in heparin-containing vacutainer tubes (Becton Dickinson, 
Franklin Lakes, USA) and peripheral blood mononuclear cells (PBMC) were freshly isolated 
by density gradient centrifugation using Lymphoprep (Axis-Shield, Oslo, Norway) according 
to the manufacturer’s protocol. CD4 T cells were sorted by fluorescence-activated cell 
sorting (FACS) as CD3+CD4+ and CD8 T cells as CD3+CD4-. Within the CD4 and CD8 T-
cell subsets, naïve (CD45RO-) and memory (CD45RO+), truly TNAIVE (CD45RO-CCR7+) and 
terminally differentiated (TEMRA) cells (CD45RO-CCR7-); as well as CD3+ and CD31- 
populations were isolated using combinations of the following anti-human monoclonal 
antibodies: CD3-e450, CD4-A647 (eBioscience, Vienna, Austria), CD45RO-FITC, CCR7-
PE, CCR7-PECY7 and CD31-PE (BD Bioscience, Breda, The Netherlands). See 
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cellular ageing we used T-cell clones with low and high population doublings as an in vitro 
model of ageing (10). Extensive inter-clonal heterogeneity made it difficult to establish a 
clear correlation for miR-223, but there was a borderline significant increase in miR-21 with 
increasing PD when averaging the results from all the clones. This heterogeneity is not 
unexpected among monoclonal T cell populations of different individuals. Next to the 
proposed role of miR-21 on survival of TEMRA and central naïve T cells, we propose that an 
age-related increase in miR-21 expression levels may also contribute to the increased miR-
21 levels in ageing T cells.  MiR-21 was found to induce replicative and stress-induced 
senescence in human endothelial cells via targeting p21(CIP) and CDC25A cell cycle genes 
(38). These T-cell clone experiments thus provide a first indication that changes in levels of 
miR-21 and potentially also miR-223 measured longitudinally may be related to cellular 
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Conclusions  
Taken together, our results provide an evidence for an age-related miRNA expression 
pattern especially in CD45RO- T cells. These changes are most likely defined by a 
combination of ageing-related changes in T-cell composition, activation and the number of 
cell divisions. MiR-223 changes are associated specifically with an accumulation of TEMRA 
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cells, whereas increase in miR-21 levels are related to the number of cell divisions, the 
accumulation of TEMRA and CD31- central naïve T cells, the latter likely reflecting post-thymic 
TCR stimulation. 
 
Material and Methods 
Participants  
In total 27 healthy young (≤ 30 yrs) and 24 healthy elderly (≥ 55 yrs) participants were 
included in this study. Demographic characteristics of all donors and miRNA analysis 
strategies are summarized in Supplementary Table S1. Healthy young and old were 
recruited via advertisements and contacting the elderly association and were selected for 
healthiness based on the Senieur health admission criteria for immunogerontological studies 
(17). None of the subjects had a history of infection, malignancy, autoimmune disease, 
chronic liver or kidney disease, alcohol or drug abuse, diabetes mellitus, current pregnancy 
or immunosuppressive therapy. An elevated blood pressure and the use of anti-hypertensive 
treatment were accepted. 
T-cell clones were generated from phytohaemagglutinin (PHA) – stimulated peripheral blood 
mononuclear cells (PBMC) by limiting dilution in the presence of IL-2 using irradiated 
PBMCs as feeder cells (10,18). In total, we included 16 CD4+ T-cell clones for each clone a 
sample with a low and a sample with a high number of population doublings. The T-cell 
clones were initially isolated from 5 individual donors (Table S2).   
Ethics statement 
All participants provided written informed consent according to the Declaration of Helsinki to 
participate in this study that was approved by The Medical Ethical Committee (METC) 
(project number: 2009.118) of the University Medical Center Groningen UMCG.  
PBMC isolation and fluorescence-activated cell sorting (FACS) of human primary 
lymphocyte subsets 
Peripheral blood was collected in heparin-containing vacutainer tubes (Becton Dickinson, 
Franklin Lakes, USA) and peripheral blood mononuclear cells (PBMC) were freshly isolated 
by density gradient centrifugation using Lymphoprep (Axis-Shield, Oslo, Norway) according 
to the manufacturer’s protocol. CD4 T cells were sorted by fluorescence-activated cell 
sorting (FACS) as CD3+CD4+ and CD8 T cells as CD3+CD4-. Within the CD4 and CD8 T-
cell subsets, naïve (CD45RO-) and memory (CD45RO+), truly TNAIVE (CD45RO-CCR7+) and 
terminally differentiated (TEMRA) cells (CD45RO-CCR7-); as well as CD3+ and CD31- 
populations were isolated using combinations of the following anti-human monoclonal 
antibodies: CD3-e450, CD4-A647 (eBioscience, Vienna, Austria), CD45RO-FITC, CCR7-
PE, CCR7-PECY7 and CD31-PE (BD Bioscience, Breda, The Netherlands). See 




RNA extraction and purification 
Total RNA was extracted using the miRNeasy Mini Kit (Qiagen, Venlo, The Netherlands) 
following the manufacturer’s instructions. Micro Bio-SpinTM chromatography columns, 
supplied with Bio-Gel P-6 polyacrylamide gel matrices, were applied for efficient purification 
of RNA samples (Bio-Rad laboratories B.V. Veenendaal, The Netherlands). RNA 
concentration was measured on a NanoDrop ND-1000 Spectrophotometer (NanoDrop 
Technologies, Wilmington, USA). RNA samples with 260 / 280 and 260 / 230 ratio of ≥ 1.90 
were used for further analysis.  
MiRNA profiling 
Equal amounts of RNA samples from FACS sorted CD3+CD4+CD45RO+/- and CD3+CD4-
CD45RO+/- T cells from healthy young (n=5) and elderly (n=5) donors were pooled for 
miRNA expression profiling. Microarray profiling was performed using the SurePrint Human 
miRNA Array Kit with 8x15K format (V2, sequence source from miRBase 10.1) from Agilent 
(G447013) according to manufacturer’s protocol (Agilent Technologies, Santa Clara, 
California, USA). Arrays were scanned using an Agilent scanner according to the 
manufacturer's instructions (Agilent Technologies). Array images were analyzed using 
Agilent feature extraction software. For data analysis, raw data were log2 transformed and 
normalized using a 90th percentile shift using GeneSpring software (v.11.5.1). We excluded 
control probes and probes detecting viral miRNAs. MiRNAs detected in at least 7 out of 8 
samples were included for further analysis. Visualization of normalized data and hierarchical 
clustering was performed with Pearson correlation distance and complete linkage clustering 
parameters using Genesis software (v.1.7.6) (Graz University of Technology, Graz, Austria)  
(19). The microarray data were deposited in Gene Expression Omnibus and are accessible 
with the following series record number: GSE69191. 
Quantitative RT-PCR 
MiRNA expression levels were determined by quantitative (q)RT-PCR. Multiplexed cDNA 
synthesis for up to 6 specific miRNAs was performed using Taqman MicroRNA Reverse 
transcription kit with a multiplexed reverse transcription primers of TaqMan microRNA 
Assays (Life Technologies, Carlsbad, USA): for miR-21 (000397), miR-223 (002295), miR-
451 (001141), miR-22 (000398), miR-15a (000389), miR-197 (000497), miR-766 (001986), 
miR-574-3p (002349), miR-328 (000543), miR-483-3p (CSS07FR), miR-885-5p 
(241451_mat), miR-28-5p (000411)  and RNU49 (001005) as described earlier (20). RNU49 
served as a reference gene to normalize miRNA expression levels.  
All PCR reactions were run in triplicate. Mean cycle threshold (Ct) values were quantified 
with the Sequence Detection Software (SDS, version 2.3, Life Technologies, Amsterdam, 
The Netherlands). Relative expression levels were quantified using the 2–ΔCt (Δ Ct = Ct gene 
– Ct reference gene).  
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T cell stimulation with αCD3/CD28 monoclonal antibodies (Abs) 
Culture plates were coated with goat-anti-mouse IgG2a Ab (Cat. No. 1080-01, Southern 
Biotechnology, Uden, The Netherlands) and mouse anti-human CD3 hybridoma supernatant 
(clone WT32, IgG2a). CD3+CD4+CD45RO- and CD3+CD4-CD45RO- T cells were seeded 
at a density of 0,5x106 cells/mL in RPMI medium (Lonza, Breda, The Netherlands) 
supplemented with 5% V/V mouse anti-human CD28 hybridoma (clone 20-4669, IgG1), 2% 
HSA (Sanquin, Amsterdam, The Netherlands). Cells were split and placed in fresh medium 
supplemented with αCD3/CD28 on day 3, 5 and 7. On day 10 cells were harvested and 
stained for FACS analysis or lysed for RNA isolation.  
Analysis of cell surface markers 
Cell surface markers on in vitro activated T cells were assessed using mAbs against human 
CD25-PE (BC96) (eBioscience, Vienna, Austria) and CD45RO-FITC (UCHL1) (BD 
Biosciences, Breda, The Netherlands). Cells were analyzed on BD LSR-II Flow Cytometer 
by Diva software (BD Biosciences). Data analysis was performed on Kaluza Flow Analysis 
Software (1.2) (Beckman Coulter, Woerden, The Netherlands). 
Statistical analysis 
Results obtained from qRT-PCR are expressed as median respectively. Unpaired samples 
were compared using the Mann-Whitney test and paired samples using the Wilcoxon 
signed-rank test. For comparisons of paired unstimulated and stimulated CD4+ and CD8+ T 
cells, we applied the Wilcoxon matched pairs test. T-cell clones with low and high PD were 
compared using a paired Wilcoxon signed-rank test. Statistical analyses were performed 
with GraphPad Prism version 5.0 (GraphPad Software, San Diego, CA, USA) and SPSS 
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Table S1. Characteristics of the donors  
Donors Gender Age (y) miRNA analysis Data 
y1 M 26 array; validation 
Fig.1 A-C 
y2 F 28 array; validation 
y3 F 27 array; validation 
y4 M 27 array; validation 
y5 M 28 array; validation 
y6 M 28 validation; T cell stimulation 
Fig. 1 C 
Fig. 4 A-D 
y7 F 28 validation; T cell stimulation 
y8 F 28 validation; T cell stimulation 
y9 F 27 validation; T cell stimulation 
y10 M 24 validation; T cell stimulation 
y11 M 27 validation; T cell stimulation 
y12 F 24 validation; T cell stimulation 
y13 F 27 TNAIVE / TEMRA 
Fig. 2 A-D 
y14 F 26 TNAIVE / TEMRA 
y15 F 25 TNAIVE / TEMRA 
y16 F 28 TNAIVE / TEMRA 
y17 M 27 TNAIVE / TEMRA 
y18 F 29 TNAIVE / TEMRA 
Y19 M 27 TNAIVE / TEMRA 
y20 F 28 CD31+ / CD31- 
Fig. 3 A-D 
y21 F 22 CD31+ / CD31- 
y22 F 29 CD31+ / CD31- 
y23 M 23 CD31+ / CD31- 
y24 F 28 CD31+ / CD31- 
y25 F 27 CD31+ / CD31- 
y26 M 28 CD31+ / CD31- 
y27 F 21 CD31+ / CD31- 
o1 M 62 array; validation 
Fig. 1 A-C 
Fig. 2 A-D 
o2 F 71 array; validation 
o3 F 56 array; validation; TNAIVE / TEMRA 
o4 F 67 array; validation ;TNAIVE / TEMRA 
o5 F 64 array; validation; TNAIVE / TEMRA 
o6 F 62 validation 
Fig. 1 C 
o7 M 65 validation 
o8 F 67 validation 
o9 F 72 validation 
o10 F 61 validation 
o11 M 68 validation 
o12 F 65 validation 
o13 F 72 validation 
o14 F 71 TNAIVE / TEMRA 
Fig. 2. A-D o15 F 76 TNAIVE / TEMRA o16 F 81 TNAIVE / TEMRA 
o17 M 64 TNAIVE / TEMRA 
o18 F 77 CD31+ / CD31- 
Fig. 3 A-D 
o19 M 72 CD31+ / CD31- 
o20 F 82 CD31+ / CD31- 
o21 M 66 CD31+ / CD31- 
o22 F 75 CD31+ / CD31- 
o23 M 75 CD31+ / CD31- 
o24 F 70 CD31+ / CD31- 
 
        Y= young donors, o= old donor
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hsa-let-7a 40,1 32,9 49,7 47,0 32,5 38,2 41,1 45,5 
hsa-let-7b 18,7 12,6 23,9 16,3 20,2 13,8 30,6 21,0 
hsa-let-7b* 0,8 1,0 0,6 0,5 0,8 0,6 0,6 0,9 
hsa-let-7c 2,2 1,3 3,1 2,2 2,3 1,5 3,3 2,4 
hsa-let-7d 6,8 6,1 7,3 6,9 6,7 6,3 6,8 6,6 
hsa-let-7d* 0,5 0,6 0,2 0,3 0,4 0,1 0,3 0,4 
hsa-let-7e 0,5 0,2 0,5 0,4 0,7 0,4 0,9 0,6 
hsa-let-7f 24,4 22,3 35,1 39,1 22,6 32,5 29,9 37,1 
hsa-let-7f-1* 0,6 0,7 0,5 0,5 0,7 0,6 0,6 0,6 
hsa-let-7g 76,6 76,2 104,5 92,4 64,1 76,6 77,8 79,1 
hsa-let-7i 11,7 13,6 16,5 20,1 20,0 23,3 23,9 22,8 
hsa-miR-101 1,1 1,3 1,6 1,8 0,8 1,4 1,1 1,2 
hsa-miR-103 5,6 7,7 7,3 10,1 7,6 12,5 7,9 10,9 
hsa-miR-
106b 2,2 3,0 2,3 3,9 2,5 4,3 2,8 3,6 
hsa-miR-107 4,3 5,1 5,5 7,4 6,8 8,2 6,6 8,7 
hsa-miR-
1224-3p 0,8 0,4 0,2 0,3 0,8 0,0 0,6 0,5 
hsa-miR-
1225-3p 0,7 0,8 0,7 0,5 0,9 0,7 0,8 0,7 
hsa-miR-
1225-5p 1,2 1,7 1,4 1,2 1,5 1,6 1,6 1,5 
hsa-miR-
1227 0,4 0,5 0,3 0,3 0,4 0,2 0,3 0,4 
hsa-miR-
1228 0,9 1,0 0,9 0,7 1,1 1,2 1,1 1,0 
hsa-miR-
1229 0,4 0,4 0,3 0,3 0,5 0,3 0,4 0,3 
hsa-miR-
1234 1,3 1,3 1,1 0,8 1,4 1,1 1,2 1,1 
hsa-miR-
1236 0,3 0,4 0,1 0,2 0,3 0,1 0,2 0,3 
hsa-miR-
1237 0,5 0,6 0,5 0,4 0,5 0,5 0,6 0,6 
hsa-miR-
1238 0,8 1,0 0,8 0,6 1,1 0,9 1,0 0,9 
hsa-miR-
125a-5p 0,5 0,2 0,5 0,3 0,8 0,3 0,9 0,3 
hsa-miR-
125b 1,9 0,3 1,7 1,2 0,2 0,0 0,2 0,0 
hsa-miR-126 0,1 0,2 0,5 0,6 0,1 0,3 0,4 0,4 
hsa-miR-128 0,2 0,1 0,2 0,3 0,1 0,2 0,2 0,4 
hsa-miR-
130b 0,1 0,1 0,2 0,3 0,4 0,2 0,4 0,4 
hsa-miR-
139-3p 0,2 0,2 0,3 0,1 0,2 0,1 0,2 0,1 
hsa-miR-
140-3p 3,9 3,7 3,7 4,5 4,5 4,9 3,9 4,4 
hsa-miR-
140-5p 1,5 1,8 1,5 2,5 1,5 2,7 1,5 2,9 





142-3p 27,0 36,3 47,9 63,5 27,2 47,6 36,8 68,8 
hsa-miR-
142-5p 2,9 4,1 3,6 5,4 2,8 5,5 3,1 4,9 
hsa-miR-
146a 2,2 1,5 2,0 4,9 10,7 6,1 10,6 9,8 
hsa-miR-
146b-5p 9,2 14,3 12,3 12,1 6,3 5,1 7,3 4,8 
hsa-miR-
148a 0,2 0,1 0,2 0,3 0,2 0,4 0,3 0,3 
hsa-miR-149 0,8 0,9 0,5 0,5 0,9 0,6 0,6 0,8 
hsa-miR-150 583,1 366,2 549,4 327,7 584,3 334,0 603,1 316,3 
hsa-miR-
150* 0,1 0,1 0,1 0,1 0,1 0,1 0,2 0,1 
hsa-miR-
151-5p 1,8 0,4 1,3 0,6 0,5 0,2 0,5 0,1 
hsa-miR-155 2,1 1,6 2,4 2,5 5,9 5,3 7,0 6,5 
hsa-miR-15a 2,3 2,3 4,1 6,6 4,9 9,1 6,8 12,7 
hsa-miR-15b 17,0 12,2 12,4 15,2 24,5 19,3 21,9 20,3 
hsa-miR-16 26,9 21,7 29,7 39,5 49,3 48,0 53,2 51,0 
hsa-miR-17 3,8 4,4 4,0 4,0 3,8 4,2 3,6 3,0 
hsa-miR-
181a 7,1 6,7 5,0 4,1 3,7 2,9 2,7 3,2 
hsa-miR-
181b 1,2 1,3 0,8 1,0 0,9 0,8 0,8 0,8 
hsa-miR-
181d 0,7 0,7 0,3 0,3 0,6 0,6 0,3 0,2 
hsa-miR-185 0,2 0,3 0,4 0,7 0,4 0,8 0,4 0,7 
hsa-miR-186 0,6 0,6 0,6 0,9 0,5 0,8 0,6 0,9 
hsa-miR-
191* 0,7 1,0 0,7 0,5 0,8 0,8 0,9 0,8 
hsa-miR-192 0,9 1,1 0,8 1,0 0,8 1,0 0,8 0,9 
hsa-miR-
193b 0,6 0,4 0,5 0,3 0,1 0,0 0,0 0,2 
hsa-miR-194 0,2 0,2 0,3 0,3 0,2 0,3 0,2 0,3 
hsa-miR-
195* 0,3 0,3 0,1 0,2 0,3 0,1 0,2 0,3 
hsa-miR-
196a 0,1 0,1 0,1 0,3 0,2 0,2 0,1 0,2 
hsa-miR-197 9,0 4,9 3,3 2,6 5,9 3,8 4,5 3,9 
hsa-miR-
199b-3p 0,1 0,2 0,6 0,5 0,1 0,2 0,3 0,3 
hsa-miR-19a 1,6 2,3 1,9 2,7 1,4 2,7 1,6 1,9 
hsa-miR-19b 12,7 14,8 11,7 14,2 9,3 14,3 10,0 10,0 
hsa-miR-20a 10,3 14,6 11,6 12,3 8,6 11,5 9,6 8,5 
hsa-miR-20b 1,9 1,8 2,1 1,8 1,0 1,2 1,2 1,1 
hsa-miR-21 13,6 17,1 25,8 36,6 65,6 40,6 82,1 64,9 
hsa-miR-21* 0,1 0,1 0,2 0,2 0,7 0,4 0,5 0,3 
hsa-miR-211 0,5 0,6 0,2 0,3 0,4 0,1 0,2 0,5 
hsa-miR-212 0,6 0,7 0,6 0,6 0,6 0,7 0,4 0,7 
hsa-miR-22 0,7 2,2 1,9 5,4 4,5 8,9 4,5 9,5 
hsa-miR-
220b 0,0 0,1 0,0 0,1 0,1 0,0 0,1 0,0 
hsa-miR-221 0,2 0,1 0,3 0,3 0,2 0,3 0,4 0,4 
hsa-miR-222 0,2 0,2 0,1 0,4 0,9 0,5 0,7 0,6 
hsa-miR-223 2,7 2,5 6,0 4,8 3,4 4,1 4,1 4,8 
hsa-miR-23a 3,6 4,2 5,8 8,7 8,5 14,5 9,0 15,7 
hsa-miR-23b 0,5 0,4 0,5 0,7 0,4 0,7 0,6 0,8 
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220b 0,0 0,1 0,0 0,1 0,1 0,0 0,1 0,0 
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hsa-miR-25 5,5 6,1 6,5 7,5 5,7 6,9 6,0 7,0 
hsa-miR-26a 19,2 15,7 21,3 18,2 14,2 14,4 14,7 13,4 
hsa-miR-26b 11,2 12,3 13,5 23,3 12,9 23,9 13,3 23,8 
hsa-miR-27a 0,8 1,6 1,6 2,5 2,5 4,8 2,7 4,9 
hsa-miR-27b 0,2 0,2 0,3 0,5 0,3 0,5 0,3 0,5 
hsa-miR-28-
5p 0,7 1,0 0,9 2,2 1,2 2,4 1,4 2,2 
hsa-miR-
296-5p 0,4 0,4 0,3 0,2 0,4 0,4 0,3 0,4 
hsa-miR-29a 26,4 30,7 30,5 40,9 41,0 44,2 38,1 38,6 
hsa-miR-29b 2,8 4,6 5,3 7,5 4,9 8,6 6,0 7,8 
hsa-miR-
29b-1* 0,1 0,2 0,3 0,3 0,4 0,4 0,5 0,4 
hsa-miR-29c 9,1 11,6 12,3 13,2 6,8 9,7 8,2 9,2 
hsa-miR-
29c* 0,3 0,3 0,1 0,3 0,2 0,1 0,3 0,3 
hsa-miR-30b 5,2 6,3 5,6 6,0 4,0 5,2 3,8 4,7 
hsa-miR-30c 1,9 1,7 1,4 1,8 1,5 1,9 1,6 1,9 
hsa-miR-30d 1,4 1,4 1,3 1,4 1,1 1,5 1,2 1,4 
hsa-miR-30e 1,3 1,9 1,6 2,5 1,2 2,5 1,4 2,3 
hsa-miR-
30e* 0,3 0,3 0,4 0,5 0,3 0,4 0,2 0,5 
hsa-miR-31 0,8 1,6 1,2 1,0 0,4 0,4 0,8 0,4 
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hsa-miR-
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hsa-miR-
33b* 0,4 0,6 0,5 0,3 0,6 0,5 0,6 0,6 
hsa-miR-
342-3p 80,0 58,5 68,7 50,8 56,1 48,7 58,2 45,1 
hsa-miR-
342-5p 8,2 7,0 8,5 5,2 6,4 4,9 6,4 4,8 
hsa-miR-34a 0,1 0,2 0,2 0,3 0,3 0,3 1,1 0,6 
hsa-miR-34b 0,8 0,3 0,1 0,1 0,7 0,0 0,3 0,4 
hsa-miR-
361-3p 1,4 1,4 1,6 1,9 1,7 1,7 1,7 1,6 
hsa-miR-
361-5p 1,0 0,9 1,2 1,2 0,8 1,1 0,9 1,2 
hsa-miR-363 2,2 1,4 1,8 1,1 0,3 0,6 0,5 0,4 
hsa-miR-365 0,5 0,5 0,5 0,3 0,4 0,2 0,3 0,2 
hsa-miR-
374a 0,3 0,6 0,5 1,1 0,5 1,2 0,6 1,0 
hsa-miR-
374b 0,4 0,4 0,5 0,9 0,9 1,1 0,8 1,0 
hsa-miR-
423-5p 1,1 1,0 1,5 1,0 1,2 1,1 1,5 1,1 
hsa-miR-425 0,9 1,0 1,0 1,5 1,4 2,0 1,3 1,7 
hsa-miR-
425* 0,6 0,9 0,6 0,5 0,8 0,7 0,7 0,7 
hsa-miR-451 2,2 2,6 8,0 9,6 2,3 3,3 7,8 8,4 
hsa-miR-454 0,0 0,1 0,1 0,3 0,3 0,2 0,3 0,3 
hsa-miR-
483-3p 1,4 1,1 0,4 0,5 1,4 0,2 1,0 1,1 




hsa-miR-484 0,3 0,3 0,2 0,3 0,4 0,3 0,4 0,4 
hsa-miR-
485-3p 0,7 0,6 0,2 0,3 0,7 0,2 0,6 0,6 
hsa-miR-
486-5p 0,1 0,2 0,3 0,2 0,2 0,1 0,4 0,2 
hsa-miR-494 3,5 3,2 4,5 2,9 3,8 4,4 14,4 4,6 
hsa-miR-549 0,0 0,1 0,0 0,0 0,1 0,0 0,0 0,6 
hsa-miR-550 0,4 0,6 0,5 0,4 0,5 0,5 0,6 0,5 
hsa-miR-563 0,3 0,5 0,3 0,2 0,3 0,5 0,3 0,4 
hsa-miR-564 0,6 0,8 1,0 0,5 0,8 0,7 0,8 0,5 
hsa-miR-572 0,0 0,1 0,1 0,2 0,1 0,1 0,1 0,1 
hsa-miR-
574-3p 15,1 9,6 5,1 3,8 11,3 7,7 9,4 5,8 
hsa-miR-
574-5p 4,2 0,9 1,3 0,7 3,9 0,6 3,5 2,0 
hsa-miR-575 0,8 0,7 0,8 0,6 0,9 0,6 0,9 0,7 
hsa-miR-586 0,0 0,1 0,0 0,0 0,1 0,0 0,0 0,2 
hsa-miR-
590-5p 0,2 0,4 0,2 0,6 0,2 0,6 0,2 0,4 
hsa-miR-595 1,0 0,7 0,3 0,3 1,0 0,3 0,6 0,5 
hsa-miR-602 0,3 0,6 0,3 0,3 0,5 0,6 0,4 0,5 
hsa-miR-613 0,4 0,4 0,1 0,2 0,3 0,1 0,1 0,3 
hsa-miR-
615-3p 0,3 0,4 0,1 0,2 0,3 0,1 0,3 0,3 
hsa-miR-623 0,4 0,3 0,1 0,1 0,3 0,1 0,1 0,2 
hsa-miR-625 0,9 0,8 0,9 0,8 0,9 0,8 1,0 1,0 
hsa-miR-631 0,4 0,3 0,1 0,1 0,3 0,0 0,2 0,2 
hsa-miR-634 0,3 0,3 0,1 0,1 0,2 0,2 0,3 0,3 
hsa-miR-638 1,5 1,8 1,7 1,4 1,9 1,5 1,7 1,5 
hsa-miR-647 0,5 0,2 0,0 0,1 0,4 0,0 0,2 0,2 
hsa-miR-652 0,1 0,1 0,2 0,2 0,1 0,3 0,1 0,2 
hsa-miR-
654-3p 0,6 0,3 0,1 0,1 0,4 0,0 0,5 0,3 
hsa-miR-660 0,1 0,1 0,2 0,3 0,1 0,1 0,1 0,1 
hsa-miR-7 0,2 0,4 0,3 0,7 0,3 0,6 0,3 0,6 
hsa-miR-7-
1* 0,3 0,4 0,4 0,5 0,3 0,5 0,3 0,4 
hsa-miR-
744* 0,6 0,4 0,1 0,1 0,2 0,3 0,1 0,1 
hsa-miR-766 3,6 2,5 1,6 1,4 2,6 2,1 2,3 1,8 
hsa-miR-
768-3p 153,1 161,5 186,6 134,7 193,8 193,8 182,6 160,0 
hsa-miR-
768-5p 4,5 3,6 4,0 3,3 4,7 4,1 4,1 3,8 
hsa-miR-
769-5p 0,3 0,5 0,2 0,3 0,2 0,4 0,3 0,3 
hsa-miR-801 0,5 0,4 0,5 0,3 0,5 0,5 0,7 0,6 
hsa-miR-874 0,4 0,5 0,5 0,3 0,3 0,4 0,4 0,2 
hsa-miR-
877* 0,8 0,6 0,4 0,3 0,9 0,4 0,7 0,6 
hsa-miR-
885-5p 1,3 0,8 0,3 0,4 1,0 0,1 0,6 0,7 
hsa-miR-
886-3p 0,0 0,1 0,1 0,2 0,2 0,3 0,1 0,3 
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hsa-miR-26a 19,2 15,7 21,3 18,2 14,2 14,4 14,7 13,4 
hsa-miR-26b 11,2 12,3 13,5 23,3 12,9 23,9 13,3 23,8 
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hsa-miR-92a 13,2 10,5 14,1 8,4 8,9 7,2 9,8 6,7 
hsa-miR-
92b 0,3 0,7 0,3 0,3 0,4 0,3 0,3 0,5 
hsa-miR-93 0,9 0,9 1,2 1,7 1,4 1,9 1,6 1,8 
hsa-miR-
933 0,4 0,5 0,3 0,2 0,4 0,5 0,3 0,4 
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937 0,5 0,4 0,2 0,2 0,5 0,1 0,3 0,4 
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939 1,0 1,5 1,3 1,3 1,9 2,2 1,4 1,8 
hsa-miR-
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hsa-miR-574-3p Up 12,4 4,5 2,7 
hsa-miR-197 Up 6,8 3 2,3 
hsa-miR-766 Up 3 1,5 2 
hsa-miR-574-5p Up 2 1,9 2 
hsa-miR-328 Up 1,3 0,4 3,4 
hsa-miR-483-3p Up 1,2 0,43 3,5 
hsa-miR-885-5p Up 1 0,4 2,3 
hsa-miR-181d Up 0,7 0,2 3,7 
hsa-miR-595 Up 0,7 0,1 4,3 
miR-877* Up 0,5 0,1 3,2 
hsa-miR-1224-3p Up 0,3 0,1 3,5 
hsa-miR-21 Down 15,6 31,5 2 
hsa-miR-223 Down 2,6 5,5 2 
hsa-miR-451 Down 2,5 9 3,6 
hsa-miR-15a Down 2,3 5,3 2,3 
hsa-miR-22 Down 1,1 3,3 2,8 
hsa-miR-28-5p Down 0,7 1,4 2,1 
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Fig S1. Representative scatter plots demonstrating T cell subsets sorting strategies. Sorting of 
CD45RO- T cells from (A) young and (B) old donors. Sorting was performed on blood samples from 25 
donors; young (n=12) / old (n=13). TNAIVE (CD4/CD8) and TEMRA (CD8) sorting based on CCR7 and 
CD45RO expression from (C), (D) young and (E), (F) old donors; representative examples are shown. 
Sorting was performed on blood samples from 15 donors; young (n=7) / old (n=7). Sorting of CD31+ 
and CD31- (CD4/CD8) (CD45RO-) T cells from (G), (H) young and (I), (J) old donors. Sorting was 
performed on blood samples from 15 donors; young (n=8) / old (n=7). 
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Fig S2. Representative scatter plots demonstrating T cell subsets purity following cell sorting.  
(A) CD3+CD4+CD45RO- and CD3+CD4-CD45RO- sorted cells from young and old (B) 
CD3+CD4+CD45RO-CCR7+, CD3+CD4-CD45RO-CCR7+ and CD3+CD4-CD45RO-CCR7- sorted cells 
from young and old (C) CD3+CD4+CD45RO-CD31+, CD3+CD4+CD45RO-CD31-, CD3+CD4-CD45RO-
CD31+ and CD3+CD4-CD45RO-CD31- sorted cells from young and old. The average percentages (%) 
with standard deviation (SD) of the sorted T cell population purities are indicated below the scatter plots. 




















Fig S3. MiRNA expression signature 
characterizing naïve (CD45RO-) and memory 
(CD45RO+) T cells from young and old CD4 
and CD8 T cell subsets. Unsupervised 
hierarchical clustering of the 166 miRNAs 
detected in at least 7 out of 8 samples shows a 
first separation between CD45RO- and 
CD45RO+ subsets. Within the CD45RO- subset 
further clustering is based on age and within the 
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Fig S3. Validation of microRNA array.  Expressions of miR-197, miR-28-5p, miR-451, miR-328 and 
miR-766 were normalized to the expression of RNU49 (line indicates median). For miR-22, miR-483-3p, 
miR-885-3p and miR-574-3p the Ct values of miRNAs were above 35. For miR-574-5p the design of a 
custom assay failed due to high content of G-U (guanine-uracil) repeats.  Filled symbols indicate CD4+ 







Fig S4. Phenotype of activated CD45RO- T cells. Expression of (A) cell surface activation marker 
CD25 and (B) CD45RO analyzed at day 10 following stimulation with anti-CD3/CD28, depicted as 
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Accumulation of CD28- cytotoxic T lymphocytes (CTLs) is one of the most prominent feature 
of T-cell ageing in vivo. Ex-vivo culture of CD28+ naïve CTLs in the presence of IL-15 also 
induces loss of CD28. Moreover, CD28- CTLs are characterized by high levels of the 
members of the miR-23a~24-2 cluster compared to CD28+ CTLs. Here we tested whether 
the IL-15 driven downregulation of CD28 is mediated through the induction of the three 
miRNAs of this cluster. We confirmed significant higher levels of all three miRNA cluster 
members in CD28- as compared to CD28+ CTLs. Treatment of CD28+ CTLs with IL-15 
induced downregulation of CD28 and a significant induction of miR-23a, miR-24 and miR-
27a. Both the downregulation of CD28 and the induction of these miRNAs were more 
pronounced in IL-15 treated truly naïve CTLs (CD8+CD28+CD45RO-CCR7+) as compared 
to CD8+CD28+ CTLs. The induction was most prominent for miR-24 and miR-27a. By 
luciferase reporter assays we showed that both miR-24 and miR-27a can directly bind to the 
3’-UTR of the CD28 transcript. Preliminary data show a mild decrease of CD28 expression 
upon exogenously expression of miR-24 and miR-27a in Jurkat cells. We confirm IL-15-
induced downregulation of CD28 in truly naïve CTLs and show a pronounced IL-15 induced 
upregulation of the miR-23a~24-2 cluster that possibly contributes to the subsequent 
downregulation of CD28. 









Loss of CD28 in both naïve and memory CD8+ cytotoxic T lymphocyte (CTL) subsets has 
been regarded as one of the most profound and consistent age-associated feature of T cells 
(1-2). CD28-CD8+ T cells are derived from CD28+ as a consequence of active cell 
proliferation, especially in response to latent viral infections, commonly observed in the 
elderly population (3-4). Downregulation of CD28 on CD8+ T cells has been well 
documented not only in response to TCR cross-linking but also in response to homeostatic 
cytokines, such as those which share common γ-chain receptors including IL-15 (2,5,6). IL-
15 is a homeostatic cytokine which supports cell survival and proliferation of naïve 
CD8+CD28+ cells in the absence of continuous TCR stimulation (2). However, little is known 
about the mechanisms that underlie the IL-15 mediated loss of CD28.  
High expression of the three members of the miR-23a~24-2 cluster has been shown in 
CD8+CD28- T cells (7). Increased expression of miR-24, i.e one of the member of this 
cluster, has been reported in CD28- T cells and was associated with an increased 
susceptibility to cell death, which was counterbalanced by IL-15 (7). Age-related 
accumulation of the CD8+CD28- T cell population has been reported in elderly individuals 
and was more pronounced in the bone marrow than in circulation. This accumulation was 
shown to be driven by a local age-related increase of IL-15 and to a lesser extent by IL-6  
(8).  
In this study, we tested the hypothesis that the IL-15 induced loss of CD28 on CTLs is 
mediated by the induction of the miR-23a~24-2 cluster.  
 
Results and Discussion 
We first determined the effect of IL-15 on the regulation of the miR-23a~24-2 cluster 
members in CD8+CD28+ and CD8+CD28- sorted T cells from peripheral blood of 6 healthy 
young study participants (median age 27) (Supplementary Table S1). We observed a 
significant induction of miR-24, miR-27a and miR-23a in CD8+CD28- cells when compared 
to CD8+CD28+ T cells (Supplementary Figure S1 B-D). These findings are in line with the 
results described in a recent study (7). To assess the effect of IL-15 on the expression of 
these miRNAs, CD8+CD28+ T cells were cultured and stimulated with different 
concentrations of IL-15 for 5 days. Expression levels of all three miRNAs were significantly 
induced in IL-15 stimulated versus non stimulated or IL-4 stimulated cells (Figure 1A-C). 
This shows that the induction is specific for IL-15 and is not a general activation dependent 
effect. Induction of miR-23a, miR-24 and miR-27a expression in T cells upon IL-15 
stimulation has not been reported previously.  
Since it is known that CD28 expression is downregulated in actively proliferating cells in the 
presence of IL-15, we next assessed CD28 loss. CD3+CD8+CD28+ T cells showed a 
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Figure S1 E). The moderate downregulation of CD28 is likely related to the differential 
sensitivity T-cell subsets present within the CD3+CD8+CD28+ population, i.e. naïve and 
memory T cells, to the IL-15 induced CD28 downregulation. Indeed, naïve CD8+CD28+ T 














Figure 1. IL-15 induces expression of members of the miR-23a~24-2 cluster and downregulates 
expression of CD28 in naïve CD8+ T cells.  A, Expression levels of miR-24 B, miR-27a C, miR-23a in 
CD3+CD8+CD28+ T cells stimulated with IL-4 or IL-15 and in untreated cells. D, Dynamics of CD28 
loss in naïve CD3+CD8+ CD45RO-CCR7+CD28+ T cells at the protein and  E, mRNA level following IL-
15 stimulation for 15 days. F, expression level of miR-24, G, miR-27a and H. miR-23a in naïve 
CD3+CD8+ CD45RO-CCR7+CD28+ T cells following IL-15 stimulation for 15 days. Expression of 
miRNAs was normalized to the expression of RNU48 (lines indicate median), expression of CD28 
mRNA was normalized to expression of TBP (lines indicate median) ***p ≤ 0.001.  
To study the dynamics of CD28 expression as well as expression of the miR-23a~24-2 
cluster members upon IL-15 stimulation, we next sorted naïve CD8+CD28+ T cells from 6 
healthy young donors (median age 28, Supplementary Table S1 and Figure S2 A). 
Expression of CD28 protein and mRNA levels significantly reduced after 15 days of 
stimulation with IL-15. The percentage of CD28+ T cells decreased from 100% at day 0 to 
36% at day 10 and this loss was confirmed at the mRNA level (Figure 1D,E). Expression of 
miR-23a, miR-27a and miR-24-2 significantly increased upon IL-15 stimulation (Figure 1F-
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H). IL-15 treated naïve CD8+CD28+ cells gained a memory phenotype with enhanced 
expression of CD45RO and decreased expression of CCR7 (Supplementary Figure S2 B,C) 
consistent with previous studies (2). In addition, the majority of the cells gained expression 
of the cellular senescence marker, p16INK4a (Supplementary Figure S2 D). These findings 
indicate that the IL-15 mediated induction of the miR-23a~24-2 cluster is associated with 
downregulation of CD28 and upregulation of p16INK4a.  
Several miRNA target gene prediction algorithms denote two conserved miR-24 and miR-
27a and one conserved miR-23a binding site in the 3’UTR of CD28. This suggests a direct 
relation between the loss of CD28 and the induction of the miR-23a~24-2 cluster members 












Figure 2. CD28 is a direct target of miR-24 and miR-27a. A, Schematic overview of miR-24, miR-27a 
and miR-23a binding sites in the 3’UTR of the CD28 transcript. B, Results of the luciferase reporter 
assay of miR-24 and miR-27a alone or combined shows that these miRNAs can interact with the 3’UTR 
of CD28. Cos-7 cells were co-transfected with psiCHECK-2 construct harboring the CD28 3’UTR and 
control miR-24, miR-27a or a combination of miR-24 and miR-27a miRNA precursors. Shown is the 
Renilla over Firefly luciferase ratio set to 1 for the control precursor transfected cells.  C, Quantification 
of CD28 surface expression in Jurkat T cells upon miR-24 or miR-27a overexpression. Two 
independent experiments are shown (Exp. 1 and Exp. 2). Mean fluorescence intensity values (MFI) 
were determined in EV, miR-24 and miR-27a overexpressing cells. Shown are the fold changes 
calculated from MFI values of the transduced (GFP+) cells normalized to non-transduced (GFP-) cells. 
D, Quantification of CD28 expression in Jurkat T cells by Western blot. Cells were harvested from the 
same 2 independent experiments as shown in C. For exp.1 cells were harvested at day 39 and for exp.2 
at day 32. GAPDH was used a loading control. *p ≤ 0.05, **p ≤ 0.01. 
To determine if these miRNAs indeed bind to the 3’UTR of the CD28 transcript, we 
performed a luciferase reporter assay in COS-7 cells. As miR-23a expression levels were
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very low, we focused our analysis on miR-24 and miR-27a. Significant reduction in relative 
luciferase levels were observed both for miR-24 and for miR-27a co-transfected cells and 
not in control transfected cells (Figure 2B). This confirms that miR-24 and miR-27a directly 
target the 3’UTR of the CD28 transcript.   
To determine the effect of miR-24 and miR-27a on regulation of CD28 expression in Jurkat 
T cells, we stably overexpressed miR-24 and miR-27a in Jurkat T cells using a viral vector 
system (Supplementary Figure S3). Initially, we did not observe an effect of miRNA 
overexpression on the MFI of CD28 at day 32 (Figure 2C (exp. 1)) However, when we 
repeated the experiment we observed a slight decrease of the MFI of CD28 at day 17 and 
32 post infection with the miR-27a vector in GFP+ sorted Jurkat T cells (Figure 2C (exp. 2)). 
For miR-24 we only observed an effect at day 32. The flow cytometry results of experiment 1 
and 2 were confirmed by Western blot, with no effect for experiment 1 and a slight reduction 
in CD28 levels in experiment 2 (Figure 2D). Further experiments are ongoing to establish a 
potential effect of these miRNA on loss of CD28 expression in Jurkat and primary T cells. 
In summary, our results revealed a clear IL-15 induced expression of miR-24 and miR-27a 
in naïve CTLs. Luciferase results support a direct role of miR-24 and miR-27a in the 
regulation of CD28 expression, but this needs to be confirmed at the protein level. IL-15 
driven downregulation of CD28 has in part been attributed to the induction of TNFα secretion 
(6), which alters the promoter activity of the CD28 gene (5). However, we did not study a 
possible role of TNFα on the miRNAs or on CD28 in this study. Thus, in Jurkat cells, miR-24 
and miR-27a in combination with additional CD28 regulatory factors, such as TNFα, regulate 
expression of CD28. Therefore, it would be of interest to study IL-15 mediated CD28 loss in 
a TNFα deficient condition.  
 
Conclusion 
Taken together, we show preliminary results indicating the involvement of IL-15 induced 
expression of miR-24 and miR-27 in the regulation of CD28 loss in naïve CTLs.   
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Materials and Methods 
Participants  
28 healthy young (≤ 30 yrs) individuals were included in this study. Demographic 
characteristics of all donors are summarized in Supplementary Table S1. Informed consent 
was obtained of all participants in accordance with the Declaration of Helsinki. The Medical 
Ethical Committee (METC) of the University Medical Center Groningen approved the study. 
 
Fluorescence-activated cell sorting (FACS) of human primary lymphocyte subsets 
and analysis of cell surface markers 
Peripheral blood mononuclear cells (PBMC) were freshly isolated by density gradient 
centrifugation using Lymphoprep (Axis-Shield, Oslo, Norway) according to the 
manufacturer’s protocol. CD3+CD8+CD28+, CD3+CD8+CD28- and CD3+CD8+CD45RO-
CCR7+CD28+ T cells were isolated by fluorescence-activated cell sorting (FACS) using 
combinations of the following anti-human monoclonal antibodies: anti-CD3-e450, anti-CD8a-
APC-e780 (eBioscience, Vienna, Austria), anti-CD45RO-FITC, anti-CCR7-PE (BD 
Biosciences, Breda, The Netherlands), anti-CD28 PeCy7 (Biolegend, Uithoorn, The 
Netherlands). Sorting strategies are shown in Supplementary Figures S1A and S2A. Cells 
were sorted using a MoFlo flow cytometry cell sorter (Beckman Coulter, Woerden, The 
Netherlands).  
Expression of cell surface markers on T cells was assessed using mAbs against human 
CD28-PECY7 (CD28.2) (Biolegend), CCR7-PE (3D12) and CD45RO-FITC (UCHL1) (BD 
Biosciences). Cells were analyzed using a BD LSR-II Flow Cytometer and the Diva software 
(BD Biosciences). Data analysis was done using the Kaluza Flow Analysis Software (1.2) 
(Beckman Coulter). 
 
RNA extraction and purification 
Total RNA was extracted using the miRNeasy Mini Kit (Qiagen, Venlo, The Netherlands) 
following the manufacturer’s instructions. Micro Bio-SpinTM chromatography columns, 
supplied with Bio-Gel P-6 polyacrylamide gel matrices, were applied to purify the obtained 
RNA samples (Bio-Rad laboratories B.V. Veenendaal, The Netherlands). RNA concentration 
was measured on a NanoDrop ND-1000 Spectrophotometer (NanoDrop Technologies, 
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Quantitative-RT-PCR    
MiRNA expression levels were determined by quantitative RT-PCR. Multiplexed cDNA 
synthesis for all miRNAs and the reference gene was performed using Taqman MicroRNA 
Reverse transcription kit and reverse transcription primers of TaqMan microRNA Assays 
(Life Technologies, Amsterdam, the Netherlands) as described earlier (9). Assays used:  
miR-23a (000399), miR-24 (000402), miR-27a (000408) and RNU48 (001006). RNU48 
served as a reference gene to normalize miRNA expression levels.  
cDNA synthesis for mRNA was performed using Superscript III RTase (Life Technologies). 
The qPCR reaction was performed using qPCR MasterMix Plus (Eurogentec, Liege, 
Belgium). Primers and probe (Integrated DNA Technologies, Coralville, USA) used for 
detection of TBP: forward 5’-GCCCGAAACGCCGAATAT-3’, reverse 5’-
CCGTGGTTCGTGGCTCTCT-3’, probe 5’-6-FAM-ATCCCAAGCGGTTTGCTGCGG-BHQ-1-
3’ and p16INK4a: forward 5’-CCAACGCACCGAATAGTTACG-3’, reverse 
5’GCGCTGCCCATCATCATG-3’, probe 5’-FAM-CCTGGATCGGCCTCCGAC-MGB-3’. TBP 
served as a reference gene to normalize CD28 mRNA and p16INK4a expression levels. 
Taqman gene expression assay was used for detection of CD28: Hs01007422_m1 (Life 
Technologies).  
All PCR reactions were run in triplicate. Mean cycle threshold (Ct) values were quantified 
with the Sequence Detection Software (SDS, version 2.3, Life Technologies). Relative 
expression levels were shown as 2–ΔCt (ΔCt= Ct gene – Ct reference gene) values. 
T cell stimulation with human recombinant IL-15 
FACS sorted CD3+CD8+CD28+ and CD3+CD8+CD28+CD45RO-CCR7+ T cells were 
suspended in RPMI medium (Lonza, Breda, The Netherlands) supplemented with 10mg/ml 
gentamycin sulfate (Lonza) and 10% fetal bovine serum (FBS)(Thermo Scientific, Breda, 
The Netherlands) in a volume of 3mL and seeded at a density of 1x106/mL in T25cm flasks. 
A final concentration of 50ng/mL human recombinant IL-15 (Peprotech, London, UK) or 
20ng/mL human recombinant IL-4 (R&D, Minneapolis, USA) was added to the cell culture at 
day 0 and refreshed every 5th day. T cells were cultured in a humidified atmosphere at 37ºC 
in 5% CO2. On day 5, 10 and 15 of culture, cells were harvested and stained for flow 
analysis and / or lysed for RNA isolation.  
 
Culture of COS-7 cells 
COS-7 cells (African Green Monkey SV40- transformed kidney fibroblast cell line) were 
cultured in Dulbecco modified Eagle medium (DMEM)(Lonza) supplemented with 10% fetal 
bovine serum (Thermo Scientific), 200mM L-glutamine and 10mg/mL gentamycin sulfate 
(Lonza,) in a humidified atmosphere at 37⁰C in 5% CO2.  
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Cloning of 3’UTR in a luciferase reporter construct, transient transfection and 
luciferase reporter assays 
The CD28 3’UTR sequence harboring the putative miR-24, miR-27a and miR-23a binding 
sites was amplified from genomic DNA using primers containing an Xhol (5’) or Notl (3’) 
restriction site, forward: 5’- GCUCCUGCACAGUGACUACA-3’, reverse 5’-
ACCUUCUGCCUGACCACUUC-3’ and cloned into psiCHECK2 vector (Promega, Leiden, 
the Netherlands), as previously described (10). The insert was sequence verified 
(BaseClear, Leiden, The Netherlands). COS-7 cells (1,2 x104) were transfected with 125ng 
of the psiCHECK2 construct and either 50nM hsa-miR-24 (MC10737), hsa-miR-27a 
(MC10939) mimics or a miRNA precursor negative control #1 (Life Technologies) using the 
Saint-MIX compound (Synvolux Therapeutics BV. Groningen, Netherlands) according to the 
manufacturer’s protocol. Cells were lysed 48hrs after transfection and Renilla (RL) and 
Firefly (FF) luciferase activity was assessed using Dual-Luciferase Reporter Assay System 
(Promega) according to manufacturer’s protocol. For each transfection, luciferase activity 
was measured in duplicate with the Luminoskan Ascent Microplate Luminometer (Thermo 
Scientific). The RL/FF) luciferase ratio for miR-24 and miR-27a was calculated. The RL/FF 
ratio of control precursor was set to one.  
 
Viral transduction 
Lentiviral particles were produced by calcium phosphate mediated transfection of HEK293T 
cells with 2,5M CaCl2, 1µg pMSCV-VSV-G, 1µg pRSV.REV, 1µg pMDL-gPRRE and 2µg 
pCDH-EF1-MCS-IRES-GFP. Empty vector and miR-24 and miR-27a overexpression 
constructs were obtained from SBI (System Biosciences, Uden, The Netherlands). Vector 
without insert was used as a negative control (EV). Lentiviral particles were passed through 
a 0,45µM millex-HV PVDF filter (Millipore, Amsterdam, The Netherlands) before infection. 
Jurkat cells at a concentration of 250,000 cells/mL were transduced with the virus and 
placed in a 6 wells plate in a humidified atmosphere at 37⁰C and 5% CO2 overnight. The 
next day, cells were washed 3x times with PBS and diluted to 250,000 cells/mL. Transduced 
cells were sorted based on expression of green fluorescent protein (GFP)  using a MoFlo 
flow cytometry cell sorter (Beckman Coulter). 
 
Western blotting 
Cells (5x106 cells) were lysed in 250µL Radio ImmunoPrecipitation Assay (RIPA) lysis buffer 
(Millipore). Protein concentration was measured with the PierceTM BCA Protein Assay Kit 
(Thermo Scientific). 15 µg of total protein was run on 12,5% polyacrylamide gel and 
transferred to nitrocellulose blot. The blot was blocked with 5% milk in Tris buffer saline 
tween (TBST) for 1hr and incubated overnight with a polyclonal goat antibody against CD28, 
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Quantitative-RT-PCR    
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with the Sequence Detection Software (SDS, version 2.3, Life Technologies). Relative 
expression levels were shown as 2–ΔCt (ΔCt= Ct gene – Ct reference gene) values. 
T cell stimulation with human recombinant IL-15 
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Culture of COS-7 cells 
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Cloning of 3’UTR in a luciferase reporter construct, transient transfection and 
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(1:500, ab113358, Abcam, Cambridge, UK) and monoclonal antibody against GAPDH 
(1:20,000, SC47724, Santa Cruz, Heidelberg, Germany) in  5% milk in Tris buffer saline 
tween (TBST) at room temperature for 1hr.  After being rinsed, the blot was incubated with 
peroxidase-labeled secondary Rabbit  anti-mouse antibody (1:1000 dilution) for 1hr for the 
detection of GAPDH and with Rabbit anti-goat (1:1000) for the detection of CD28. Staining 
was visualized using Supersignal ® Chemiluminescent Substrate (Thermo Scientific). Band 
intensities were quantified using the Gel DocTM EZ system software. (Bio-Rad). 
 
Statistical analysis 
Results obtained from qRT-PCR are expressed as median ± standard deviation 
respectively. Differences between paired samples were tested using the Wilcoxon signed-
rank test. For comparisons of paired unstimulated vs stimulated samples with unequal 
replicates at different time points, the generalized estimating equation (GEE) analysis with 
Wald Chi-Square test was applied. Statistical analyses were performed with GraphPad 
Prism version 5.0 (GraphPad Software, San Diego, CA, USA) and SPSS Statistics version 
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Supplementary Figure S1. MiR-24, miR-
27a and miR-23a are upregulated in 
CD8+CD28- vs CD8CD28+ T cells; IL-15 
induces mild downregulation of CD28. A, 
Representative example of the sorting 
strategy of CD3+CD8+CD28+ and 
CD3+CD8+CD28- T cells. B, Expression of 
miR-24, C, miR-27a and D, miR-23a in 
sorted CD8+CD28+ and CD8+CD28- T 
cells. Expression of miRNAs was 
normalized to the expression of RNU48 
(lines indicate median) E, Percentage of 
CD28 positive cells following stimulation of 
CD8+CD28+ T cells with IL-15 after 15 
days determined by flow cytometer. Cells 
have been stimulated with IL-15 (50ng/ml). 
* p ≤ 0.05. 
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Supplementary Figure S2. Phenotype of CD3+CD8+CD28+ T cells following treatment with IL-15. 
A, Sorting strategy of naïve CD3+CD8+CD28+CD45RO-CCR7+ T cells. B, Percentage of 
CD3+CD8+CD28+CD45RO-CCR7+ T cells expressing CD45RO and C, CCR7 after IL-15 treatment. 
Expression of cell surface markers was determined by flow cytometry and depicted as percentage of 
positive cells. D, p16INK4A mRNA levels in naïve CD3+CD8+CD28+CD45RO-CCR7+ T cells treated 
with IL-15. P16INK4A mRNA expression was normalized to the expression of TBP (median is 









Supplementary  Figure S3. Overexpression of miRNA’s via 
viral vector system. Expression of A, miR-24 and B, miR-27a 
in Jurkat cells transduced with virus carrying miR-24 and 
miR-27a overexpression vectors. MiRNA expression was 
normalized to the expression of RNU48.
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MiR-21 is an important suppressor of T-cell apoptosis, but the relevant miR-21 target genes 
are largely unknown. In this study, we applied Ago2 RNA Immuno Precipitation followed by 
gene expression profiling (RIP-Chip) in Jurkat cells to identify apoptosis-associated miR-21 
target genes. We showed that expression of miR-21 rapidly increases upon αCD3/αCD28 
activation of Jurkat cells. Inhibition of miR-21 resulted in reduced cell growth and induced 
apoptosis. We observed a significant enrichment of miRNA binding motif gene sets in the IP 
fraction of miR-21 overexpressing Jurkat cells as compared to IP of empty vector control 
Jurkat cells. In addition, we found marked differences in enrichment of two apoptosis related 
gene sets. We noted a systematic decrease in transcript levels of predicted miR-21 target 
genes compared to EV control. By applying a 2 fold enrichment in the IP fraction we 
identified 84 genes with a predicted miR-21 binding site of which 71 were enriched 2 fold 
more  in the miR-21 overexpressing cells as compared to EV Jurkat cells. The target gene 
for which the enrichment was most prominent upon miR-21 overexpression was LATS1. 
Luciferase reporter assays confirmed direct targeting of the LATS1 3’UTR by miR-21. 
Western blot analysis and experiments to show if siRNA against LATS1 can rescue the 
phenotype of miR-21 inhibition are ongoing.  
Key words: miR-21, T cells, LATS1, apoptosis 
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Introduction 
Increased miR-21 levels have been shown in various types of solid tumors as well as in 
hematological malignancies (1-5). Consistent with the marked overexpression in cancer, 
several studies showed an anti-apoptotic effect of miR-21. Knockdown of miR-21 correlates 
with increased apoptosis and reduced proliferation of breast cancer cells (2,3). Multiple 
cancer relevant miR-21 target genes, such as Tropomyosin 1 (TPM1), Programmed cell 
death 4 (PDCD4), Phosphatase and tensin homolog (PTEN), Maspin and SNF related, 
matrix associated, actin dependent regulator of chromatin, subfamily A, member 4 
(SMARCA4), have been identified (4-7). More recent studies also showed effects of miR-21 
in T-cell activation and survival (8-11). We showed that memory T cells are characterized by 
a high expression of miR-21. In addition, we showed that activation-induced miR-21 in 
memory T cells provides anti-apoptotic signals allowing long-term survival (9,12). However, 
the miR-21 target genes relevant to the miR-21 induced apoptosis in T cells remain 
unknown. 
In this study we set out to investigate miR-21 target genes related to its anti-apoptotic effects 
in T cells. We employed a high throughput experimental RNA Immuno Precipitation followed 
by gene expression profiling (RIP-Chip) based approach (13) in Jurkat cells, which is a 
frequently used T-cell model to study regulatory pathways involved in T-cell activation and 
apoptosis. We identified the pro-apoptotic molecule, Large tumor suppressor kinase 1 
(LATS1), as the most Ago2-IP enriched miR-21 target gene.  
 
Materials and Methods 
Cell lines  
The Jurkat, human acute leukemic T-cell line was cultured in RPMI 1640 supplemented with 
10% fetal bovine serum (FBS), 200 mM L-glutamine, 100 mM Na-pyruvate, 10 mg/ml 
gentamycin (Lonza, Breda, The Netherlands), 0.05M β-mercapto-ethanol (Merck, 
Darmstadt, Germany) at 37°C in 5% CO2 (complete media). The SV40 Large T-antigen-
transformed human embryonic kidney cell line, HEK293T and Phoenix-Ampho were cultured 
in Dulbecco’s modified Eagle medium (DMEM) supplemented with 10% FBS, 200mM L-
glutamine and 10mg/ml gentamycin sulfate (Lonza) at 37°C in 5% CO2. African Green 
Monkey SV40-transformed kidney fibroblast cell line COS-7 were cultured in Dulbecco 
modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum (FBS) (Thermo 
Scientific, Breda, The Netherlands), 200mM L-glutamine and 10mg/ml gentamycin sulfate at 
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T cell activation with αCD3/αCD28 monoclonal antibodies (mAbs)  
TCR stimulation of Jurkat T-cells was performed with plate-bound anti-CD3 and soluble anti-
CD28 mAbs. Briefly, culture plates were incubated with goat-anti-mouse-IgG2a Ab (Cat. No. 
1080-01, Southern Biotechnology, Uden, The Netherlands) overnight at 4°C, followed by 
washing with PBS and 1h incubation with hybridoma-culture supernatant, containing anti-
human-CD3 IgG2a mAb (clone WT32, approx. conc. 1µg IgG/mL) at RT. Unbound anti-CD3 
antibody was removed by washing 4 times with an excess of PBS. Cells were seeded at the 
density of 0.25x106 cells/mL in medium supplemented with 5% V/V hybridoma-culture 
supernatant containing anti-CD28 IgG1 mAb (clone 20-4669), resulting in a final 
concentration of 0.1µg IgG/mL. At the indicated time points, cells were harvested, lyzed with 
the Qiazol reagent (Qiagen) and stored at -20°C. 
 
Viral constructs 
To stably overexpress miR-21, the pre-miR-21, and ~150nt of the flanking sequence was 
amplified from genomic DNA using forward 5'-gtcagaatagaatagaattgggg-3' and reverse 5'-
gctgcattatggcacaaaag-3' primers. NheI and Xho1 restriction sites were added to the forward 
primer and an EcoRI site was added to the reverse primer to allow directional cloning into 
the retroviral MXW-PGK-IRES-GFP vector (14) using standard laboratory procedures. To 
stably inhibit miR-21 function we used a lentiviral miR-21 inhibition vector (pmiRZip-21) (Cat. 
Nr: MZIP21-PA-1) with a non-targeting lentiviral inhibitor vector (control-inhibitor) as a 
control (Cat. Nr: MZIP000-PA-1, both from Systems Biosciences, Mountain View, USA). 
 
Viral transduction 
Lentiviral particles were produced by calcium phosphate (CaPO4)-mediated 
transfection of HEK293T packaging cells with pmiRZip-21 (miR-21 inhibitor) or 
pmiRZip-scrambled hairpin (control-inhibitor) (Systems Biosciences, Uden, The 
Netherlands) together with pCMV-Δ8.91 and pMD2.G expression vectors in a ratio 
of 4:4:1. Lentiviral particles were collected 48h after transfection and passed 
through a 0.45µm Millex-HV filter (Millipore, Billerica, USA). Lentiviral transduction 
of Jurkat cells was carried out for 24h in the presence of 4µg/ml polybrene (Sigma-
Aldrich, St. Louis, USA).  
Retroviral particles were produced by calcium phosphate (CaPO4)-mediated transfection of 
Phoenix-Ampho packaging cells with 10µg p633-miR-21 (miR-21 overexpression) or p633-
EV (control) and 0,63µg of pSuper-DGCR8 in T25 flask. Retroviral particles were collected 
48h after transfection, passed through a 0.45µm Millex-HV filter (Millipore, Amsterdam, The 
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Netherlands) and concentrated with Retro-X concentrator (Clontech, Saint-Germain-en-
Laye, France) according to the manufacturer’s protocol. Jurkat cells were transduced with 
the virus by spinning at 2,000rpm for 2hrs.  
Transduced cells were sorted based on the green fluorescent protein (GFP) expression 
using MoFlo sorter (Beckman Coulter, Woerden, The Netherlands). 
 
GFP competition assay 
GFP percentage of pmiRZip-21 or pmiRZip-scrambled infected Jurkat cells were followed 
over a period of 22 days. The starting GFP percentage varied between 30-40%. Data were 
acquired on FACS Calibur flow cytometer (BD PharMingen) and analyzed using FlowJo 
software (version 7,6, Treestar, Ashland, OR). The GFP percentage analyzed at the first day 
of measurement (day 4) was set to 1. The GFP competition assay was performed 3 times.  
 
Apoptosis measurement 
Percentages of apoptotic cells were assessed in Jurkat cells transduced with miR-21 or 
control inhibitor in at >95% of the cells on day 4, 6 and 8following viral transduction by 
FACS-based measurement of mitochondrial transmembrane potential loss. Briefly, cells 
were stained for 20min at 37°C in cell culture medium containing 50nM DilC1 (Enzo Life 
Sciences, NY,USA), which was followed by a washing step with PBS. Cells were kept on ice 
and DiLC staining was measured at the FACS Calibur flow cytometer using Cell Quest 
software (BD Biosciences, Breda, The Netherlands). Data were analyzed using Kaluza Flow 
Analysis Software (Beckman Coulter). 
 
Quantitative RT-PCR 
Total cellular RNA was extracted using the miRNeasy Mini Kit (Qiagen, Venlo, The 
Netherlands) following the manufacturer’s instructions. The RNA quantity was measured on 
a NanoDrop ND-1000 Spectrophotometer (NanoDrop Technologies, Wilmington, DE). Gene 
expression levels were analyzed by quantitative reverse-transcription-polymerase chain 
reaction (qRT-PCR). RNA was reverse transcribed using the Taqman MicroRNA Reverse 
Transcription kit in combination with multiplexed reverse transcription primers of TaqMan 
microRNA assays (Life Technologies, Carlsbad, USA): for miR-21 (ID: 000397) and RNU48 
(ID: 001006) (15). The qPCR reaction was performed using qPCR MasterMix Plus 
(Eurogentec, Liege, Belgium) and Taqman Gene expression assays. RNU48 served as 
endogenous control. Mean cycle threshold (Ct) values were quantified with the Sequence 
Detection Software (SDS, version 2.3, Life Technologies, Amsterdam, The Netherlands), 
501394-L-sub01-bw-Nato
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TCR stimulation of Jurkat T-cells was performed with plate-bound anti-CD3 and soluble anti-
CD28 mAbs. Briefly, culture plates were incubated with goat-anti-mouse-IgG2a Ab (Cat. No. 
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using ABI7900HT thermo cycler (Life Technologies). Relative expression levels were 
determined using the 2-ΔCt formula, where ΔCt = Ctgene – CtRNU48.   
 
Ago2-RIP-Chip procedure 
Immunoprecipitation of Ago2-containing RISC complexes was performed as described 
previously by Tan et al. (16) and Slezak-Prochazka et.al (17). Briefly, cleared lysates of 40 
million cells were incubated with protein G Sepharose beads (GE Healthcare) coated with 
anti-Ago2 antibody (Clone 2E12-1C9, Abnova, Taiwan) at 4°C overnight. IP with Anti-IgG 
antibody was used as a negative control (Millipore BV, Amsterdam, The Netherlands). After 
washing the beads, RNA was harvested for microarray and qRT-PCR analysis and protein 
lysates were made for Western blot. Western blot for Ago2 was performed as described 
previously(18). RNA from total (sample taken before start of the IP procedure), flow through 
(sample taken of the supernatant after collection of the IP fraction) and IP fractions were 
isolated with miRNeasy Mini kit (Qiagen, Venlo, The Netherlands) according to 
manufacturer’s protocol. RNA from total and Ago2-IP fractions of Jurkat-miR-21 and Jurkat-
EV cells was used for microarray analysis. Labeling and hybridization was performed using 
two-color Low Input Quick Amp Labeling Kit, according to the manufacturer’s protocol 
(Agilent, Santa Clara, USA). Briefly, 40-100ng of RNA from total cell lysate and Ago2-IP 
samples was used for cDNA synthesis, followed by cRNA amplification and Cy-3 and Cy-5 
labeling. cRNA was purified with RNeasy Kit (Qiagen) and quantified on NanoDropTM 1000 
Spectrophotometer (Thermo Fisher Scientific Inc.). Equal amounts of cRNA Cy-3 and Cy-5-
labelled samples were combined and hybridized at 65°C for 17hrs on the 60k SurePrint 
G3Human Whole Genome Oligo Microarray (Agilent). Next, slides were washed and 
scanned with SureScan Dx Microarray Scanner (Agilent). Scanned images were used for 
Agilent Feature Extraction software version 10.5, converted into Linear and Lowess 
normalized data. Quality control report was generated for each array. Using GeneSpring GX 
version 12.5 (Agilent), quantile normalization of the signals was performed. Next, probes not 
detected in more than half of the samples and probes that are inconsistent (more than 2 fold 
different) in Cy-3 and Cy-5 replicates of the same sample were filtered out. The averaged 
signals for Cy-3 and Cy-5 replicates were used to calculate the IP/T ratio for each sample.  
 
Western blotting 
Cells were lyzed in RIPA lysis buffer (Millipore) supplemented with protease inhibitor cocktail 
(PIC, Sigma-Aldrich, Zwijndrecht, The Netherlands). Lysates were sonicated twice on ice for 
5 sec. (Bandelin sonopuls HD, Berlin, Germany), centrifuged at 12.000rpm for 15min at 4°C, 
and supernatant was collected. Protein concentration was determined using DC Protein 
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Assay following the manufacturer’s instructions (Bio-Rad Laboratories, Hercules, USA). 
Samples were separated on 10% polyacrylamide gels and transferred onto nitrocellulose 
membranes. Membranes were blocked using Odyssey blocking buffer (LI-COR Biosciences, 
Nebraska, USA). Rabbit polyclonal anti-human-PDCD4 antibody (ab51495, Abcam, 
Cambridge, UK) and mouse anti-human-β-actin antibody (C4, Santa Cruz Biotechnology, 
Santa Cruz, USA) were diluted 1000x in Odyssey blocking buffer supplemented with 0.1% 
Tween-20. Immunoblots were incubated with primary antibodies at 4ºC overnight. 
Secondary polyclonal goat anti-mouse antibody conjugated with IRdye 680, and polyclonal 
goat anti-rabbit antibody conjugated with IRdye 800 (both from LI-COR Biosciences) were 
used. Signal was detected with the Odyssey Infrared Imaging System, Odyssey CLx, and 
protein bands were visualized and quantified with Image studio software version 2.0.38 
(both from LI-COR Biosciences). 
 
Cloning of 3’-UTRs in reporter constructs, transient transfection and luciferase 
assays 
3’UTR sequences of LATS1 (LATS1.1 / LATS1.2) harboring miR-21 binding sites were PCR 
amplified from genomic DNA using primers with an Xhol (forward) or Notl (reverse) 
restriction site, for LATS1.1 forward: 5’- AAGGAGAAACCTGGTATCTAT-3’, reverse 5’-
GAAACTAAGGAATACAGGG-3’ and LATS1.2 forward: 5’- AAATTGCTGATACCAAAGG-3’, 
reverse 5’-GGAGGGGACTGAAATGTTAGG -3’ and cloned into psiCHECK2 vector 
(Promega, Madison, USA), as previously described (19). The inserts were sequence verified 
(BaseClear, Leiden, The Netherlands). 1,2 x104 Cos-7 cells were transfected with 125ng of 
the psiCHECK2 construct and 50nM miR-21 inhibitor, molecule ID: 4102261-101 or 
Negative Control #1 inhibitor, (Exiqon, Vedbaek, Denmark), using the Saint-MIX compound 
(Synvolux Therapeutics B.V., Groningen, The Netherlands), in 250µl serum-free medium. 
Four hours following the transfection, 500µl of medium supplemented with 10% FBS was 
added. Cells were lyzed 24h after transfection and Renilla and Firefly luciferase activity was 
measured using the Dual-Luciferase Reporter Assay System (Promega, Leiden, The 
Netherlands) according to the manufacturer’s instructions. For each transfection, luciferase 
activity was measured in duplicate with the Luminoskan Ascent Microplate Luminometer 
(Thermo Scientific). The Renilla over Firefly (RL/FF) luciferase ratio for miR-21 inhibitor was 
calculated. The RL/FF ratio of negative control was set to a value of one. Transfections were 
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Prediction of miRNA target genes  
The miRNA target prediction program TargetScan 6.2 (http://www.targetscan.org/) was used 
to determine predicted target genes of miR-21 (307 conserved genes), miR-146a (224 
conserved genes), and miR-17 (1.220 conserved genes).  
 
Functional annotation analysis 
The functional annotation of genes was performed using the DAVID Bioinformatic 
Resources 6.7 (http://david.abcc.ncifcrf.gov/home), based on the following GO categories: 
GOTERM_BP_FAT, GOTERM_CC_FAT, GOTERM_MF_FAT, KEGG_PATHWAY, 
SP_PIR_KEYWORDS. One to 4 GO terms were considered for description of each gene. 
 
Gene set enrichment analysis 
Gene sets significantly enriched in the Ago2-IP in comparison to total cell lysate fraction of 
Jurkat-EV and Jurkat-miR-21 were determined by the Gene Set Enrichment Analysis using 
the Molecular Signatures Database (GSEA; http://www.broad.mit.edu/gsea) (20). Lists 
containing the expression values of 14,415 genes detected in IP and Total fractions of 
Jurkat-EV or Jurkat-miR-21 were uploaded for the analysis. 
 
Statistical analysis 
For comparison of qRT-PCR data of non-stimulated and stimulated Jurkat cells we applied 
the Friedman repeated measurements nonparametric test. Data from day 0 was compared 
to other days of stimulation (Day 1,2,3). To test for significant difference between 
percentages of viable and apoptotic Jurkat cells upon transduction with control or miR-21 
inhibitor, we applied two-way repeated measures ANOVA with a Bonferroni posttests. The 
average decline of GFP from 3 measurements was used to determine whether the decline in 
GFP percentages of miR-21 inhibited cells was significantly different from the GFP 
percentages of the cells infected with control-inhibitor. For the GFP competition assay, we 
used repeated measures one-way ANOVA, with Dunnet's multiple comparison posttest. A p-
value <0.05 was considered significant. Statistical analysis were performed with GraphPad 
Prism version 5.0 (GraphPad Software, San Diego, CA, USA) and SPSS Statistics version 
22.0 (IBM Corp. Armonk, NY, USA).  
 
Results and Discussion 
To assess if the Jurkat cell line is a suitable model to study the function of miR-21, we 
determined miR-21 expression levels at baseline and after stimulation with αCD3/αCD28. In 
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comparison to other miRNAs known to be expressed in T cells (i.e. miR-17, miR-146a) miR-
21 levels were moderate (Fig 1A). Activation of Jurkat cells with αCD3/αCD28 for 3 days 
revealed a marked induction of miR-21 (≥ 25 fold, p<0.001) (Fig 1B) consistent with previous 




















Fig 1. Validation of the Jurkat cell line as a model to study miR-21 function in T cells. A Relative 
expression of miR-17, miR-21, and miR-146a was analyzed by qRT-PCR in Jurkat cells. MiRNA 
expression was normalized to the expression of RNU48 (error bars indicate SD). B MiR-21 expression 
levels in Jurkat cells analyzed by qRT-PCR with and without αCD3/αCD28 activation. MiR-21 
expression was normalized to RNU48 (Friedman test). C Relative growth of Jurkat cells as determined 
by a GFP competition assay. Cells were stably transduced with miR-21 inhibitor and control inhibitor 
vectors that co-express GFP. The percentage of GFP+ cells was followed for 22 days in three 
independent experiments.  D Percentages of viable Jurkat cells upon transduction with control or miR-
21 inhibitor based on the forward and side scatter pattern obtained by FACS. Median values with 
ranges are depicted. E Percentages of apoptotic Jurkat cells in culture upon transduction with control or 
miR-21 inhibitor. Apoptotic cells were defined by the loss of mitochondrial trans-membrane potential as 
assessed by FACS analysis using DilC compound (50nM). F Representative FACS plot depicting the 
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Fig 1. Validation of the Jurkat cell line as a model to study miR-21 function in T cells. A Relative 
expression of miR-17, miR-21, and miR-146a was analyzed by qRT-PCR in Jurkat cells. MiRNA 
expression was normalized to the expression of RNU48 (error bars indicate SD). B MiR-21 expression 
levels in Jurkat cells analyzed by qRT-PCR with and without αCD3/αCD28 activation. MiR-21 
expression was normalized to RNU48 (Friedman test). C Relative growth of Jurkat cells as determined 
by a GFP competition assay. Cells were stably transduced with miR-21 inhibitor and control inhibitor 
vectors that co-express GFP. The percentage of GFP+ cells was followed for 22 days in three 
independent experiments.  D Percentages of viable Jurkat cells upon transduction with control or miR-
21 inhibitor based on the forward and side scatter pattern obtained by FACS. Median values with 
ranges are depicted. E Percentages of apoptotic Jurkat cells in culture upon transduction with control or 
miR-21 inhibitor. Apoptotic cells were defined by the loss of mitochondrial trans-membrane potential as 
assessed by FACS analysis using DilC compound (50nM). F Representative FACS plot depicting the 
increase of apoptotic cells upon miR-21 inhibition as loss of DiLC staining. *p<0.05, ***p<0.001. 
 
501394-L-sub01-bw-Nato
 CHAPTER 7   
130  
Inhibition of miR-21 in Jurkat cells in a GFP competition assay revealed a significant 
decrease of miR-21 inhibitor transduced GFP+ cells when compared to GFP-non-
transduced cells (Fig 1C). Cells transduced with the non-targeting control inhibitor showed 
no effect on cell growth in the GFP competition assay. Jurkat cells transduced with miR-21 
inhibitor at a percentage of >90%, showed a significant decrease of live cells at day six , 
which was not observed with control transduced cells (Fig 1D). This effect was mirrored by 
an increase of apoptotic cells reaching >80% (Fig 1E,F). These findings are consistent with 
the findings in primary T cells (9) and indicate that the endogenous levels of miR-21 in 
Jurkat cells provide essential anti-apoptotic signals. Together, these data show that the 
Jurkat cell line is a suitable model to study the anti-apoptotic properties of miR-21 in T cells.  
To identify the anti-apoptotic miR-21 target genes, we performed Ago2-RIP-Chip (Fig 2A) on 
Jurkat cells overexpressing miR-21 (Jurkat-miR-21) and used Jurkat cells transduced with 
an empty vector construct (Jurkat-EV) as a control (Fig 2B). The efficiency of the Ago2 
immunoprecipitation (Ago2-IP) as determined by Western blot was comparable between 
Jurkat-EV and Jurkat-miR-21 cells (Fig 2C). MiR-21 was strongly enriched in the Ago2-IP 
fractions in comparison to the total fractions, with 86-fold higher levels in the Ago2-IP 
fraction of Jurkat-miR-21 cells (Fig 2D).  
Gene set enrichment analysis (GSEA)(22) revealed a strong enrichment of miRNA binding 
motifs in both Jurkat-miR-21 and Jurkat-EV (Table 1). Comparison of both top-10 enriched 
gene sets revealed a marked overlap between Jurkat-miR-21 and Jurkat-EV cells with 8 
shared gene sets (Table 1). A marked difference was observed for 2 apoptosis related gene 
sets. Genes regulated upon treatment with the growth and survival factor IL-6 were among 
the top 10 most enriched gene sets in Jurkat-EV but not in Jurkat-miR-21 (position 258). 
Genes involved in sensitivity to TRAIL induced apoptosis were found among the top 10 most 
enriched in Jurkat-miR-21 but not in Jurkat-EV (position 1237). The expression levels of the 
latter gene set showed an overall decrease in the total cell lysate of Jurkat-miR-21 as 
compared to Jurkat-EV (Supplementary Fig S1). These differences can be explained by 
either direct or indirect effects of miR-21 and fit with the observed anti-apoptotic role of miR-
21 in Jurkat cells. The miR-21-binding motif was at the 46th position of most enriched gene 
sets in Jurkat-EV (false discovery rate (FDR) = 0.0013) and at the 28th position in Jurkat-
miR-21 (FDR<0.001). Comparison of the expression levels of all miR-21 predicted target 
genes (n=209 out of 14,514 unique genes) between the total cell lysate of Jurkat-EV and 
Jurkat-miR-21 revealed a systematic decrease in mRNA levels in Jurkat-miR-21 (Fig 3A). 
This indicates that transcript levels of predicted miR-21 genes were decreased upon miR-21 
overexpression. As a control, we also analyzed differences in the expression levels of 
predicted miR-146a targets (162 out of 14,514) and predicted miR-17 levels (929 out of 
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14,514). No difference was observed for the predicted miR-146a target genes, while a mild 
























Fig 2. Efficiency of Ago2-RISC immunoprecipitation in Jurkat-EV and Jurkat-miR-21 cells. A 
Schematic representation of the RISC immunoprecipitation procedure using an antibody against 
endogenous Ago2 protein. B qRT-PCR analysis of miR-21 in Jurkat cells transduced with empty vector 
(EV) or miR-21. MiR-21 expression was normalized to RNU48 and the level detected in Jurkat-EV was 
set to 1. C Western blot analyses of Ago2 to determine the efficiency of the Ago2 immunoprecipitation 
(α-Ago2 IP) in Jurkat-EV and Jurkat miR-21. Immunoprecipitation with mouse IgG1 served as a 
negative control. T - total cell lysate, FT - flow through, IP - immunoprecipitation. D qRT-PCR analysis of 
miR-21 levels in RNA isolated from T, FT and IP fractions of αAgo2 and control mouse α IgG1 
immunoprecipitation experiments of Jurkat-EV and Jurkat-miR-21 cells. MiR-21 expression was 
normalized to RNU48 and the level detected in the total cell lysate of Jurkat-EV was set to 1. MiR-21 
was enriched in the αAgo2 IP fractions of Jurkat-EV and Jurkat-miR-21, and was 86 fold higher in the IP 
fraction of Jurkat-miR-21 as compared to the IP fraction of Jurkat-EV. 
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This latter observation can be explained by the marked overlap between the miR-21 and 
miR-17 predicted target genes, i.e. 62 shared predicted target genes. In line with these 
observations we noted a specific enrichment of predicted miR-21 target genes among the 
top 1800 genes enriched in the IP of Jurkat-miR-21 (n=84) as compared to the IP of Jurkat-
EV (n=57). The enrichment was even more pronounced among the top 250 enriched genes 
(n=20 versus n=10) (Fig 3B). 
 
As a control, we also analyzed enrichment of the predicted target genes of miR-146a and 
miR-17, which revealed no differences between Jurkat-EV and Jurkat-miR-21 (Fig 3B). 
Together these data show an efficient enrichment of miRNA target genes in the IP fractions 
of both conditions and a marked enrichment of miR-21 predicted target genes in Jurkat-miR-
21.  









TGAATGT,MIR-181A,MIR-181B,MIR-181C,MIR-181D 9 2 
GCACTTT,MIR-17-5P,MIR-20A,MIR-106A,MIR-106B,MIR-20B,MIR-
519D 1 3 
TTTGCAC,MIR-19A,MIR-19B 8 4 
ACACTAC,MIR-142-3P 4 5 
GTGCAAT,MIR-25,MIR-32,MIR-92,MIR-363,MIR-367 6 6 
TGCACTT,MIR-519C,MIR-519B,MIR-519A 7 7 
TTGCACT,MIR-130A,MIR-301,MIR-130B 10 8 
HAMAI_APOPTOSIS_VIA_TRAIL_UP 1237 9 
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ACTTTAT,MIR-142-5P 5 17 
ATAAGCT,MIR-21 46 28 
BROCKE_APOPTOSIS_REVERSED_BY_IL6 3 258 
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84 predicted miR-21 targets were at least 2 fold enriched in Jurkat-miR-21 IP as compared 
to the total fraction. 71 out of these targets were enriched at least 2-fold more in the IP of 
Jurkat-miR-21 as compared to Jurkat-EV. The gene ontologies of these genes are shown in 
Table 2. Six genes were related to regulation of apoptosis, i.e. PDCD4, Ras homology family 
member B (RHOB), Mitogen – activated protein kinase 1 (MAP3K1), Protein kinase C 















Fig 3. MiR-21 targets are more enriched in the Ago2-IP fraction upon miR-21 overexpression and 
their transcript levels are decreased. A Bland-Altman plots comparing the expression levels of miR-
21, miR-146a and miR-17 predicted target genes in total cell lysates of Jurkat-EV and Jurkat-miR-21. 
The expression difference of each gene is plotted against its mean expression. Red lines represent the 
best fit to the data. B Percentages of predicted miR-21, miR-146a, and miR-17 target genes in all 
14,514 expressed genes and in the top 1800 and top 250 most enriched genes in the IP fraction of 
Jurkat-EV and Jurkat-miR-21. White bars and black bars indicate genes enriched in the Ago2-IP fraction 
of Jurkat-EV and Jurkat-miR-21, respectively.   
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Table 2. Functional annotation of 71 predicted miR-21 target genes enriched ≥ 2 fold in miR-21 IP








 LATS1 4,8 126,9 26,6 cell cycle regulation (negative), serine/threoninekinase activity
FAM63B 1,2 19,3 16,5 phosphoprotein
MBNL1 2,2 34,7 15,8 RNA splicing regulation
TRPM7 1,9 21,8 11,3 transmembrane protein, cation channel activity
CDK6 0,8 7,8 9,7 cellcycle regulation, cyclin-dependent protein kinase activity, p53 signaling pathway
RAB22A 0,8 6,4 7,9 intracellular signaling cascade, GTPase activity
PAG1 0,9 7 7,8 immune system, lymphocyte activaiton (negative), molecular adaptor activity
TET1 1,7 13,4 7,8 oxidoreductase activity
  BMPR2 2,5 19,8 7,8 phosphorylation regulation (positive), serine/threonine kinase activity, TGF-beta signaling pathway
PLAG1 7,8 61,2 7,8 transcription regulation, transcription factor activity
STAG2 0,9 6,5 7,4 cell cycle regulation, chromosome segregation, mitosis, meiosis
FAM126B 2,4 17,2 7,2 phosphoprotein
UBN2 1,7 11,8 7 phosphoprotein
 PIK3R1 1,3 9,3 6,9 immune system development, lymphocyte activation, kinase regulator activity, T cell receptor signaling
YOD1 2,8 19,6 6,9 proteolysis, peptidase activity
RPS6KA3 0,6 4,1 6,5 serine/threonine kinase activity, MAPK signaling pathway
NFAT5 2 12,7 6,4 immune system, transcription regulation (positive), transcription factor activity, T cell receptor signaling
FBXO28 3 18,1 6,1 proteolysis
LCORL 1,3 7,7 6,1 transcription regulation
  PDCD4 0,9 5,3 5,7 apoptosis regulation (positive), cell cycle regulation(negative), negative regulation of kinase activity
PAN3 4,1 23,5 5,7 mRNA catabolism process, protein kinase activity
MSL1 0,9 5,3 5,6 chromatin organization
PLEKHA1 6 31,3 5,3 enzyme linked receptor protein signaling pathway
AP4E1 1 5,1 5,3 intracellular protein transport
KLHL15 3,4 17,8 5,3 na
PBRM1 0,7 3,7 5,2 cell cycle regulation, chromatin regulator
ZYG11B 0,8 4,1 5,1 proteolysis
CPEB3 4,2 20,9 5 RNA binding
PRPF4B 1 4,8 5 RNA processing, serine/threonine kinase activity
PIKFYVE 0,8 3,9 4,9 intracellular signaling cascade, phosphatidylinositol signaling system
SATB1 1,5 7,3 4,8 transcription regulation (negative), chromatin organization
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RASGRP1 1 4,6 4,7 immune system, intracellular signaling cascade, T cell receptor signaling pathway
FBXO11 1,2 5,6 4,6 proteolysis, ubiquitin ligase complex
 PURB 1,5 6,9 4,6 transcription regulation (negative), transcription factor activity
WWP1 2 9 4,4 proteolysis, ubiquitin ligase complex
TOPORS 0,9 3,8 4,4 proteolysis, response to DNA damage stimulus
FAM3C 4,7 20,3 4,3 cytokine activity
 BCL11A 2,8 12,2 4,3 immune system development, lymphocyte activation, transcription repressor activity
C10orf12 0,8 3,5 4,3 phosphoprotein
KLF12 1 4,1 4,3 transcription regulation, transcription factor activity
CHIC1 3,2 13,5 4,2 cytoplasmic membrane-bounded vesicle
SLC10A7 2,5 10,2 4,1 ion transport, organic acid:sodium symporter activity
RASA1 1,6 6,2 3,9 apoptosis regulation (negative), GTPase activity, MAPK signaling pathway
SECISBP2L 1,7 6,4 3,9 phosphoprotein
 FRS2 5,4 20,6 3,8 cell-cell signaling, phosphorylation regulation, phosphatase regulator activity
TRIM33 1 3,9 3,7 transcription regulation (negative)
EIF2C4 1,1 4,2 3,7 translation regulation (negative), ribonucleoprotein complex
ZNF217 3,3 12 3,6 transcription regulation, transcription factor activity
CHD7 1 3,6 3,5 immune system development, lymphocyte activation, helicase activity
NFIA 1,1 3,9 3,4 transcription regulation, transcription factor activity
SKI 2,5 8,1 3,3 transcription regulation (negative), transcription factor activity
C5orf41 7,5 24,5 3,3 transcription regulation, transcription factor activity
ZNF367 13,7 38,5 2,8 transcription regulation, transcription factor activity
EIF4EBP2 3,3 9,3 2,8 translation regulation (negative)
RECK 2,7 7,5 2,8 vasculature development, peptidase inhibitor activity
MARCH5 2,9 7,5 2,6 proteolysis
  TNRC6B 1,4 3,6 2,6 translation regulation (negative), ribonucleoprotein complex
RHOB 1,9 4,8 2,5 apoptosis regulation (positive), cell cycle regulation (negative), GTPase activity
AP3M1 1,4 3,6 2,5 intracellular protein transport
ATPAF1 2,1 5,2 2,5 protein complex assembly, mitochondrion
KBTBD6 1,9 4,7 2,5 proteolysis
PPP1R3B 2 4,8 2,4 insulin signaling pathway, glucose metabolism process
ZFP36L2 2,5 6 2,4 mRNA stability regulation, transcription factor activity
BCL7A 2,7 6,5 2,4 transcription regulation (negative)
 MAP3K1 1,5 3,4 2,3 apoptosis regulation (positive), stress-activated protein kiase signaling pathway, MAPK signaling pathway
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CNOT6 1,8 4,2 2,3 transcription regulation, nuclease activity
CD69 31,9 72,6 2,3 transmembrane protein
KLF3 2,1 4,4 2,1 transcription regulation, transcription factor activity
PRKCE 2,1 4,1 2 apoptosis regulation (positive), calcium-independent protein kinase C activity
SLC7A6 1,8 3,7 2 organic acid transport, amino acid transmembrane transporter activity
In grey target genes  present in EV and miR-21; not gray: target genes specific for Jurkat-miR-21 cells; 
in bold: genes selected for validation
Involvement of miR-21 in regulation of the tumor suppressor PDCD4 has been well 
established (21,1). We confirmed the upregulation of PDCD4 protein expression upon miR-
21 inhibition in Jurkat cells (Supplementary Fig S2). LATS1 was the most strongly enriched 
target gene in the Jurkat-miR-21 IP fraction (Table 2). We identified one 8-mer and two 7-
mer miR-21 binding sites in the 3’UTR of LATS1 (Fig 4A). Luciferase reporter assays with 
two constructs including one or two of the predicted miR-21 binding sites (Fig 4A) confirmed 
binding of miR-21 to the 3’UTR of LATS1 (Fig 4B). 
Fig 4. Luciferase reporter assay for LATS1 3’UTR. A Schematic presentation of the location of the 
miR-21 binding sites in the 3’UTR of LATS1 and the regions cloned into the reporter vector. Binding site 
sequences are shown in the lower part. B Luciferase reporter assay shows that miR-21 can bind to the 
miR-21 binding sites in LATS1. Plotted is the ratio of Renilla luciferase (RL) to firefly luciferase (FL) 
signal detected in lysates of Cos-7 cells transfected with psiCHECK-2 construct and co-transfected with 
miR-21 inhibitor or control inhibitor. 
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Further confirmation of a miR-21 dependent regulation at the protein level and phenotype 
copy/rescue experiments are ongoing. LATS1 has been shown to be involved in apoptosis 
regulation via induction of pro-apoptotic protein p53 (22) and was shown to be a direct target 
of miR-21 in cervical cancer cells (23). These data support a potential role of the miR-21 
target gene LATS1 in Jurkat cells. 
Conclusion
In summary, we showed that the Jurkat cell line is a suitable model to study the role of miR-
21 in the regulation of T cell apoptosis. We experimentally identified multiple miR-21 target 
genes via employing Ago2 RIP-Chip, with LATS1 being a potentially relevant target for the 
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Supplementary Fig S1.  
Bland-Altman plots comparing the expression levels of apoptosis related gene sets in total cell lysates 
of Jurkat-EV and Jurkat-miR-21. The expression difference of each gene is plotted against its mean 
expression. Red lines represent the best fit to the data. 
 
 
Supplementary Fig S2.  
Western blot depicting PDCD4 protein expression in 
Jurkat cells transduced with control or miR-21 
inhibitor. Two independent miR-21 inhibition 
experiments are depicted. PDCD4 to β-actin ratio in 
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Summary and Discussion 
Altered T cell subset composition and functionality are well acknowledged changes that 
occur during ageing (1-4). At present, the molecular mechanisms underlying these age-
related changes in T cell subset composition and function are not fully understood. Gene 
expression changes caused by miRNAs is one of the molecular mechanisms that impact T-
cell physiology.  
The overall aim of this thesis was to study T-cell activation induced kinetics of miRNA 
expression, determine age related changes in miRNA expression in defined T-cell subsets 
and to dissect the role of specific miRNAs in the age related alterations of T cell composition 
and function. 
In chapter 2 we reviewed the literature with respect to involvement of miRNAs in specific T 
cell subsets during maturation and upon ageing. An extensive number of studies describe 
crucial roles for miRNAs in differentiation of defined T-cell subsets. The expression levels of 
specific miRNAs change upon antigen engagement of T cells and regulate downstream 
signaling pathways of TCR (5,6). In addition, studies showing age-associated changes in 
miRNA levels in T cells are emerging. Single miRNAs have been shown to interfere with 
specific pathways important for physiological function of T cells, e.g. TCR signaling, cell 
cycle and impaired DNA damage responses (7-9). Despite of these relative recent findings, 
there only are a limited number of studies that have addressed dynamics of activation 
induced miRNA changes. Moreover, comprehensive overviews of ageing-related changes in 
miRNA expression and concepts on how they are involved in ageing of T cells are still 
lacking. 
In Chapter 3 we investigated changes in miRNA expression patterns in CD4 and CD8 T 
cells upon in vitro T-cell stimulation with αCD3/αCD28. We showed dynamic activation 
induced changes, with upregulation of several miRNAs, such as miR-21, miR-155 and miR-
146a, in agreement with previously published studies (10-12). Strong upregulation of miR-21 
in both CD4 and CD8 T cells is likely to play an important role in immune responses. MiR-21 
targets genes involved in TCR signaling, such as AP-1 and CD69 (13). Thus, increased 
expression of miR-21 in T-cell subsets is likely to negatively modulate signal transduction 
downstream of TCR and hence dampen immune responses. In addition, we identified 
downregulation of miR-31, miR-223 and miR-451 following T-cell activation. Differential 
regulation between CD4 and CD8 T cells was observed for four miRNAs. These are new 
findings that add to current knowledge on T-cell activation. Specifically, we showed induction 
of miR-18a and miR-21 and downregulation of miR-223 and miR-451 which was, for all four 
miRNAs, more pronounced in CD4 then in CD8 T cells. This can be explained as a result of 
differential responses of CD4 and CD8 T cells to antigen. Interestingly, we observed 
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downregulation of miR-31 in contrast to a previous study that reported an increased 
expression of miR-31 following CD4+ T-cell activation (6). This discrepancy may be 
explained by differences in the experimental set up between these two studies such as the 
concentrations of αCD3/αCD28 and the incubation time. Overall, we present a complex 
pattern of miRNA expression regulation upon T-cell activation which reflects activation 
kinetics and may play a role downstream of T-cell signaling.  
 
Age related miRNA expression changes in T cells  
In Chapter 4 we generated miRNA signatures of T-cell clones of healthy young and elderly 
donors with low and high population doublings (PD’s) by small RNA-sequencing. We 
showed that the most pronounced changes were related to population doublings (PD’s) of T-
cell clones regardless of the age of the donors. High PD T-cell clones are accepted to 
represent a state resulting from chronic antigenic stress and, as such, are used to study the 
effects of clonal T-cell expansion (14). High PD T-cell clones are characterized by loss of 
CD28 expression and reduced production of IL-2. We showed increased expression of miR-
9 and miR-34 in T-cell clones with high number of PD’s. Potential target genes of these 
miRNAs identified by AGO2-RIP-Chip experiments in Jurkat cells included genes associated 
with cellular senescence and cell cycle pathways. For one of these targets, CR4-NOT 
Transcription Complex Subunit 6- Like (CNOT6L), the expression levels in the T-cell clones 
showed an inverse correlation with high PD’s. Further work is required to validate if CNOT6L 
is a true target of miR-9 and/or miR-34a. In addition, we showed increased miR-9 levels in 
CD28- T cells as compared to CD28+ T cells. A possible direct targeting effect was 
proposed based on the identification of two binding sites of miR-9 in 3’UTR transcript of 
CD28, but inhibition of miR-9 in Jurkat cells did not result in increased expression of CD28  
(see below).  
We further determined a positive regulation of IL-2 by miR-9, which is consistent with a 
previously published study (15). Inhibition of miR-9 in Jurkat cells resulted in a decreased 
amount of soluble IL-2. MiR-9 has been suggested to positively regulate IL-2 production via 
targeting PR domain containing 1, with ZNF domain (PRMD1) which is a suppressor of IL-2 
(15). We observed a negative correlation between IL-2 levels and PD’s and a positive 
correlation between miR-9 and PD’s. A possible explanation for this observation might be a 
sustained expression of PRDM1 in longitudinally cultured cells due to ineffective inhibition by 
miR-9We have not studied expression levels of PRDM1 in T-cell clones which, thus, 
remains to be established. 
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In Chapter 5 we studied age-associated differences in miRNA signatures in naïve 
(CD45RO-) and memory (CD45RO+) T cells. We observed age-related differences in 
miRNA expression predominantly within the CD45RO- and not in CD45RO+ T-cell 
compartment. Seventeen miRNAs showed at least 2-fold change in between CD45RO- T 
cells obtained from young and old donors. We validated age-dependent increase in the 
levels of miR-21, miR-223 and miR-15 in CD45RO- T cells. The age-associated differences 
in miR-21 expression were restricted to naïve (CD45RO-) T cells. The age-related 
differential miRNA expression in naïve CD45RO- T-cells could present true age associated 
differences or differences related to changes in the composition of this T-cell subset  in 
elderly individuals. The two main changes in the CD45RO- T-cell compartment during 
ageing are the accumulation of highly differentiated effector memory T cells (TEMRA) and the 
increase of peripherally expanded CD31- Tnaive cells. We observed increased expression of 
miR-21 and miR-223 in TEMRA cells when compared to naïve T cells. In addition, we found 
increased expression of miR-21 in CD31- Tnaive cells. The observed findings are consistent 
with a previous study that reported high expression of miR-21 in effector memory and TEMRA 
subsets of CD8 T cells (16). Expression of miR-223 within T-cell subsets has not been 
studied previously. We observed increased expression of miR-21 upon T cell activation 
while we observed decreased expression of miR-223. Moreover, miR-21 but not miR-223 
levels were increased in T-cell clones with high population doublings. Age-related increase 
in miR-21 is likely driven by post-thymic TCR stimulation. As miR-21 has a known anti-
apoptotic role, we speculate that increased expression of mR-21 in TEMRA and CD31- Tnaive 
cells is protective against apoptotis and one of the explanations for the prolonged survival 
and accumulation of these T-cells with age.  
In both chapter 4 and chapter 5 we identified changes in miRNA expression corresponding 
to T-cell ageing. In chapter 4 miRNA expression differences reflected cellular ageing of T 
cells, while in chapter 5 miRNA expression changes reflected combination of T-cell 
composition changes, activation and cellular ageing. We did not identify the same miRNA 
expression changes in chapters 4 and 5. This can be explained by the distinct T-cell 
populations used for analysis, e.g. CD4 T-cell clones, while ex vivo isolated naïve CD45RO-  
cells were included both CD4 and CD8 T-cell subsets.  
 
The role of miRNAs in the regulation of CD28 expression 
In chapter 6, we studied the involvement of the miR-23a~24-2 cluster in the IL-15-induced 
downregulation of CD28. IL-15 treatment was previously shown to induce an effector 
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decreased expression of CD28 following IL-15 treatment. In addition, we showed a 
significant upregulation of the miR-23a~24-2 cluster by IL-15. Moreover, we showed direct 
targeting of CD28 by two members of this cluster, i.e. miR-24 and miR-27a, in luciferase 
reporter assays. To determine whether endogenous CD28 transcripts are also targeted by 
miRNA-24 and miR-27a, we overexpressed these miRNAs in Jurkat cells that express high 
levels of CD28. We were not able to demonstrate a clear effect on CD28 expression upon 
miRNA overexpression in Jurkat cells. In chapter 4 we also failed to see an effect of miR-9 
inhibition on CD28 expression (see above). The failure to show an effect on CD28 
expression may in part be related to the high expression of CD28 in Jurkat cells, which may 
be hard to modulate by the overexpression or inhibition of single miRNAs. Alternatively, we 
might not see an effect on CD28 expression due to presence of other high affinity targets, 
which can act as sponges and prevent binding to and regulation of the CD28 transcript.  
To further study the possible regulation of CD28 protein expression in Jurkat cells by 
miRNAs, we determined which miRNAs were predicted to bind to the 3’UTR by at least two 
target gene prediction programs. In addition to the miR-23a~24-2 and miR-9 binding sites 
discussed above, we revealed two miR-31 binding sites (Figure 1). We have previously 
identified decreased expression of miR-31 upon T-cell stimulation in chapter 3. However, 
we found increased levels of miR-31 in CD28- T cells when compared to CD28+ T cells 
(Figure 2A). The high number of predicted miRNA binding sites for different miRNAs, might 
at least in part explain why we were not able to show an effect on CD28 protein expression 






Figure 1. Schematic overview of miRNA binding sites in the 3’UTR of CD28. MiRNA binding sites, 
as identified by at least two different miRNA target gene prediction programs are depicted. In addition, 
we indicated the two 6-mer miR-9 seed sequences as identified in chapter 4.  
 
To determine the endogenous levels of the above mentioned miRNAs, we performed qRT-
PCR in Jurkat cells (Figure 2B). This revealed high expression of miR-9, moderate 
expression of miR-24 and relatively low expression of miR-27a, miR-23a and miR-31. As 
CD28 levels are high in Jurkat, it is unlikely that the highly expressed miR-9 alone can 
regulate CD28 expression in Jurkat cells. In line with the high CD28 expression in Jurkat 
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cells we did not observe enrichment of the CD28 transcript in the AGO2-IP fraction 
indicating that CD28 transcripts are not targeted by miRNAs in Jurkat cells. It may very well 
be that multiple miRNAs that can bind to the 3’UTR of CD28 need to be expressed at high 
levels to reach effective targeting of CD28. Despite of the effectiveness of using cell line 
models for studying many T cell properties, Jurkat cells may not represent the right model to 
study miRNA-dependent regulation of CD28. Maybe, other cell lines, e.g. lymphoblastic 
leukemia cell line Molt4 with moderate CD28 expression levels or primary T cells need to be 







Figure 2. MiRNA expression in primary T-cell subsets and Jurkat T cells. 
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23a, miR-24a, miR-27a, miR-31 and miR-9 expression levels in Jurkat T cells. Expression of miRNAs 
was normalized to the expression levels of RNU48.  
 
The role of miR-21 in T cells  
MiR-21 has been well characterized in terms of its pro-survival and anti-apoptotic properties 
in T cells (10,18). In line with these findings, we observed reduced cell growth and induction 
of apoptosis upon inhibition of miR-21 in Chapter 7. Despite of the existing evidence on 
functional involvement of miR-21 in T-cell survival and apoptosis, so far no studies have 
provided a comprehensive overview of genes targeted by miR-21 in T cells. To identify T-
cell specific miR-21 target genes, we performed AGO2 RNA Immuno Precipitation (RIP) 
experiments followed by gene expression profiling (Chip) in Jurkat cells with miR-21 
overexpression. We identified the pro-apoptotic molecule large tumor suppressor kinase 1 
(LATS1) as the most enriched miR-21 target gene and verified LATS1 as a direct target of 
miR-21. In line with our findings, a very recent study also showed a role for miR-21 in the 
regulation of LATS1 in cervical cancer cells (19). LATS1 is a member of Hippo signaling 
pathway and is involved in regulation of cell proliferation and survival which was 
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was demonstrated by showing that overexpressing inhibited cell growth and induced 
apoptosis in breast cancer cells (21). Activation of the p16-Rb pathway has been linked to 
reduced LATS1 levels contributing to cell cycle arrest in human fibroblasts (22). 
Overexpression of miR-21 was shown to reduce replicative lifespan of endothelial cells via 
affecting p21 and CDK2 levels, while miR-21 inhibition extended replicative lifespan of 
endothelial cells (23). It may be anticipated that miR-21 contributes to T-cell survival and 
senescence via suppression of LATS1 levels via similar mechanisms. MiR-21 was shown to 
target other genes involved in apoptosis, such as PDCD4 and PTEN (24,25). Consistent 
with these findings, we identified PDCD4 as a highly enriched miR-21 target and showed 
increased expression following miR-21 inhibition. PTEN is not expressed in Jurkat cells and 
is therefore not identified as a target by us (26). We provided evidence for miR-21 
involvement in preventing T-cell apoptosis and identified novel target genes, including the 
pro-apoptotic LATST1, via which miR-21 may exert this function. 
 
Conclusion 
Data presented in this thesis include miRNA changes during T-cell activation and ageing in 
distinct in vitro and ex vivo isolated T-cell subsets. Our data support an age-dependent 
increase of miR-21 in highly differentiated T cells and its anti-apoptotic role. Moreover, we 
show replicative senescence induced changes in expression levels of miRNAs, such as 
miR-9 and miR-34a. These miRNAs may potentially target genes involved in senescence 
pathways. In addition, we provide preliminary results on the role of miR-23a~24-2 in IL-15 
mediated downregulation of CD28. Other miRNAs, such as miR-9 and miR-31 may also be 
part of the CD28 regulatory pathways.   
 
Future Perspectives 
Regulation of CD28 is critical in T-cell activation and, as such, in the immune response (27). 
While a single miRNA can target many genes, multiple miRNAs may be needed to 
effectively regulate a single gene (28). To date, regulation of CD28 by miRNAs is poorly 
understood. In this thesis we provide preliminary evidence for potential regulation of CD28 
expression by miR-24, miR-27a, miR-23a, miR-9 and miR-31 in Jurkat cells. All five miRNAs 
show differential expression in CD28+ vs CD28- T cells (Figure 3A). However, 
overexpression or inhibition of these miRNAs in Jurkat cells did not reveal significant effects 
on CD28 expression. We show that miR-23a~24-2 cluster members are induced by IL-15 
stimulation, whereas expression of miR-9 and miR-31 were shown to be upregulated via 
TCR activation potentially affecting expression of CD28 (Figure 3B). 















Figure 3. miRNA expression in primary CD28+ and CD28- T cells and regulation of CD28 by 
miRNAs. A, Expression of miR-24, miR-31, miR-27a, miR-9 and miR-23a in CD28+ and CD28- T cells. 
T-cell subsets were obtained from n=6 healthy young and n=4 healthy old. Expression of miRNAs to the 
expression levels of RNU48. B, Schematic overview of CD28 regulation by IL-15 and TCR signaling via 
induction of miR-23a~24-2 and miR-31 in T cells.  
 
It will be of interest to expand studies on miR-31, miR-24, miR-27a, miR-23a and miR-9 to 
primary human CD28 T cells. Modulation of one or combination of these miRNAs, might 
reveal possible effects on CD28 expression. Another approach to investigate effect of 
miRNAs on CD28 expression is to knockdown dicer, DGCR8 or Drosha in primary T cells. 
Hence, reconstitution of such cells with individual miRNAs may lead to identification of 
miRNAs that lead to functional repression of CD28. 
In this thesis we showed that miR-21 expression is induced by T-cell stimulation and 
increased in TEMRA cells, which accumulate during ageing (1,29). Therefore, it would be of 
interest to study which genes and pathways are affected by miR-21 in these cells. As an 
alternative to the Ago2-RIP-CHIP, several other methods can be applied that allow a more 
direct linking of individual miRNAs to target genes. High-throughput sequencing technique of 
RNA isolated by crosslinking immunoprecipitation (HITS-CLIP) (30) can potentially identify 
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providing an extensive insight in miRNA targeting. However, current protocols still require 
high numbers of starting cells to yield enough RNA of the IP-fractions. Nevertheless, it can 
be anticipated that technological advances will allow downscaling of these procedures 
allowing analysis of primary T-cell subsets.  
We showed elevated expression of several miRNAs in T cells following TCR stimulation e.g. 
increased expression of miR-155, miR-17, miR-18a, miR-19a, miR-19b, miR-20a. These 
miRNAs have repeatedly been observed to play a role in differentiation of effector memory T 
cells and regulation of immune responses (31,32). TEMRA cells are derived from effector 
memory CD8+ T cells that undergo chronic antigenic stimulation (1). MiRNA expression 
profiles in different subsets of ex vivo sorted human CD8+ T cells have been previously 
described (16). However, comprehensive analysis linking miRNA signatures to TEMRA cells 
derived from CD8 and CD4 T cells, the latter consists of minor populations, is still lacking. 
Thus, it would be of interest to study expression levels of these miRNAs in TEMRA cells and 
determine possible differences also in other minor T-cell subsets. In addition, it would be 
interesting to see how these differences in miRNA levels relate to specific phenotypes of the 
cells following antigenic challenge and/or cytokine treatment. This approach can be 
challenging as it may be difficult to isolate sufficient amounts of these low abundant cells. 
Recently, a new technique has been developed which allows for the simultaneous high-
throughput detection of mRNAs and miRNAs at the single cell level by flow cytometry Flow-
FISH (33). This technique allows detection of specific RNA molecules in various leukocyte 
subsets and detection of cytokine-producing antigen-specific T-cell subsets in combination 
with miRNAs in heterogeneous cell populations. Hence, expression of TCR stimulation 
induced miRNAs can be analyzed in defined T-cell subsets using this Flow-FISH method. 
As a next step to determine if ageing related miRNA expression changes in T cells are 
associated with the inflamm-ageing phenotype, these miRNAs should be studied in healthy 
elderly vs frail elderly individuals, characterized with chronic inflammatory  diseases. This 
can be achieved by microarray or more advanced methods such as small RNA sequencing 
or alternatively high-throughput microfluidic qRT-PCR technique which allows for miRNA 
and mRNA profiling analysis of a single cell (34). Dissection of the physiological function of 
miRNAs in aged T cells is essential for a better understanding of the molecular pathways 
affected in age-related diseases. 
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T cel veroudering wordt gekarakteriseerd door veranderingen in het aantal en de 
functionaliteit van specifieke subpopulaties. De moleculaire mechanismen die ten grondslag 
liggen aan deze veranderingen zijn slechts ten dele opgehelderd. Een van de mogelijke 
factoren die hieraan kunnen bijdragen door het reguleren van de eiwit expressie zijn de 
microRNAs. In dit proefschrift hebben we microRNA expressie veranderingen door T cel 
activatie en ten gevolge van T cel veroudering bestudeerd. Daarnaast hebben we de rol van 
een aantal geselecteerde microRNAs bestudeerd.  
In hoofdstuk geven we 1 geven we een  algemene inleiding over T cellen en microRNAs. In 
hoofdstuk 2 geven we een overzicht van de huidige kennis op het gebied van T cel 
ontwikkeling, T cel maturatie, T cel veroudering en T cel activatie. We gaan met name in op 
de tot nu toe bekende microRNA veranderingen in specifieke T cel subpopulaties zoals, 
naïve en memory CD4+ T-helper en CD8+ cytotoxische T cellen en hun rol bij de regulatie 
van deze processen. Het is duidelijk dat microRNAs direct betrokken zijn bij een groot aantal 
van deze processen. Echter, onze kennis op het gebied van T cel activatie geïnduceerde 
microRNA expressie en T cel veroudering geassocieerde veranderingen is nog beperkt. 
Voor een aantal individuele microRNAs is reeds aangetoond dat ze betrokken zijn bij 
processen die de T cel functionaliteit bepalen, zoals de T cel receptor signalering, de cel 
cyclus en de DNA schade herstel respons.  
In hoofdstuk 3 hebben we T cel activatie geïnduceerde microRNA expressie veranderingen 
bestudeerd in CD4+ en CD8+ T cellen op verschillende tijdstippen. We vonden dynamische 
verschillen tussen CD4+ en CD8+ T cellen. Expressie niveau van een aantal microRNAs 
(miR-21, miR-155 en miR-146a) werd sterk opgereguleerd onder invloed van activatie, 
terwijl expressie van andere microRNAs (miR-31, miR-223 en miR-451) juist werd verlaagd. 
Daarnaast vonden we ook duidelijke verschillen tussen CD4+ en CD8+ T cellen, waarbij de 
activatie geïnduceerde veranderingen, toename van miR-18a en miR-21 en verlaging van 
miR-223 en miR-451, over het algemeen sterker en op een vroeger tijdstip zichtbaar waren 
in de CD4+ T cellen. Onze resultaten tonen aan dat er T cel subpopulatie specifieke 
activatie geïnduceerde microRNA veranderingen zijn. 
In hoofdstuk 4 hebben we miRNA expressie profielen bepaald in T cel klonen afkomstig van 
T cellen van gezonde jonge en oudere donoren. T cel klonen met een hoog aantal populatie 
verdubbelingen worden gekarakteriseerd door verlies van CD28 en verminderde IL2 
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klonen worden om die redden vaak gebruikt als model voor het bestuderen van T cel 
verouderingsprocessen. Van elke T cel kloon hebben we RNA geïsoleerd na een laag 
aantal populatie verdubbelingen en een RNA geïsoleerd na een hoog aantal populatie 
verdubbelingen. Om het microRNA expressie profiel te bepalen hebben we met behulp van 
“next generation” sequentie technieken het expressie profiel van de microRNAs bepaald in 
de cel klonen na een laag en hoog aantal populatie verdubbelingen. We vonden de meest 
opmerkelijke veranderingen tussen de klonen met een laag en een hoog aantal populatie 
verdubbelingen en niet tussen T cel klonen afkomstig van jonge en oudere donoren. De 
expressie veranderingen konden worden gevalideerd voor miR-9 en miR-34. Potentiele 
target genen van deze twee microRNAs warden geïdentificeerd door te kijken welke genen 
verrijkt waren in het microRNA processor complex (RISC) door middel van AGO2-RIP-Chip 
experimenten in Jurkat T cellen. Van een aantal van deze targets was reeds bekend dat ze 
geassocieerd waren met senescence en cel cyclus regulatie. Daarnaast konden we 
aantonen dat de miR-9 niveaus hoger waren in CD28- T cellen ten opzichte van CD28+ T 
cellen. Inhibitie van miR-9 in T cellen resulteerde in inductie van IL-2, waarschijnlijk door 
miR-9 geïnduceerde remming van negatieve regulatoren van IL-2.  
In hoofdstuk 5 hebben we microRNA genexpressie veranderingen bestudeerd in naïeve 
(CD45RO-) en memory (CD45RO+) T cellen van gezonde jonge en oudere donoren. 
Veroudering geassocieerde veranderingen bleken met name aanwezig te zijn in de 
CD45RO- T cellen en niet in de CD45RO+ T-cellen. We konden de veroudering 
geassocieerde veranderingen valideren miR-21, miR-223 en miR-15. Vervolgens hebben 
we aangetoond dat de verhoogde miR-21 en miR-223 niveaus ten dele werden veroorzaakt 
door een toename van het aantal TEMRA cellen. Voor miR-21 konden we ook aantonen dat 
toename van het aantal “post thymic” CD31- T cellen bij droeg aan de verhoogde miR-21 
niveaus. De toename in “post thymic”  CD31- T cellen wordt toegeschreven aan post-
thymus T cel stimulatie en de daardoor geïnduceerde toename in circulerende naïeve T 
cellen. Consistent hiermee konden we inderdaad aantonen dat miR-21 wordt geïnduceerd 
door T cel stimulatie. Voor miR-223 zagen we juist verlaging van de expressie na T cel 
stimulatie. Tot slot konden we aantonen dat miR-21 ook verhoogd tot expressie kwam in T 
cel klonen met een hoog aantal populatie verdubbelingen ten opzichte van T cel klonen met 
een lag aantal verdubbelingen. Samenvattend konden we aantonen dat miR-21 expressie 
geassocieerd is met veroudering, toename van TEMRA en CD31- T cellen en met activatie. 
Voor miR-223 konden we aantonen dat de expressie was geassocieerd met veroudering en 
met toename van het aantal TEMRA cellen. 
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In hoofdstuk 6 hebben we de rol van het miR-23a~24-2 cluster onderzocht bij het IL-15-
geinduceerde verlies van CD28 expressie in T cellen. We zagen een significante inductie 
van de drie microRNAs van het miR-23a~24-2 cluster door behandeling van naïeve T cellen 
met IL-15. Vervolgens konden we aan de hand van luciferase reporter experimenten 
aantonen dat deze microRNAs via binding aan de 3’-UTR van het CD28 transcript de 
expressie van CD28 konden reguleren. We konden echter geen effect aantonen op de 
CD28 eiwit expressie in Jurkat cellen door overexpression van deze microRNAs. Mogelijk 
komt dit door de zeer hoge CD28 expressie waarden in combinatie met de aanwezigheid 
van andere miR-21 target genen die zorgen voor competitie met de hoeveelheid 
beschikbare miR-21.  
In hoofdstuk 7 hebben we laten zien dat blokkeren van miR-21 in Jurkat cellen resulteerde 
in celdood, overeenkomstig met het effect op primaire T cellen. Vervolgens hebben we aan 
de hand van AGO2-RIP-Chip experimenten in wild type Jurkat cellen en Jurkat cellen met 
miR-21 overexpression, T cel specifieke miR-21 target genen geïdentificeerd. Een van de 
sterkst verrijkte target genen was “large tumor suppressor kinase 1 (LATS1)”, een pro-
apoptotisch eiwit. Luciferase reporter experimenten bevestigde binding van miR-21 aan de 
3’-UTR van dit gen. Experimenten om het effect op eiwit niveau te bevestigen en aan te 
tonen dat remmen van LATS1 het miR-21 geïnduceerde fenotype kon voorkomen moeten 
nog worden uitgevoerd.  
Samenvattend hebben we in dit proefschrift aangetoond date r duidelijk T cel activatie en 
veroudering geassocieerde microRNA expressie veranderingen zijn. Daarnaast tonen we 
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